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Abstract 
  
This thesis detail attempts to develop a procedure, based on the Maitland-Japp reaction, 
for the formation of functionalised tetrahydropyran (THP) rings. Previous work in the 
Clarke group has focused on the development of the Maitland-Japp reaction, but it 
produced mixtures of diastereomeric THPs. 
The work described in this thesis details the stereocontrolled synthesis of functionalised 
2,6-cis- and 2,6-trans-THP rings from dihydropyran (DHP) rings, as well as the synthesis 
of 3,3,6-trisubstituted THP rings. The formation of 2,6-cis THP rings was achieved by 
the addition of hydride nucleophiles to C2-substituted DHPs, and trapping with carbon 
electrophiles. Treatment of 2H-DHPs with carbon nucleophiles led to the formation of 2, 
6-trans THP rings. Reduction of 2H-DHPs with L-Selectride® produce the 3,6-
disubstituted THP rings, while trapping of the intermediate enolate with carbon 
electrophiles give formation of 3,3,6-trisubstituted THP rings. 
The development of a successful method for the synthesis of functionalised THP rings 
led to a synthesis of the A-ring of Lasonolide A and Diospongin B. 
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1.0      Introduction 
1.1      Natural product synthesis  
Tetrahydropyran (THP) rings are common and important building blocks in natural 
products as they are found in many biologically active compounds.1 There are highly 
functionalized tetrahydropyran rings in molecules such as lasonolide A 1 which posseses 
a quaternary stereocentre and displays anti-cancer activity with 50% inhibitory 
concentration (IC50) values against the A-549 human lung carcinoma and P388 murine 
leukemia cell lines of 40 and 2 ng/ mL, respectively. It also inhibits cell adhesion in the 
EL- 4.IL-2 cell line with an IC50 of 19 ng/mL.
2 Multi-substituted 2,6-cis and 2,6-trans 
THP core units can be found in phorboxazoles A and B 2, which show potent activity 
against C. albicans and in the National Cancer Institute's panel of 60 tumor cell line with 
exceptional inhibition of cell growth (GI50's < 7.9 x 10
-10 M).3 (-)-Mandelalide A 3 
posseses potent biological activity with nanomolar cytotoxicities against both human 
NCI-H460 lung cancer cells respectively with IC50 12 nM and mouse neuro-2A 
neuroblastoma cells respectively with IC50, 29 nM,
4 also features 2,6-cis THPs ring in the 
structure. The 2,6-trans THPs ring can be observed in diospongin B 4, which showed 
anti-osteoporotic properties.5 
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Our interest in the construction of tetrahydropyrans in the synthesis of natural products 
led us to investigate a new method to construct funtionalized THPs such as 2,6-cis, 2,6-
trans, 3,6-disubstituted and 3,3,6-trisubstituted THPs ring. Several approaches have been 
reported.7 
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1.2      Cyclisation onto oxocarbenium ions 
The Prins cyclisation is one of most utilised methods to construct the THP ring in the 
synthesis of natural products. The Prins reaction, first reported by Hendrik Jacobus Prins 
in 1919,6 proceeds via acid-catalyzed electrophilic addition of olefins to aldehydes to 
generates carbenium ions (A, Scheme 1). This intermediate (A) can be intercepted by a 
nucleophile such as a second equivalent of an aldehyde to form 1,3-dioxanes 6. Prins 
cyclization can occur when a homoallylic alcohol reacts with an aldehyde in the presence 
of a Lewis acid to form oxocarbenium intermediates (B, Scheme 1) which then cyclizes 
to give functionalized tetrahydropyrans 8.7 
 
 
Scheme 1: Prins reaction and cyclisation. 
 
The Aggarwal group used a three-component allylboration-Prins reaction sequence to 
synthesise the THP core of (-)-clavosolide A with high stereoselectivity. They applied 
allylic boronic ester 9a with aldehyde 10a followed with aldehyde 11, but unfortunately 
it gave a low yield of THP 13 due to cleavage of the silyl protecting group (Scheme 2). 
With a simple aldehyde like acrolein 12 it gave an excellent yield of THP 14 with good 
diastereoselectivity (71%, 96 : 4 dr).8 
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Scheme 2 Reagent & Conditions: i) nBuLi (1.1 eq), THF, ‒78 °C, 15 min; ii) TFAA (1.2 
eq), ‒78 °C, 30 min; iii) 10a (1.5 eq), ‒78 °C (or ‒100 °C), 2 hr then RT, 16 hr; iv) CH2Cl2, 
11 (2.5 eq) or acrolein 12 (4 eq), TFA:CH2Cl2 (1:3), RT, 2 hr;  K2CO3 (1.5 eq), MeOH, 
RT, 30 min, 13 (39%) and 14 (71%) . OCb = N, N-diisopropyl carbamate. 
 
A novel cascade strategy has been developed by Subba Reddy group for synthesis of 
spirochroman derivatives using the condensation of 2-(5-hydroxy-3-
methylenepentyl)phenol 15 with aromatic or aliphatic aldehyde. The reaction was 
successful when attempted with BF3•OEt2 at 0 - 25°C (Scheme 3).9 
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Scheme 3 Reagent & Conditions: i) BF3•OEt2, CH2Cl2, 0 – 25 °C, 1 hr, 70-95 %. 
 
The Prins methodology was also applied successfully in the synthesis of cocosolide 18 in 
8 steps. Gunasekera’s group used the TMSOTf-promoted Sakurai annulation of 
allylsilane 19 with aldehyde 20 to construct the 2,6-cis THP 21 containing an exo-
methylene in the 4-position. The THP 21 was formed rapidly at ‒78 oC (Scheme 4).10 
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Scheme 4 Reagent & Conditions: i) TMSOTf, Et2O, 4 Å MS, ‒78 oC, 75%. 
 
Another example has employed a TMSOTf catalysed silyl Prins reaction by the 
Rychnovsky group in the total synthesis of cyanolide A 22, where they formed the exo-
olefin dimer 24 in 76% yield (Scheme 5).11 With a further 3 steps they constructed  
cyanolide A 22. 
7 
 
 
Scheme 5 Reagent & Conditions: i) TMSOTf, CH2Cl2, 76%, ii) OsO4, NMO then NaIO4, 
82%, iii) NaBH4, 96 %, iv) MeOTf, MS 4Å, Et2O, 25 °C, 48 hr, 18%. 
 
 
The Furman group also reported the use of a Prins reaction in the total synthesis of (-)-
centrolobine 26, the cyclisation of 27 with 4-tosyl-oxybenzaldehyde 28 was attempted 
with TMSOTf, to give dihydropyran 29 in 87% yield. Reduction of the olefin led to the 
formation of THP 30 in 78% yield, which was then elaborated to form (-)-centrolobine 
26 in 73% over 3 steps (Scheme 6).12 
 
Scheme 6 Reagent & Conditions: i) TMSOTf, Et2O, ‒78 oC, 87% ii) Pd/C, H2, EtOAc, 
78%. 
Dobb’s et al. reported the formation of DHP 33 using an InCl3 Lewis acid mediated 
addition of homoallylic alcohols 32 to aldehydes 31. The DHP 33 was produced as a 
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single diastereomer and in an excellent 95% yield (Scheme 7). Hydrogenation both 
reduces the olefin and removes the benzyl group and finally the alcohol was oxidised to 
give the Civet secretion natural product 34 in 54 % yield.13 
 
Scheme 7 Reagent & Conditions: i) InCl3, CH2Cl2, 16 hr, RT, 95%. ii) H2, Pd/C (10%), 
EtOH, iii) CrO3,/H2SO4,H2O, 54%. 
 
The Petasis-Ferrier rearrangement is another method for cyclisation onto oxocarbenium 
ions where an acid is used as a promoter for rearrangement. Cleavage of the adjacent C-
O bond 35, results in the formation of the oxocarbenium enolate 36, which can be cyclized 
directly to form 2,6-cis-THP 37 (Scheme 8).14 
 
Scheme 8 The Petasis-Ferrier rearrangement. 
 
The Smith III’s group has applied this method to construct the 2,6-cis THP ring in total 
synthesis of (-)-Enigmazole A.15 The carbon skeleton of the THP ring was synthesined 
using  ‘the three-stage Petasis-Ferrier union/rearrangement’ where the large fragment of 
38 and 39 was combined and produced the THP ring 42 with 84% yield (Scheme 9). 
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Scheme 9 Reagent & Conditions: i) 38, HMDS, THF, 39, TMSOTf, H2O, CH2Cl2, ‒78 
oC, 95%, ii) Cp2TiMe2, PhMe, THF, μ Wave 100 oC, 3 hr, 87%, iii) Me2AlCl, CH2Cl2, ‒
78 oC, 30 sec, then Ph3P=CH2, 84%. 
 
The Petasis-Ferrier reaction has been utilised in many syntheses including in seven 
natural product total syntheses from the group of Amos Smith III: (+)-phorboxazole A,16 
(+)-Zampanolide,17 (+)-Dactylolide,16 (+)-Spongistatin 1,18 (−)-Kendomycin,19 (−)-
Clavosolide A,20 and (−)-Okilactomycin.21 
 
The formal total synthesis of brevisamide 48 has been achieved via a tandem 
isomerization/C-O and C-C bond formation reaction. The Mohapatra group performed 
the cyclization by subjecting 43 and allyltrimethylsilane 44 to iodine which allowed 
10 
 
stereoselective allylation and produced the trans-DHP 45 as a single product in 96% yield. 
Fragment 46 was epimerised at C-12 through a retro-oxa-Michael/oxa-Michael process 
with potassium tert-butoxide in THF to yield the cis-2,6-THP 47, the important skeleton 
in brevisamide 48 (Scheme 10).22 
 
Scheme 10 Reagent & Conditions: i) THF, I2, 45 min, 96%, ii) CH2N2, Et2O, 0 °C, 15 
min, 91%, iii) potassium tert-butoxide, THF, 0 °C, 92%. 
 
1.3       Reduction of cyclic hemi-ketals 
There are other ways to construct the THP rings in natural products, including the 
reduction of cyclic hemi-ketals. This reaction proceeds via a cyclic oxocarbenium ion 
intermediate which is trapped by the incoming nucleophile. The 2,6-cis or 2,6-trans THP 
ring can be formed depending on the nucleophile, where the nucleophile addition to the 
cyclic oxocarbenium ion usually occurred from a pseudoaxial orientation. The Mohapatra 
group applied this method to form the THP ring of herboxidiene 52, where the treatment 
of 49 with DIBAL-H at ‒78 °C gave the lactol 50 in 83% yield. This was followed by 
11 
 
treatment with allyltrimethylsilane and catalytic AuCl3 to give 51 in 87% yield (Scheme 
11). After 9 steps, the total synthesis of herboxidiene 52 was completed.23 
  
Scheme 11 Reagent & Conditions: i) DIBAL-H, CH2Cl2, ‒78 °C, 2 hr, 83%, ii) AuCl3, 
RT, 3 hr, 87%. 
 
 
The Cossy group also applied the same method to synthesise the trans-THP ring of the 
macrocyclic core of Leucascandrolide A 57, where the reduction of lactone 53 by 
DIBAL-H followed by acylation gave 54 in 98% yield. Compound 54 was coupled with 
fragment 55 by using a Mukaiyama-type reaction, where an oxocarbenium intermediate 
was generated by treatment of 54 with ZnCl2, then quenched with enol ether 55 to produce 
tetrahydropyran 56 with 89% yield (trans: cis = 13: 1) (Scheme 12).24 
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Scheme 12 Reagent & Conditions: i) DIBAL-H, CH2Cl2, ‒78 °C, then Ac2O, Py, DMAP, 
98%, ii) ZnCl2, CH2Cl2, ‒78 °C to RT, 89%. 
 
Smith III’s group applied a similar method to synthesize the cis-THP ring of (+)-
Spongistatin 1. A Grignard reagent was added to lactone 58 followed by reduction of 
lactol with Et3SiH and BF3•Et2O to produce the desired cis-THP ring 59 in 89% yield 
(Scheme 13).25 
 
Scheme 13 Reagent & Conditions: i) Et3SiH, BF3•Et2O, 89%. 
 
The Zakarian group used an Achmatowicz rearrangement as a key step to produce a cyclic 
hemi-ketal in their synthesis of Brevisamide 48. Furan 60 was treated with NBS and 
oxidative ring expansion was performed and followed by reaction with BF3•Et2O and 
Et3SiH to produce intermediate 61 in 54% yield. A diastereoselective conjugate addition 
of Me2CuLi gave lactone 62 and then the ketone was reduced by NaBH4 to give cis-THP 
13 
 
ring of (+)-Brevisamide 63 as a single diastereomer in 85% yield (Scheme 14). A further 
3 steps gave (+)-Brevisamide 48.26 
 
Scheme 14 Reagent & Conditions: i) NBS, NaHCO3, NaOAc, THF: H2O (10:1), 0 °C 
then Et3SiH, BF3•Et2O, CH2Cl2, 0 °C, 54%, ii) Me2CuLi, Et2O, ‒60 °C, iii) NaBH4, THF: 
H2O (10:1), 85%. 
 
1.4      Michael reactions in THP synthesis 
Michael reactions are widely applied reations in organic synthesis. There are hetero-
Michael reactions such as the aza-Michael, sulfa-Michael, phospha-Michael and oxa-
Michael (oxo- or oxy-Michael) reactions.27 Oxa-Michael addition, the addition of an 
alcohol to a conjugate acceptor, was published by Loydl as early as 1878.28 Moreover, 
oxa-Michael reactions can be an eﬃcient method to access oxygen-containing 
heterocycles such as tetrahydropyrans, chromenes or xanthones.29 Fuwa has used it in the 
synthesis of 2,6-cis-tetrahydropyran cis-65 and 2,6-trans-tetrahydropyran trans-65 of 
Aspergillides B 66 and A 67. The intermolecular oxa-conjugate cyclization of 64 formed 
trans-65 as the major diastereomer (17: 1) in 96% yield when exposed to KOt-Bu 
(Scheme 15); however, when 64 was treated with DBU in toluene at 135 °C, it gave the 
thermodynamically favoured cis-65 with diastereomer (11: 1) in 81% yield. Either trans-
65 or cis-65 could be synthesized from 64 by switching the reaction conditions.30 
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Scheme 15 Reagent & Conditions: i) KOt-Bu, THF, ‒78 °C, 0.5 hr, 96%, ii) DBU, 
toluene, 135 °C, 36 hr, 81%. 
 
The Trost group also synthesized the THP ring of aspergillides B 66 but they used 
ruthenium-catalyzed trans-hydrosilylation. The hydrosilylation/protodesilylation was 
used to reduce the alkyne 68 chemoselectively and form an E-double bond, followed by 
deprotection/oxy-Michael reaction to form 2,6-trans THP 69 in 38% yield. THP 69 was 
then be transformed into aspergillides B 66 in 3 additional steps (Scheme 16).31 
 
Scheme 16 Reagent & Conditions: i) Cp*Ru(CH3CN)3PF6, (EtO)3SiH, DCE 0 °C - RT, 
10 hr, 38%. 
 
Lee’s group used a Michael reaction to construct trans-THP 73 and cis-THP 76 ring of 
leucascandrolide A macrolactone 57. The trans-THP ring 71 was formed as the major 
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diastereomer (10: 1) from aldehyde 70 by using piperidine as the catalyst at ‒40 °C, but 
when they used a higher temperature of 25 °C the undesired cis-THP was formed. This 
was followed by coupling 73 and 74 as the key step for allylic oxidation/oxy-Michael 
reaction (Scheme 17). The synthesis of leucascandrolide A macrolactone 57 was 
completed with 5 additional steps and in 96% yield over 5 steps from 76.32 The Evans 
group also applied a similar strategy to synthesise the THP ring of leucascandrolide A 
macrolactone 57.33 
 
Scheme 17 Reagent & Conditions: i) piperidine, ‒40 °C, 24 hr, CH2Cl2, 96%, ii) t-BuLi, 
HMPA/THF, ‒78 °C, 10 min then, 74, ‒78 °C, 1 hr, 92%, iii) MnO2, CH2Cl2, 25 °C, 12 
hr, 86%. 
 
The cis-THP ring of cyanolide A 22 was synthesized by Hong using a Michael reaction. 
The one-pot allylic oxidation/oxa-Michael/oxidation of aldehyde 78 formed 2,6 –cis THP 
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methyl ester 79 as a single diastereomer with 88% yield with no trace of 2,6 –trans THP 
methyl ester (Scheme 18). This is probably due to a highly rigid chair-like transition state 
induced by “double gem-disubstituent effect” of C4-gem-dimethyl and C5-1,3-dithiane 
groups.34 The Reddy group also applied the same method oxa-Michael cyclization 
reaction to form THP ring of cyanolide A 22.35 
 
Scheme 18 Reagent & Conditions: i) MnO2, CH2Cl2, 25 °C, 4 hr then dimethyl triazolium 
iodide, DBU, MnO2, MeOH, MS 4 Å, 25 °C, 12 hr, 88%. 
 
The C1-C11 fragment of madeirolide A 84 was synthesised by the Paterson group using 
Fuwa’s acidic cyclisation conditions.36 The condensation of aldehyde 80 with thioester 
phosphonate 81 under Masamune-Roush conditions38 provided 82 in 95% yield. Removal 
of the acetonide and cyclisation occurred when 82 was treated with TsOH•H2O. 
Deprotection of the ether PMB with DDQ gave the A ring diol 83. With 2 further steps 
the C1-C11 madeirolide A fragment 84 was synthesized (Scheme 19).38 
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Scheme 19 Reagent & Conditions: i) LiCl, NEt3, THF, ‒15 °C, 40 hr, 95%, ii) TsOH, 
CH2Cl2, 4.5 hr, (dr > 20:1), iii) DDQ, CH2Cl2, ph7 Buff, 0 °C, 1 hr, 61%. 
 
The oxy-Michael reaction promoted by pyrrolidine catalyst 86 can create the key THP 
ring of (+)-dactylolide 87 as constructed by the Lee group (Scheme 20). This method 
gave 87 in an excellent yield of 98% as a 20: 1 diastereomeric mixture.39 
 
Scheme 20 Reagent & Conditions: i) BzOH (20 mol%), PhMe, 0 °C, 10 hr, 98%. 
 
1.5       Hetero-Diels-Alder reaction 
The Hetero-Diels-Alder (HDA) reaction is another method to construct THP rings in 
syntheses of natural products. The HDA reaction has high regioselectivity and endo-
18 
 
stereoselectivity depending on conditions. Ghosh used the chiral tridentate Schiff base 
chromium (III) complex 90, developed by Jacobsen40 in an asymmetric HDA reaction in 
the key step in synthesis of B ring 92 of Lasanolide A. The reaction between diene 88 and 
89, uses TBAF/AcOH to remove the TES group and to give ketone 91 in 71% yield. 
Reduction of ketone with Dibal-H gave the THP of B ring in 96% yield (axial alcohol 92: 
equatorial alcohol 93 = 1: 2) (Scheme 21).41 
  
Scheme 21 Reagent & Conditions: i) 90, ii) TBAF, AcOH, 71%, iii) Dibal-H, CH2Cl2, 
96%. 
 
The Raghavan group synthesised the THP ring of the macrolactone core of (+)-
Neopeltolide 94, by using the same method, a HDA reaction. The THP ring was formed 
between aldehyde 95 and siloxy diene 96 promoted by Jacobsen’s catalyst ((S,S)-Cr(III)-
salen-BF4
+) 97. A further 8 steps to give 94 in 60% yield (Scheme 22).42  
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Scheme 22 Reagent & Conditions: i) TBME, ‒30 °C, 24 hr, then TFA, 2 hr, 75%. 
 
An enantioselective HDA approach to the syn-1,3-dimethyl synthons of Azaspiracid-1 
104 was used by the Evans group. A HDA reaction took place between 99 and 100 when 
promoted with copper complex 101 (2 mol %). These conditions gave a mixture of cis 
and trans diastereomers (94: 6) of dihydropyran 102 and hydrogenation of the 
tetrasubstituted olefin gave THP 103 in 95% yield (Scheme 23).43 
Scheme 23 Reagent & Conditions: i) 3Å MS, Et2O, ‒40 °C, dr 94 : 6, 97% ee, 84% ii) 
H2 (1 atm), Pd/C (5 mol%), EtOAc, 95%. 
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The synthesis of the THP core of pederin 110 by the Rawal group also employed a HDA 
reaction. Aldehyde 105 and diene 106 underwent HDA reaction in presence of Al(2,6-
diphenylphenol)2Me and TMSOTf to produce the pyranone 107 in 65% yield. The 
pyranone 107 was then treated with silyl ketene acetal 108 to produce ester 109 in 
excellent diostereomeric excess (dr = 20: 1). Then the reduction on the ketone with L-
Selectride® gave the THP ring 110 in 92% yield (dr = 12: 1) (Scheme 24).44 
 
Scheme 24 Reagent & Conditions: i) Al(2, 6-diphenylphenol)2Me, TMSOTf, CH2Cl2, 
65%, ii)Sc(OTf)3 (10 mol%), CH2Cl2, ‒78 °C to RT, 10% HF/MeCN, iii) L-Selectride®, 
THF, ‒78 °C, 92%. 
 
1.6       Metal-mediated cyclisations 
Metal-mediated cyclisations can be a method of constructing the THP ring in natural 
products. For example the Clark group applied this method to construct the THP ring of 
neoliacinic acid 114. They used a copper catalyst, Cu(hfacac)2 on diazo ketone 111 to 
form 112 which proceeded via a metal carbenoid oxonium ylide rearrangement. Over 2 
steps 113 was formed, which was followed with methylenation of the ketone carbonyl to 
give the THP ring 114 in 81% yield (Scheme 25).45 
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Scheme 25 Reagent & Conditions: i) Cu(hfacac)2 2 mol%, CH2Cl2, reflux, 69%, ii) EtSH, 
AIBN, C6H6, reflux iii) m-CPBA, CH2Cl2, reflux, 80%, iv) Cp2TiMe2, THF, reflux, 81%. 
 
The Roulland group also used a metal-mediated cyclisation to synthesize the A ring of 
(-)-exiguolide 118. They used three different variations of a ruthenium complex-catalysed 
reaction. The applied method proceeds via an ene-yne coupling/oxy-Michael addition 
with ruthenium-catalyst 117 to form THP A ring 118 in 78% yield and with a 
diasteromeric ratio of greater than 9 : 1 (Scheme 26).46 
 
Scheme 26 Reagent & Conditions: i) acetone, AcOH (3 mol%), RT, 2 hr, 78%. 
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1.7       Other methods 
1.7.1    Ring-closing metathesis 
Ring-closing metathesis has been used in the construction of THP rings from DHP rings 
in natural products. Fuwa has used the ring-closing metathesis method to construct the 
THP ring of (+)-neopeltolide 94, where the ring closing metathesis was employed on 
diene 119 with 10 mol% of Grubbs II catalyst in toluene at 70 °C to form DHP ring 120 
followed by stereoselective hydrogenation to give the cis-THP ring 121 in 81% yield as 
single stereoisomer (Scheme 27).47 Several additional steps were needed to form (+)-
neopeltolide. 
 
Scheme 27 Reagent & Conditions: i) Grubbs II catalyst, toluene, 70 °C, ii) H2 (1~8 atm) 
10% Pd/C, EtOAc/ MeOH (1: 1), 81%. 
 
1.7.2    Cyclisation onto epoxides 
Another method that can be used to form THP rings in natural products is cyclisation onto 
epoxides, but recently this method has become less prominent. Jamison’s group used 
endo-selective epoxide-opening with [Rh(CO)2Cl]2 as catalyst on 122 to construct of THP 
of B ring synthesis of (-)-brevisin 123 with 78% yield (Scheme 28).48 
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Scheme 28 Reagent & Conditions: i) [Rh(CO)2Cl]2 (10 mol %), THF, RT, 78%. 
 
1.7.3     Radical cyclisations 
Radical cyclisations can be useful to construct THP rings in natural products. This method 
was used by the Taylor group to form the cis-THP ring of neopeltolide 125. The formation 
of cis-THP 125 was formed from 124 in 95% yield and with a diastereomeric ratio of 19 : 
1 (Scheme 29).49 
 
Scheme 29 Reagent & Conditions: i) Azobisisobutyronitrile (AIBN), tributyltin hydride 
(n-Bu3SnH), 95%. 
 
1.7.4     Carbocation cyclisations 
A less common method used by the Mulzer group in formation of the THP ring of 
kendomycin 127 is cyclisation onto a carbocation. The reduction of ketone on 126 with 
NaBH4 produced alcohol as mixture diastereomers. The removal of acetonide and loss of 
water to produce a benzylic carbocation, followed with trapping by the hydroxyl via a 
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SN1 cyclisation. As a result, it formed benzofuran 127 as a cis-THP ring of kendomycin 
(Scheme 30).50 
 
Scheme 30 Reagent & Conditions: i) NaBH4, MeOH, RT, then 0.5N HCl ii) TsOH, PhMe, 
60 °C, 71%. 
 
1.8       The modified Maitland-Japp reaction and previous Clarke group 
work. 
As has been discussed, there are different methods to construct the tetrahydropyran ring 
(THP) in the synthesis of natural products, such as cyclisation onto oxocarbenium ions, 
reduction of cyclic hemi-ketals, Michael reactions and hetero-Diels-Alder reactions. Over 
the last few years, the Clarke group has had particular interest in the formation of THP 
rings via the Maitland and Japp reaction. In 1904, Mailand and Japp showed that 3-
butanone 129 and two molecules of benzaldehyde 128 could be condensed in a low 
yielding process to generate the substituted THP ring 130.51 In 1934, Cornubert and 
Robinet investigated the analogous acid promoted condensation of acetonedicarboxylic 
acid 131 with benzaldehyde 128, where the cyclisation proceeded with concomitant 
decarboxylation to give two stereoisomers of the pyranone product in a 250: 1 ratio (132: 
133) (Scheme 31).52 
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Scheme 31 Reagent & Conditions: i) KOH, EtOH, H2O, ii) HCl, 19%. 
 
 Our group is interested in the multi-component natue of the Maitland-Japp reaction, the 
Clarke group proposed improving the Maitland-Japp procedure; we decided to move 
away from ketones as the building block for the THP ring, instead developing a β-
ketoester reaction. Firstly, a regioselective aldol reaction at the γ position of a β-ketoester 
to give 134, followed by a Knoevenagel condensation of a second aldehyde at the α 
position of the β-ketoester to give 135, and then an intramolecular oxy- Michael reaction 
to give the pyran ring 136 (Scheme 32).53  
 
Scheme 32 Updating the Maitland-Japp reaction. 
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The two-pot reaction using the Weiler dianion of commercial available methyl 
acetoacetate 137 would give the δ-hydroxy β-ketoester 138. To form the THP ring, 
Knoevenagel condensation using a Lewis acid as promoter and an intramolecular oxy-
Michael steps was required. 54 Initial studies, using boron trifluoride diethyl etherate as 
the Lewis acid promoter, gave the pyran products as a mixture of the 2,6-cis ketone 139 
and 2,6-trans enol 140 isomers that can be separated by column chromatography in good 
yield (Scheme 33).55 
 
Scheme 33 Reagent & Conditions: i) NaH, THF, 0 °C, nBuLi, ‒78 °C, benzaldehyde, ii) 
BF3•OEt2, CH2Cl2, furaldehyde, 66% (2 steps). 
 
The Clarke group decided to explore more variation of the reactions which would lead to 
a one pot reaction and a Lewis acid mediated aldol reaction by using Chan’s diene56 141 
as the nucleophile was envisaged. The Lewis acid will also mediate a Knoevenagel 
condensation with a second aldehyde and an intramolecular oxy-Michael ring closure to 
give a mixture of keto/enol products (142/ 143) (Scheme 34). 
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Scheme 34 The revised one-pot Maitland-Japp reaction. 
 
In the one-pot reaction, titanium tetrachloride was used as a catalyst in both Mukiayama 
aldol reaction57 and Knoevenagel condensation58, but in order to develop a one-pot pyran 
reaction, the aldol product would need to be in the non-silylated form before addition of 
the second aldehyde. The trifluoroacetic acid (TFA) in THF was added into aldol product 
to deprotect the intermediate silyl ether to promote the Knoevenagel condensation 
followed with oxy-Michael reaction to form mixture of THP ring, the 2,6-cis ketone 142 
and 2,6-trans enol 143 in excellent yield (Scheme 35, Table 1).53  
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Scheme 35 Reagent & Conditions: i) TiCl4 or Yb(OTf)3, RCHO, ‒78 °C then TFA, 
R1CHO, ‒78 °C to RT. 
Entry R R1 Lewis acid Yield (%)a Ratiob 142 : 143 
a Ph Ph TiCl4 98 1 : 3 
b iPr nPr TiCl4 98 1 : 1 
c iPr Ph TiCl4 82 1 : 3 
d Ph Ph Yb(OTf)3 98 2.5 : 1 
e iPr nPr Yb(OTf)3 91 10 : 1 
f iPr Ph Yb(OTf)3 80 2.5 : 1 
aIsolated yield after column chromatography. bDetermined from the 1H NMR (400 
MHz) of the crude reaction mixture. 
Table 1 Lewis acid promoted one-pot Maitland-Japp reaction 
 
Due to favouring formation of 2,6-trans enol 143 with titanium tetrachloride, our group 
decided to investigate the effect of Lewis acid in formation of THP ring. Ytterbium triflate 
was used instead of titanium tetrachloride; interestingly 2,6-cis ketone 142 was formed 
as the major product. As titanium tetrachloride is more soluble in the reaction solvent, we 
propose that titanium tetrachloride could form a chelate with the 2,6-trans enol 143 that 
is more stable than the 2,6-cis ketone 142. This could affect a flattening of the ring and 
reducing any 1,3-diaxial interactions unfavourable interaction of pseudo-axial substituent 
in the 2,6-trans enol 143. The equatorial substituent in the 2,6-cis ketone 142 product 
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would form steric clash between the C2 and C3 substituents (Figure 1). We suggest that 
with absence of Lewis acid, the formation of 2,6-cis ketone 142 would be favoured form 
instead of 2,6-trans enol 143. The low solubility of ytterbium triflate in the reaction 
solvent, so formation of chelate in itself energetically favourable would result in increased 
amount of the 2,6-cis ketone 142. 
 
Figure 1 cis-Ti and trans-Ti chelated systems. 
 
This method was applied to the synthesis of (±)-centrolobine 26. Initially the group started 
with a two-pot reaction for the construction of tetrahydropyran-4-one, where the aldehyde 
147 was prepared and reacted with Chan’s diene 141 to form aldol reaction 144, without 
further purification of 144, the mixture of THP 145 and 146 was formed (diastereomer 1: 
0.6) in 56% yields with boron trifluoride as promoter (Scheme 36). The one-pot reaction 
was applied, where it was known that ytterbium triflate favoured in the formation of the 
2,6 cis-THP 145 over the 2,6 trans-THP 146 with diastereomer (2: 1) ratio with excellent 
yield 92%. (Scheme 37). With success in forming of 145, decarboxylation of the THP 
ring using lithium hydroxide and hydrogen peroxide gave 148, followed with removal of 
the ketone with dithiolane using Raney nickel giving (±)-centrolobine 26 in 50% yield 
(Scheme 38).59 
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Scheme 36 Reagent & Conditions: i) TiCl4, CH2Cl2, ‒78 °C, ii) anisaldehyde, BF3•OEt2, 
CH2Cl2, RT, 24 hr, 56% (2 steps). 
 
 
Scheme 37 Reagent & Conditions: i) Yb(OTf)3, ‒78 °C then TFA, anisaldehyde, ‒78 °C 
to RT, 12 hr, 92%. 
 
 
Scheme 38 Reagent & Conditions: i) H2O2, LiOH, THF, H2O, RT, 5 hr, then 70 °C, 30 
min, then RT, 12 hr, 60%, ii) HSCH2CH2SH, BF3•OEt2, CH2Cl2, RT, 100%, iii) Raney 
nickel, H2, EtOH, 30 °C, 100%. 
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Following successful formation of the THP rings via a Maitland-Japp reaction, the Clarke 
group decided to carry out further studies on an asymmetric aldol reaction of bis-silylenol 
ether 151 with aldehyde 150. However, the undesired syn diastereomer was formed as the 
major product in low yield 152 (13%) (Scheme 39). 
 
Scheme 39 Reagent & Conditions: i) Ti(Oi-Pr)4 (8 mol%), (R)-BINOL (8 mol %), 4 Å 
MS, THF, ‒78 °C to RT, 13%. 
  
The group decided to change strategy by using the Masamune-Abiko auxiliary to form 
anti-aldol products asymmetrically. β-Keto-ester 153 could be made from aldehyde 150 
in 3 steps and in a 75% combined yield. β-Keto-ester 153 was reacted with aldehydes 
under Lewis acid-catalyzed Maitland-Japp cyclisation conditions to form THP rings. 
Unfortunately, under all conditions attempted the reaction produced a complex mixture 
of 2,6-cis/trans diastereomers and keto/enol tautomers complicating seperation. The 
group changed strategy to form dihydropyran 154 by using dimethyl acetal dimethyl 
acetamide. The dihydropyran 154 was reduced and trapped with MeI to form THP 155 in 
75% yield, which has an axial methyl group present as in the C-23 position of 
phoboxazoles A and B (Figure 2). The group believe the selectivity is due to pseudo-axial 
attack of hydride on the double bond of 154 followed by alkylation of the resultant enolate 
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from the pseudo-axial trajectory. After several steps, the synthesis of the C-23 epimer of 
the C-21 – C-32 THP core of the phoboxazoles A and B were formed. (Scheme 40).60  
 
Scheme 40 Reagent & Conditions: i) MeC(OMe)2NMe2, PhMe, RT, 74%, ii) L-
Selectride®, THF, ‒78 °C, then MeI, RT, 75%, iii) TFA, CH2Cl2, iv) PhH, reflux, 93% 
(2 steps), v) NaBH4, MeOH, 0 °C, 60%. 
 
 
Figure 2 chair-like intermediate of 2,6-cis THP of 155 
 
 
Another asymmetric Maitland-Japp reaction was investigated by the Clarke group. Due 
to having to prepare the Chan’s diene, which required two steps to synthesise, diketene 
157 was used instead as it was commercially available. In the diketene Maitland-Japp 
reaction, the mono-γ-titanium enolate of a β-ketoester is formed by nucleophilic ring-
opening of diketene via ligand transfer from the activating Lewis acid (TiCl4 or Ti(iOPr)4). 
The addition of methanol or isopropanol as a nucleophile would produce methyl or 
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isopropyl δ-hydroxy-β-ketoesters. The asymmetric Maitland-Japp reaction was 
developed by using Ti(iOPr)4 as the Lewis acid with addition of a chiral Schiff’s base 
ligand 158 to form δ-hydroxy-β-ketoester in moderate yield. Then the Knoevenagel/oxy-
Michael cyclisation proceeded to give asymmetric THP ring (Scheme 41).61 
 
Scheme 41 Reagent & Conditions: i) Ti(iOPr)4, 158, R
1CHO, R2OH, CH2Cl2, ‒20 °C, ii) 
TiCl4, R
3CHO, ‒78 °C to RT. 
 
Due to the successful development of an asymmetric Mailand-Japp reaction, Clarke 
decided to attempt this method for the synthesis of the C1-C19 bis-pyran unit of the 
phorboxazoles. The synthesis began with an asymmetric Maitland-Japp reaction between 
diketene 157 and aldehyde 3-benzyloxypropanal to give δ-hydroxy-β-ketoester followed 
with cyclisation to form a mixture of THP ring 160 and 161 with oxazole aldehyde 159 
as the second aldehyde. The mixture of 160 and 161 were separable and 161 was re-
equilibrated by Yb(OTf)3 to form 160: 161 with diastereomeric ratio of 2:1, increasing 
the yield of 160 to 70% yield. The decarboxylation of THP 160 under microwave 
conditions was followed with reduction of ketone with NaBH4 and protection of the 
hydroxyl group with TIPS to give 162. Benzyl ether deprotection using H2 and 10% Pd/C 
then Dess-Martin oxidation was performed on primary alcohol to give aldehyde 163. A 
second Maitland-Japp reaction was carried out by using the Evans Cu(pybox) catalysed 
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reaction of Chan’s diene and benzyloxy acetaldehyde to form δ-hydroxy-β-ketoester 164, 
then Maitland-Japp cyclisation was applied with aldehyde 163 followed by 
decarboxylated to give cis-THP 165 in 68% yield.  An additional 6 steps from cis-THP 
165 furnished the C1-C19 bis-pyran unit 166 of the phorboxazoles with overall yield 
10.4% (Scheme 42).62 
 
Scheme 42 Reagent & Conditions: i) Ti(iOPr)4, 157, 3-benzyloxypropanal, MeOH, 
CH2Cl2, ‒78 °C, ii) TiCl4, 159, ‒78 °C to RT iii) 300 W, μW (160 °C), 10 min,DMF/H2O, 
91%, iv) NaBH4, MeOH, 0 °C, 100%, v) TIPSCl, imidazole, DMF, 50 °C, 86%, vi) 10% 
Pd/C, H2, MeOH, 100%, vii) DMP, CH2Cl2, 100%, viii) TiCl4, 164, CH2Cl2, ‒20 °C to 
RT, ix) 300 W, uW (160 °C), DMF/H2O, 68%. 
 
 
The asymmetric diketene Maitland-Japp reaction in the synthesis of C1-C19 bis-pyran 
unit of the phorboxazoles, took a long reaction time (> 5 days) and the moderate 
enatioselectivities need further work.61 Clarke decided to refocus back to the use of 
Chan’s diene as a nucleophile to form the THP ring. The asymmetric addition of Chan’s 
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diene was achieved by use of Ti(iOPr)4/Binol/LiCl conditions to give δ-hydroxy-β-
ketoester, the Knoevenagel/Michael steps to form mixture of THP 142 and 143 was 
promoted by TiCl4 as a Lewis acid (Scheme 43). This method was applied to improve the 
previous route synthesis of (±)-centroboline 26, in 55% yield and 91 % ee, and synthesis 
C1-C19 bis-pyran unit 166 of the phorboxazoles, 69% yield and 84 % ee.63 The utility of 
this reaction provides advantages complimenting the group’s previous work.  
 
Scheme 43 Reagent & Conditions: i) Ti(iOPr)4, Binol, LiCl, RCHO, THF, RT, ii) TiCl4, 
R1CHO, CH2Cl2 
 
Several approaches towards developing efficient routes by Maitland-Japp reaction for the 
synthesis of THP ring in natural products were produced in the Clarke group. In the 
synthesis of phorboxazole 2, the group pursued a strategy of breaking phorboxazole into 
three fragments 166, 167 and 168 (Figure 3). The formation of C1-C19 2,6-cis- and 2,6-
trans-bispyran 166 of the phorboxazoles was success by asymmetric diketene Maitland-
Japp reaction62 and then improved by asymmetric Chan’s diene Maitland-Japp reaction.62 
Unfortunately, when the group tried to synthesise the C-20 – C-32 core 168 the synthesis 
did not give the product that they desired.60 Thus, an alternative strategy was used to 
synthesis the fragment of 168, which involved a stereodivergent oxy-Michael reaction. 
The formation of 171 constitutes a synthesis of C20-C32 core of phorboxazoles was 
achieved in seven steps with 31% overall yield (Scheme 44).64 
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Figure 3 Retrosynthetic of Phorboxazoles. 
 
Scheme 44 Reagent & Conditions: i) TFA/CH2Cl2/H2O, RT, 71%. 
 
 
The two-pot reaction, the one-pot reaction, the asymmetric diketene Maitland-Japp 
reaction and the asymmetric Chan’s diene Maitland-Japp reaction, all share one problem; 
all of these methods give mixtures of 2,6-cis ketone and 2,6-trans enol THP rings. The 
group decided to produce the dihydropyran (DHP) first which could then be converted 
selectively into either 2,6-cis or 2,6-trans THPs. 
 
In the latest work in our group the DHP 172 underwent conjugate reduction with L-
Selectride® to give a mixture of cis/ trans isomers (173 : 174) with a diasteromeric ratio 
of 10 : 1 (Scheme 45). 
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Scheme 45 Reagent & Conditions: i) L-Selectride®, THF, ‒78 °C. 
 
This method was applied in synthesis of natural product civet cat secretion 34, it began 
with formation of DHP by using dimethyl acetal of N, N-dimethyl acetamide and 
underwent conjugate reduction to give THP ring 175 then decarboxylated using 
microwave irradiation. The THP 176 was formed by the formation of dithiolane and 
removal of the benzyl group. Then reduction of dithiolane with Raney Ni and H2 gave 
177, followed with oxidized with Jones’ reagent to give carboxylic acid in 63% yield, 
finishing the total synthesis of 34 in 5 steps (Scheme 46).65 
 
Scheme 46 Reagent & Conditions: i) μ Wave, DMF/H2O, 10 min, 100%, ii) 
HSCH2CH2SH, BF3•OEt2, CH2Cl2, RT, 100%, iii) BCl3•SMe2, CH2Cl2, RT, 100%, iv) 
Raney Ni, H2, EtOH, 50 °C, 52%, v) Jones’ reagent, acetone, 63%. 
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1.9       Objectives. 
It was our aim to improve the selectivity of the Maitland-Japp reaction to allow the 
controlled synthesis both 2,6-cis or 2,6-trans THP rings. It was decided to construct the 
DHP first and use this to form the 2,6-cis, 2,6-trans, 3,6-disubstituted and 3,3,6-
trisubstituted THPS in a controlled manner. This methodology could then be used in the 
total synthesis of natural products. 
 
2.0       Results and Discussion 
The Clarke group’s original modification of the Maitland-Japp reaction has produced a 
route to very highly functionalised THPs in good yield, however, there are some 
limitations to the methodology. The main problem is that the THPs are formed as a 
mixture of 2,6-cis and 2,6-trans diastereomers, so development of a selective reaction is 
desirable. One of the main aims of this project was to develop a route towards a selective, 
controlled synthesis of either 2,6-cis or 2,6-trans THPs.  We were also interested in 
installing functionality into the THP ring, particularly incorporating substituents at the C3 
positions and creating quaternary stereocentres (Figure 4). 
 
Figure 4 Functionalisation of THPs 
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Such a method could be applied towards the synthesis of natural products such as the A 
ring of Lasonolide A 1 and phorboxazoles 2, featuring substituents at the C2, C3, and C6 
positions and creating quaternary stereocentres (Figure 5 or Figure 6).   
 
Figure 5 Lasonolide A 1 
 
 
 
Figure 6 (+)-Phorboxazole A  R1 = H, R2 = OH 
               (+)-Phorboxazole B  R1 = OH, R2 = H 
 
An additional C-5 substituent is required for the formation of the phorboxazoles  A and 
B 2. The Clarke group has synthesised the C-1 – C-19 bis pyran unit and C-21 – C-32 
penta-substituted tetrahydropyran core of phorboxazoles A and B 2 and attempted to 
methylate the C5 position. They tried to methylate the β-ketoester 178 but unfortunately 
methylation was not observed under the conditions shown (Scheme 47). 66, 67  
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Scheme 47 Reagents & Conditions: i) NaH, THF, 0 °C, 20 min; ii) nBuLi, 0 °C to RT, 
30 min; iii) MeI, ‒78 °C to RT, 4 hr, no reaction. 
 
It was decided to modify the Maitland Japp reaction, where 153 was subjected to the 
Lewis acid-catalyzed Maitland-Japp cyclisation with an aldehyde to form the penta-
substituted tetrahydropyran ring. Unfortunately, irrespective of which conditions were 
used, the reaction formed a mixture of 2,6-cis/trans diastereomers, also keto/enol 
tautomers 180 and 181, greatly complicating isolation (Scheme 48).60  
 
Scheme 48 Reagents & Conditions: i) Sc(OTf)3, BnO(CH2)2CHO, CH2Cl2, 68% 
 
For these reasons an alternative strategy was devised, where we decided to form the 
dihydropyran 154 first via Maitland-Japp reaction as in Scheme 49. These results showed 
that the products of Maitland-Japp reactions are difficult to functionalise, however, we 
found other strategies to construct the THP rings. The work detailed in this thesis will 
expand on these preliminary results to see if the DHP to THP strategy is a general one. 
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Scheme 49 Reagents & Conditions: i) MeC(OMe)2NMe2, PhMe, RT, 74%, ii) L-
Selectride®, ‒78 °C in THF then MeI, 75%. 
 
 
2.1       Aldol Reaction 
We initially attempted to carry out the aldol reaction by a method reported by 
Mukaiyama68 and later adapted by the group,61 this involved the addition of diketene to 
an aldehyde promoted by a Lewis acid. In this reaction, formation of a γ-monoenolate 
equivalent of a β-ketoester is formed by the treatment of diketene with TiCl4. This can be 
added to the aldehyde to produce δ-hydroxy-β-ketoesters on work up (Scheme 50). The 
addition of diketene 157 to an aldehyde in the presence of TiCl4 as the Lewis acid formed 
the δ-hydroxy-β-ketoesters (entries a and b, Table 2). An alternative milder Lewis acid, 
Ti(OiPr)4, can also be used (entries c-i, Table 2). In general aldol reactions with Ti(O
iPr)4 
required longer reaction times. The δ-hydroxy-β-ketoesters produced by this diketene 
method gave moderate yields (23-76%) 
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Scheme 50 Mechanism of diketene addition to aldehydes. 
 
 
Scheme 51 Reagents & Conditions: i) Lewis acid, CH2Cl2, ‒78 oC, ii) MeOH, ‒20 to ‒
10 oC, 40-90 min 
Entry R1 Lewis acid Time Yielda 
(%) 
Product 
a iPr TiCl4 40 min 52 182 
b Pr TiCl4 40 min 62 183 
c -CH2OBn Ti(O
iPr)4 90 min 23 184 
d Ph Ti(OiPr)4 90 min 52 138 
e 2-furyl Ti(OiPr)4 90 min 62 185 
f 2-nitro benzyl Ti(OiPr)4 90 min 51 186 
g 2-methyloxazole-4-
carbaldehyde 
Ti(OiPr)4 90 min 28 187 
h E- CH=CHCH3 Ti(OiPr)4 90 min 65 188 
i E- CH=CHPh Ti(OiPr)4 90 min 76 189 
aIsolated yield after column chromatography. 
Table 2 Synthesis of δ-hydroxy-β-ketoesters by diketene addition. 
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In addition to formation of the δ-hydroxy-β-ketoesters shown in Table 2, we investigated 
aldehydes 190, 191 (Scheme 52) and 159 (Scheme 53), as aldehyde 159 can be used in 
the synthesis of natural product such as phorboxazoles 2. Unfortunately, when we tried 
aldehydes 190 and 191, the formation of δ-hydroxy-β-ketoesters were not observed It was 
suspected that the Lewis acid decomposed the aldehydes (Scheme 52). Gratifyingly, 
attempts with 2-methyloxazole-4-carbaldehyde 159, formed the δ-hydroxy-β-ketoesters 
187 in a modest 28% yield (Scheme 53). 
 
Scheme 52 Reagents & Conditions: i) Lewis acid, CH2Cl2, ‒78 oC, ii) MeOH, ‒20 to  
‒10 oC, 40-90 min. 
 
 
Scheme 53 Reagents & Conditions: i) Ti(OiPr)4, CH2Cl2, ‒78 oC, ii)  MeOH, ‒20 to ‒10 
oC, 90 min, 28%. 
 
The addition of chan’s diene to an aldehyde was also investigated. The synthesis of 
Chan’s diene required two steps (Scheme 54).69 Methyl acetoacetate 137 was 
deprotonated at the α-position then trapped with chlorotrimethylsilane to give 192, 
followed by deprotonation at the γ-position with lithium diisopropylamide and trapping 
with chlorotrimethylsilane to give the bis-silyl dienolate 141. Chan’s diene should be used 
directly or as soon as possible after formation due to its instability. Aldol reaction between 
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benzyloxyacetaldehyde 193 and Chan’s diene 141 generated 184 in 76% yield (Scheme 
55). This can be compared with aldol formation between diketene 157 and 
benzyloxyacetaldehyde 193 where the highest yield was only 23%.  
 
Scheme 54 Reagents & Conditions: i) Et3N, TMSCl, Hexane, RT, 35% ii) LDA, THF, 
‒78 oC, then TMSCl, 0 oC, 51%. 
 
 
Scheme 55 Reagents & Conditions: i) TiCl4, CH2Cl2, ‒78 oC, then TFA, 76%. 
 
Due to unsuccessful or very low yields in the formation δ-hydroxy-β-ketoesters with 
aldehydes 190, 191 and 159 using diketene 157 (Scheme 52 and 53), Chan’s diene 141 
was added to aldehydes 190, 191 and 159 with TiCl4 as Lewis acid. The formation of δ-
hydroxy-β-ketoesters 187 and 194 was observed with low isolated yields but formation 
of δ-hydroxy-β-ketoester 195 with aldehyde 191 was not observed (Scheme 56). 
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Scheme 56 Reagents & Conditions: i) TiCl4, CH2Cl2, ‒78 oC, and then TFA. 
 
 
 
As product 195 proved elusive and yields of products 187 and 194 were low, we suspected 
titanium tetrachloride (TiCl4) may be the problem. It was suspected that it decomposed 
the aldehydes. We decided to investigate other methods. Thus the Weiler dianion70 was 
used to form δ-hydroxy-β-ketoesters. Of the aldehydes investigated only aldehyde 190 
led to product 194 in the best yield 35% (Scheme 57). Another δ-hydroxy-β-ketoester 
was formed by using slightly different conditions where the methylactoacetate 137 was 
deprotonated with lithium diisopropylamide, followed by treatment with acetaldehyde 
196 to form δ-hydroxy-β-ketoester 197 in 72% yield (Scheme 58). 
 
Scheme 57 Reagents & Conditions: i) NaH, THF, 0 oC, ii) nBuLi, ‒78 oC, 35%. 
 
 
 
Scheme 58 Reagents & Conditions: i) 2 eq of lithium diisopropylamide, THF, ‒78 oC, 
72%. 
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Lastly, we tried our asymmetric Chan’s diene procedure63 to form the δ-hydroxy-β-
ketoesters with aldehydes 190, 191 and 159, but unfortunately, only starting material was 
observed (Scheme 59). It was decided not to pursue these conditions further. 
 
 
 
Scheme 59 Reagents & Conditions: i) Ti(OiPr)4/ Binol (2 mol %), LiCl (4 mol %), 
THF, RT, 12 hr. 
 
 
Entry Method R1 Yielda 
(%) 
Product 
a Diketene addition iPr 52 182 
b Diketene addition Pr 62 183 
c Chan’s diene -CH2OBn 76 184 
d Diketene addition Ph 52 138 
e Diketene addition 2-furyl 62 185 
f Diketene addition 2-nitro benzyl 51 186 
g Chan’s diene 2-methyloxazole-4-
carbaldehyde 
30 187 
h Diketene addition E-CH=CHCH3 65 188 
i Diketene addition E-CH=CHPh 76 189 
j Weiler dianion OTIPS 35 194 
k Lithium 
diisopropylamide 
condition  
acetaldehyde 72 197 
                                     aIsolated yield after column chromatography. 
Table 3 Total synthesis of δ-hydroxy-β-ketoesters. 
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In summary, the δ-hydroxy-β-ketoesters were produced by diketene addition, Chan’s 
diene addition, Weiler dianion and lithium diisopropylamide conditions in yields between 
28-76% (Table 3). Diketene is stable and commercially available making this method 
particularly convienient, especially in contrast to the stability of Chan’s diene. 
 
2.2      Synthesis of Dihydropyrans 
The focus of our research towards the formation of tetrahydropyrans is based on the 
modification of the Maitland-Japp reaction to form dihydropyrans (DHPs). Because 
previous Clarke group work lead to the diastereoselective formation of 2,6-cis ketone and 
its tautomeric 2,6-trans enol THP ring. 
 
It was predicted that cyclisation of a δ-hydroxy-β-ketoester to form a dihydropyran would 
enable the diastereoselective synthesis of THPs (Figure 7). The stereocontrolled 
conjugate reduction of a 2,3-dihydropyranone would give 2,6-cis THPs (A, Figure 7). 
The electrophilic quench of the enolate intermediate should install a new substituent at 
C-3 position and form a new stereogenic centre (B, Figure 7). All of these will allow 
access to the THP skeletons that are found in the natural products such as lasonolide A 1 
and phorboxazoles A and B 2. The conjugate addition of a suitable nucleophile to 2,3-
dihydropyranone with no substituent at C2 would give a 2,6-trans THP (C, Figure 7) 
providing access to the THP skeletons found in natural products such as diospongin B 4. 
In a complementary approach a hydride conjugate addition on 2,3- dihydropyranone and 
electrophilic quench could lead to a tertiary stereogenic centre at C3 (D, Figure 7). 
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Figure 7 Proposed routes for diastereoselective THP formation. 
 
 
2.3       Synthesis of Dihydropyrans: Orthoester Cyclisations 
We initially attempted the cyclisation of the δ-hydroxy-β-ketoester with an orthoester. In 
order to form DHPs as we suspected that an orthoester could undergo a Knoevenagel-like 
condensation with a β-ketoester, which we anticipated this would be followed by oxy-
Michael cyclisation to form the DHP (Table 4).71-73 
In this reaction, we used microwave iradiation which has proved to be a highly effective 
method of heating. Different δ-Hydroxy-β-ketoesters and orthoesters were explored to 
produce DHP rings (Table 4).74-76 
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Figure 8 Proposed mechanism Knoevenagel-like condensation / oxy-Michael 
cyclisation. 
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Scheme 60 Reagent & Conditions: i) Ac2O, toluene, microwave (150 watt, 100 atm),15-
60 min. 
Entry R1 Starting 
material 
Orthoester (R2) Time Yielda 
(%) 
Product 
a Ph 138 nBu 15 min 90 199 
b -CH2OBn 184 
nBu 15 min 51 200 
c 2-furyl 185 -CH2Cl 60 min - - 
d 2-nitro 
benzyl 
186 -CH2Cl 60 min - - 
e iPr 182 -CH2Cl 60 min - - 
f -CH2OBn
 184 Phenyl 60 min - - 
g Pr 183 Phenyl 60 min - - 
h iPr 182 Phenyl 60 min - - 
i 2-furyl 185 Me 30 min 34 204 
j iPr 182 Me 30 min 36 205 
k -CH2OBn 184 Me 60 min - - 
l 2-nitro 
benzyl 
186 Me 60 min - - 
aIsolated yield after column chromatography. 
Table 4 Synthesis of dihydropyrans with orthoesters. 
 
δ-Hydroxy-β-ketoester (1 eq) was heated with trimethyl orthovalerate (2 eq) 198, and 
acetic anhydride (2 eq) under microwave irradiation (150 watt, 100 atm) for 15 minutes 
to form the DHPs. We studied δ-hydroxy-β-ketoester 137 and trimethyl orthovalerate 
198, and it produced 199 in very good yield (Scheme 61, Table 4, entry a). We then 
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looked at a different δ-hydroxy-β-ketoester 184, which gave 51% yield (Table 4, entry 
b). 
 
Scheme 61 Reagent & Conditions: i) Ac2O, toluene, microwave (150 watt, 100 atm), 
90%. 
 
Next, we attempted the reaction with a different orthoester (2-chloro-1,1,1-
trimethoxyethane 201). Unfortunately the reaction did not produce the expected DHP 
(Table 4, entry c-e). A number of different δ-hydroxy-β-ketoesters were investigated with 
trimethyl orthobenzoate 202 to produce DHPs but unfortunately none of the reactions 
generated DHP products either (Table 4, entry f-h).  There were numerous spots on the 
TLC plate, and the 1H NMR showed a complex mixture of products. Extended reaction 
times (15-60 minute) under microwave irradiation, were also investigated but it still did 
not show the desired DHP. 
 
Commercially available trimethyl orthoacetate 203 was investigated. Initially two of the 
reactions underwent Knoevenagel reaction and the subsequent oxy-Michael cyclisation 
to give the desired DHP (Table 4, entry i-j).  
Due to promising yield of reaction between trimethyl orthoacetate 203 with δ-hydroxy-
β-ketoesters 185 and 182, we tried with δ-hydroxy-β-ketoesters 184 and 186, frustratingly 
when we run reactions under these conditions no DHP was isolated. This is maybe 
because this reaction seems to be very substrate specific and is prone to either the 
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decomposition of the reagents or decomposition of the products under the reaction 
conditions. These disappointing results are presumably because of lack of reactivity 
towards the Knoevenagel step of the reaction and perhaps this is due to some problem in 
the formation of the intermediate oxocarbenium ion of the orthoester or it having poor 
susceptibility to nucleophilic attack. From these result suggest that this approach to 
synthesising DHPs would be problematic, due to limited success in reaction thus we 
decided to change to a different method to form the DHP ring. 
 
2.4       Synthesis of dihydropyrans: amide acetal cyclisations with N, N-    
dimethylacetamide dimethyl acetal 
It was apparent that the cyclisation via the orthoester route would not be easy. It seemed 
as if only a limited number of orthoesters can cyclize to construct the DHP rings. Due to 
this difficulty we searched for an alternative route.  We found literature that utilized N, 
N-dimethylformamide dimethyl acetal or N, N-dimethylacetamide dimethyl acetal to 
react with a δ-hydroxy-β- ketoester to form a DHP.60  
 
This reaction was initially tried by Dr. Jason Hargreaves within the Clarke group in a 
model study of the C21-C32 pentasubstituted THP core of the phorboxazoles (Scheme 
62).67, 60 
 
 
Scheme 62 Reagent & Conditions: i) MeC(OMe)2NMe2, toluene, RT, 74% 
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Scheme 63 Reagent & Conditions: i) HC(OMe)2NMe2, toluene, RT, 65%. 
 
These excellent results led us to focus on exploring this reaction. When the reaction was 
run with N, N-dimethylacetamide dimethyl acetal and δ-hydroxy-β- ketoester, it should 
lead to a methyl group substituent at the C2 position of the DHP which can undergo 
reduction to form 2,6-cis THPs (Scheme 62).  When N, N-dimethylformamide dimethyl 
acetal reacts with a δ-hydroxy-β- ketoester, it will install a hydrogen as the substituent at 
the C2 position (Scheme 63). At this point we shall focus on the cyclisation using N, N-
dimethylacetamide dimethyl acetal and studies towards the formation of 2,6-cis THPs 
such as those in natural products such as lasanolide A 1 (Figure 4).  
 
A multi-component one-pot reaction has been of interest to the Clarke group.56 The 
combination of pot, atom and step economy (PASE) in synthesis of organic molecules 
which can lead to significant ‘greening’ of a synthetic route. Reducing the number of 
steps in a synthesis can increase the chemical yield of the product and reduce the amount 
of reagents and solvents used in work up and product isolation, including the waste that 
is generated from cleaning equipment and glassware.61 Based on Sellars’ work, studies 
were undertaken to determine whether the two steps to form the DHPs could be carried 
out in a single reaction (Scheme 64, Table 5). Mukaiyama’s aldol method was used,68 
where the TiCl4 was used as Lewis acid to promote the addition of diketene 157 to 
benzaldehyde 128, followed with addition of N, N-dimethylacetamide dimethyl acetal.78 
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Scheme 64 Reagent & Conditions: i) TiCl4, CH2Cl2, ‒78 °C then MeOH, ‒10 °C to ‒20 
°C; ii) MeC(OMe)2NMe2. 
 
Entry Step 1  
aqueous work-up 
Step 2 Yield (%) 207 
a No CH2Cl2, RT No DHP multiple spots by  
TLC, β-ketoester remains 
b Yes PhMe, RT 43 
c Yes CH2Cl2, RT 33 
d Yes MeOH, CH2Cl2, RT 35 
e Yes Pyridine, CH2Cl2, RT 30 
f No Pyridine, CH2Cl2, RT DHP : β-ketoester  
~1 : 4 (48 % mass balance) 
 
Table 5 DHP synthesis studies 
 
As results showed in Table 5, the one-pot procedure failed to deliver good yields, hence 
it was decided to use the two-pot procedure. 
 
For our investigation, we first tried one equivalent of N, N-dimethylacetamide dimethyl 
acetal to react directly with one equivalent of δ-hydroxy-β-ketoester. The mixture was 
stirred for 45 minutes followed by addition of BF3•OEt2 as a Lewis acid.  The 1H NMR 
spectrum of the crude product clearly showed 50: 50 of starting material and product. We 
55 
 
decided to change the equivalents of N, N-dimethylacetamide dimethyl acetal and 
BF3•OEt2 from one equivalent to two equivalent which gave much better results (Table 
6, Scheme 65).  
 
 
 
Scheme 65 Reagent & Conditions: i) MeC(OMe)2NMe2, CH2Cl2, RT, ii) BF3•OEt2 
 
 
Entry        R1         eq Starting 
material 
N,N-
dimethylaceta
mide dimethyl 
acetal, eq 
BF3.OEt2, 
eq 
Product Yielda 
(%) 
a iPr 1 182 2 2 205 73 
b Pr 1 183 2 2 208 50 
c Phenyl 1 138 2 2 207 65 
d 2-furyl 1 185 2 2 204 18 
e -CH2OBn 1 184 3 3 209 55 
aIsolated yield after column chromatography. 
Table 6 Synthesis of dihydropyrans with N, N-dimethylacetamide dimethyl acetal. 
 
The cyclisation with N, N-dimethylacetamide dimethyl acetal gave the desired DHPs in 
good yield in 1 hour at room temperature in all cases (entry a – c) except when R1 = 2-
furyl (entry d) and R1 = OBn (entry e), where for entry d when we used two equivalent 
of N, N-dimethylacetamide dimethyl acetal and BF3.OEt2 showing trace of starting 
material as major product after 1 hour.  
 
For entry e, we used one equivalent of N, N-dimethylacetamide dimethyl acetal and 
BF3•OEt2 it gave 59% recovery of product and 35 % of starting material. When we used 
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two equivalents of N, N-dimethylacetamide dimethyl acetal and BF3•OEt2, trace amount 
of starting material was observed by TLC and NMR but longer reaction times led to 
decomposition. We decided to increase to three equivalents of N, N-dimethylacetamide 
dimethyl acetal and BF3•OEt2, after 20 minutes obtained 209 in 55% yield. We suspected 
the BF3•OEt2 prefers to coordinate with the oxygen atom of furfural and oxygen of the 
benzyl ether, reducing reactivity towards the Knoevenagel step of the reaction.  
 
The cyclisation to form the DHP ring by N, N-dimethylacetamide dimethyl acetal worked 
well, but in order to introduce different substituents at C2 of the DHPs, different amide 
acetals were required. Based on Sellars’ thesis, the amide acetal was limited by 
commercial availability, but fortunately we found a literature procedure for the synthesis 
of N, N-dimethylbenzamide dimethyl acetal (Scheme 66).77 The amide 211 was prepared 
from the corresponding acid chloride 210.  When heated in dimethyl sulfate, it will forms 
N, N-dimethylbenzamide-dimethyl sulfate complex where the oxygen is methylated and 
an iminium ion is formed. Then treat with sodium methoxide, the methoxide nucleophile 
attacks the iminium ion to form N, N-dimethylbenzamide dimethyl acetal 212.   
 
Scheme 66 Reagent & Conditions: i) Na2CO3, Me2NH•HCl, CH2Cl2, RT, 100 %; ii) 
dimethyl sulfate, 90 °C then NaOMe, MeOH, RT, 40 %. 
 
The N, N-dimethylbenzamide dimethyl acetal was trialled to form DHP rings, with the 
hopethat this would give access to the C2-phenyl DHPs. Unfortunately the synthesis of 
N, N-dimethylbenzamide dimethyl acetal is fairly low yielding.78 
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In summary we developed a method using a modification of the Maitland-Japp reaction 
using orthoesters and orthoamides to give a range of the DHPs in good yields. These 
could be used in the selective formation of either 2,6-cis or 2,6-trans THP rings. 
 
2.5  Synthesis of 2,6-cis tetrahydropyran: conjugate reduction/    
electrophile quench 
Towards our investigation to construct the 2,6-cis THP rings, such as the THP of A-ring 
fragment of lasonolide A 1 or THP ring of phorboxazole 2, we used L-Selectride® for the 
1,4-conjugate reduction of α, β-unsaturated esters at position C2 and C3. The reactions 
were successfully quenched with electrophiles such as iodomethane at C3. This reaction 
was successful in a model system for the core fragment of the phorboxazole and gave the 
product of C3-alkylation in 75% yield (Scheme 49).60  
Based on Sellars thesis, the selectivity for the 2,6-cis diastereomer is believed to be due 
to pseudo-axial attack of the hydride onto C-2 of the DHP when it is in a conformation 
that puts the C6 substituent in a pseudo-equatorial position (Figure 9). In order to interact 
correctly with the π*-orbital of C2, the hydride must approach the DHP ring from below 
the plane of the double bond of C2-C3 position. First, if the hydride were to approach 
from the bottom face it would form the chair-like intermediate A which has the hydrogen 
in a pseudo-axial position. On the other hand, if the hydride were to approach from the 
top face it would form the twist-boat-like intermediate B that could ring flip to put the 
hydrogen in a pseudo-equatorial position. As the twist-boat intermediate would be higher 
in energy, it should be disfavoured, so pseudo-axial hydride attack through intermediate 
A is favoured. Pseudo-axial quenching of enolate A at C3 position would be more 
favourable to give an all-equatorially substituted THP. 
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Figure 9 Hydride attack on a DHP 
 
We proceed with our next aim which was the reduction of the DHP followed by an 
iodomethane quench to give a range of THPs. We initially looked at the use of a n-butyl 
substituent at the C-2 position of the DHP ring 200 with 10 equivalents of iodomethane 
but unfortunately the iodomethane quench did not work. However, the reduction of α, β-
unsaturated esters at position C-2 and C-3 with L-Selectride® followed by a proton quench 
worked very well (Scheme 67). It was decided to try a different DHP ring 209, with a 
methyl substituent at C-2 position with 10 equivalents of iodomethane, and from the 1H 
NMR spectrum it showed a 50 : 50 ratio of reduced of unsaturated esters at position C-2 
and C-3  and product of C-3 methylated. We increased the amount of MeI to 20 
equivalents, and pleasingly it gave the expected product of reductive alkylation at the C-
3 position in 61% yield (Scheme 68). 
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Scheme 67 Reagent & Conditions: i) L-Selectride®, THF, ‒78 oC, ii) MeI 10 eq, RT, iii) 
L-Selectride®, THF, ‒78 oC, 95%. 
 
 
Scheme 68 Reagent & Conditions: i) L-Selectride®, THF, ‒78 oC, ii) MeI 20 eq, RT, 
61%. 
 
The reduction followed by an iodomethane quench was applied to a range of DHP rings 
(Scheme 69), Table 7. It can be seen that alkylation at C3 gave THPs diastereoselectivity, 
and this has proven to be a valuable diostereoselective transformation as the alkylation 
occurred in a diastereoselective fashion pseudo-axial quench of the enolate to form the 
new stereogenic centre at C3.  
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Scheme 69 Reagent & Conditions: i) L-Selectride®, ‒78 oC in THF, ii) MeI 20 eq, RT. 
 
Entry Starting 
material 
R1 R2 Yielda (%) Product 
a 209 -CH2OBn Me 61 215 
b 205 iPr Me 96 216 
c 208 Pr Me 48 217 
d 207 Phenyl Me 72 218 
e 204 2-furyl Me 53 219 
f 200 -CH2OBn n-Butyl 57 213 
aIsolated yield after column chromatography. 
Table 7 L-Selectride® reduction followed by iodomethane quench 
We re-investigated the reductive alkylation of DHP 200 and interestingly, when the L-
Selectride® reduction and methylation was carried out with 30 equivalents of 
iodomethane the alkylated product 213 was isolated.  
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Figure 10 
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2.6 Synthesis of 2,6-cis tetrahydropyran: confirmation of 
stereochemistry  
  
Figure 11 1H-1H COSY NMR Correlation of 2,6-cis THP 215  
NOE Correlation of 2,6-cis THP 215  
 
The formation of 2,6-cis THP rings were confirmed by the 1H NMR spectrum (Figure 10) 
of 215. The region between 3.51-3.45 ppm was assigned as H-6 as it has J-value of 11.8 
Hz, showed trans-diaxial coupling with H-5ax at peak 2.37 ppm and H-6 also has J-value 
of 3.1 Hz show axial-equatorial coupling with H-5eq at peak 2.10 ppm.  
 
The NOE correlation between H-2 and H-6 was 2.8%. There was also a positive NOE 
correlation between H-5ax and the C-3 methyl substituent of 0.82% (Figure 11). From 
this result, it showed that the methyl quench occurred from the expected pseudo-axial 
trajectory, which is anti to the addition of a hydride. 
 
 
 
63 
 
2.7       Synthesis of THP A ring of Lasonolide A. 
With the success of developing a method for the formation of 2,6-cis THP rings by 
conjugate reduction of L-Selectride® and electrophile quench of iodomethane on DHP 
ring, we decided to apply this method in the synthesis of a natural product fragment. The 
synthesis of the A ring of lasonolide A 1, was chosen as its synthesis should be achievable 
using our method.  Lasonolide A 1, consists of a 20-membered macrolide that contains a 
skipped 1, 4-diene, and two highly substituted tetrahydropyran rings, it was isolated from 
the Caribbean marine sponge Forcepia sp. (Figure 12) by McConnell and co-workers in 
1994.2 Lasonolide A 1 is a pale orange oil whose molecular formula was deduced as 
C41H60O9 and it has shown IC50 values of 8.6 and 89 nM against A-549 human lung 
carcinoma and Panc-1 human pancreatic carcinoma, respectively.79 Furthermore, 1 
inhibits cell adhesion in the EL- 4.IL-2 cell line with an IC50 of 19 ng/mL, however, 
toxicity against this cell line is greater than 25 ug/mL.80-82 
         
                     Lasonolide A                 Figure 12: Caribbean marine sponge Forcepia sp. 
The total synthesis of lasonolide A 1 has been achieved by the Ghosh group. The THP 
ring was constructed stereoselectively by an intramolecular 1, 3-dipolar cycloaddition 
reaction, where the oxime 220 was treated with sodium hypochlorite which led to facile 
intramolecular 1, 3-dipolar cycloaddtion via the nitrile oxide to give isoxazoline 221 as a 
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single diastereomer. A further 3 steps were required to form the THP A ring (Scheme 
70).41 
 
Scheme 70 Reagent & Conditions: i) aq. NaOCl, CH2Cl2, 74%,  ii) H2, Raney Ni, aq. 
H3BO3, MeOH, 89%, iii) L-Selectride
®, iv) CSA, Me2C(OMe)2, 87%. 
 
The Ghosh group also synthesised lasonolide A 1, by using an asymmetric hetero Diels-
Alder reaction to construct the THP A ring with a chiral Cr (III) catalyst 225 to give 226 
(Scheme 71).83 The DHP 226 was treated with MeLi, then the lithium enolate was react 
with ethyl cyanoformate to provide the β-keto ester as a mixture, the mixture went 
alkylation to provided the desired methylation product 227. Then exposed 227 in L-
Selectride® and LiAlH4 to affored THP A ring 228.
79  
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Scheme 71 Reagent & Conditions: i) MeLi, THF, NCCO2Et, ii) NaH, MeI, 74%, iii) L-
Selectride®, iv) LiAlH4, 82%. 
 
The SmI2 Molander-Reformatsky reaction was used in the synthesis of THP A ring of 
lasonolide A 233 by Jennings group. Treatment the 229 with SmI2 provided the Sm (III) 
enolate intermediate, which underwent cyclization to provide lactone 230 as a single 
diastereomer. Treatment with allyl magnesium bromide gave lactol 231, which was then 
treated with TFA to form the oxocarbenium intermediate 232, which was then reduced 
by Et3SiH. The free secondary hydroxyl group was protected by TES ether under 
reductive conditions and to give 233 in 59% yield (Scheme 72).84 
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Scheme 72 Reagent & Conditions: i) SmI2, THF, 0 °C, 1.5 hr, ii) allylMgBr, Et2O, ‒78 
°C, 2 hr, iii) TFA, Et3SiH, CH2Cl2, ‒78 °C, 4hr, 59%. 
 
The Trost group constructed the THP A ring of lasonolide A, by removing the silyl groups 
in 231 with TBAF to generate lactol 232 subsequently, the Horner-Wadsworth-Emmons 
olefination of 232 spontaneously formed the THP ring as a single diastereomer in 91% 
yield. Then 2,6-cis THP was formed by reversible nature of the conjugate addition, where 
the formation of the thermodynamic was produced 234 (Scheme 73).85, 86 
 
Scheme 73 Reagent & Conditions: i) TBAF, AcOH, 94%, ii) 236, NaH, iii) DIBAL-H, 
76%. 
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The Shishido group used methyl(trifluoromethyl)-dioxirane 239 for an epoxidation 
reaction of DHP 238 to give 240, which was then was iodinated and reduced by zinc to 
produced 241. Compound 241 was treated with triethyl phosphonoacetate in the presence 
of potassium hydride to give 242, which was reduced with lithium aluminium hydride 
give the THP A ring of lasonolide A 243 (Scheme 74).87, 88 
 
Scheme 74 Reagent & Conditions: i) 239, NaHCO3, Na2EDTA, CH3CN/H2O, ii) 
Pd(OH)2, cyclohexene, EtOH, 92%, iii) I2, PPh3, imidazole, PhH then Zn, EtOH, iv) KH, 
(EtO)2POCH2CO2Et, DMF, 87%, v) LiAlH4, THF. 
 
In the Kang group, the compound 244 underwent cyclization went treated with iodine to 
form 2,6-cis THP 245. Then the 245 went to sequence substituent, ozonolysis, a reductive 
workup and benzylidiene group was removed by hydrogenolysis to produce 246 (Scheme 
75).89  
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Scheme 75 Reagent & Conditions: i) I2, K2CO3, MeCN, -30°C to -20°C, 95%, ii) BzONa, 
NMP, 100°C, 97%, iii) O3, NaHCO3, MeOH, -78°C, 96%, iv) H2, 10% Pd/C, HOAc, 
MeOH, RT, 89%. 
 
 
2.8        Synthesis of THP A ring of Lasonolide A ˗  the reduction of ketone 
and ester by lithium aluminium hydride (LiAlH4)  
With the success of our previous reductive alkylation reaction, we proceeded toward the 
construction of the core model fragment of the lasonolide A 1. We first attempted a 
LiAlH4 reduction in order to reduce the ketone at position C4 and ester at position C3 to 
yield hydroxyl groups at C4 and C11 (Scheme 76). The reduction reaction was very rapid 
being completed in less than 1 hour, but unfortunately the stereochemical outcome was 
not what we desired. The hydroxyl on position C4 was equatorial rather than axial as in 
lasonolide A 1 (Figure 13).  
 
Scheme 76 Reagent & Conditions: i) LiAlH4, 0°C, THF, 1hr, 51%. 
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Figure 13 
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Figure 14 1H-1H COSY NMR Correlation of 2, 6-cis THP 247  
The stereochemistry of 247 was elucidated using 1D and 2D NMR techniques with 1H-
1H COSY spectrum (Scheme 76). The 1H NMR spectrum (Figure 13) showed that there 
was a multiplet at 1.42-1.35 ppm and 1.33-1.25 ppm which were assigned as H-7, H-13 
and H-14 and integrated as 6H, but since these multiplets overlapped assignment was 
complicated (Figure 13). There was also a 3H singlet peak at 0.94 ppm which was 
assigned as H-12 for methyl group, and a 3H at peak 0.89 ppm appeared as triplet and 
assigned as H-15.  
 
The two double double doublets at 1.48 ppm was assigned as H-5ax and 1.75 ppm was 
assigned as H-5eq; H-5eq has J-value of 4.8 Hz showed coupled to the 3.93 ppm, which 
was assigned as H-4 and H-5ax has J-value of 11.5 Hz showed trans-diaxial coupled to 
the H-4. The H-5ax also has J-value of 12.0 Hz showed trans-diaxial coupled to the 
multiplet at 3.61-3.58 ppm, identifying it as H-6. The doublet of doublets at 3.55 and 3.48 
ppm was assigned as H-8 and integrated as 2H has J-value of 6.5 Hz showed coupled to 
the peak at H-6.  
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Figure 15 
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The most important signal in this 1H-1H COSY spectrum, was a doublet of doublets at 
3.93 ppm which integrates for 1H, and this was assigned as H-4, as it showed trans-diaxial 
coupled to the H-5ax with J-value of 11.5 Hz. The OH position at C-4 is equatorial down 
position (Figure 14). 
 
 
Scheme 77 Reagent & Conditions: i) LiAlH4, 0 °C, THF, 1 hr, 56%. 
 
  
 
 
Figure 16 1H-1H COSY NMR Correlation of 2, 6-cis THP 248  
 
The stereochemistry of 248 was elucidated using 1D and 2D NMR techniques with 1H-
1H COSY spectroscopy used to determine the relative stereochemistry of the molecule 
(Scheme 77). There was singlet at 0.79 ppm was identified as the 3H on the C-12 methyl 
group. The 1H–1H COSY spectrum (Figure 15) confirmed the H-7 signal at peak 1.02 
ppm coupled to the quartert at 3.18 ppm and was assigned as H-2 and intergrated as 1H.  
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Figure 17 
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Next chemical shifts were very similar to those found in 247, which suggests that there 
was no change in conformation (Figure 16), which is further inspection of the 1H–1H 
COSY spectrum showed that the H-5 proton coupled to the multiplet at 3.59‒3.57 ppm, 
identifying it as H-6. The H-5ax and H-5eq also coupled to the double of doublet at 3.85 
ppm, which was intergrated as 1H and assigned as H-4. The H-5ax has J-value of 12.0 
Hz showed trans-diaxial coupling with H-4. Hence, from the 1H NMR spectrum we 
concluded the OH position at C-4 is in equatorial down position (Figure 16). 
 
2.9      Synthesis of THP A ring of Lasonolide A ˗  The Reduction of ketone 
by Lithium tri-sec-butylborohydride solution (L-Selectride®). 
Due to our unsuccesfull attempt with LiAlH4 to obtained the correct stereochemistry for 
the C-4 OH group on the THP ringfor lasonolide A 1, we decided to use L-Selectride® to 
reduce the ketone. Thankfully this reaction gave the stereochemistry we required for the 
synthesis of lasonolide A ring (Scheme 78). 
 
Scheme 78 Reagent & Conditions: i) L-Selectride®, ‒78 °C, THF, 69%. 
 
Figure 18 1H-1H COSY NMR Correlation of 2, 6-cis THP 249  
75 
 
 
 
Figure 19 
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The stereochemistry of the THPs was determined using 1D and 2D NMR spectroscopy 
with 1H NMR and 1H- 1H COSY spectra (Figure 17) - example 249 which has a CH2OBn 
substituent at C6 and C2 was n-butyl (Scheme 78). This yielded 249 in 69% yield. 
 
There was a peak at 3.84 ppm that integrated to 1H and this was assigned as H-4 which 
was a doublet of doublets, and it coupled to the H-5 protons at 1.66 ppm and 1.46 ppm, 
this coupling was observed in 1H-1H COSY. A J-value of 5.7 Hz showed coupling 
between H-4eq and H-5ax relationship and a J-value of 2.7 Hz showed the coupling 
between H-4eq and H-5eq relationship. We concluded the OH position at C-4 is in axial 
position and H4 at equatorial down (Figure 18). 
 
 
Scheme 79 Reagent & Conditions: i) L-Selectride®, ‒78°C, THF, 75%. 
 
 
 
Figure 20 1H-1H COSY NMR Correlation of 2, 6-cis THP 250  
We next investigated the reduction on compound 250, where C2 was methyl (Scheme 
79). It gave 75 % yield. In the 1H NMR spectrum there is a peak at 3.87 ppm that integrates 
for 1H and this was assigned as H-4 which was a doublet of doublets, and it coupling to 
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the H-5 protons at 1.66 ppm and 1.46 ppm, this coupling was observed in 1H-1H COSY 
(Figure 19). From the 1H NMR spectrum, coupling between H-4eq – H-5ax and H-4eq – 
H-5eq showed a small J value with the 5.7 and 3.0 Hz, we concluded the OH position at 
C-4 is axial up and H-4 at equatorial down (Figure 20).  
  
 
Scheme 80 Reagent & Conditions: i) L-Selectride®, ‒78°C, THF. 
 
Entry Starting 
material 
R1 R2 Yielda (%) Cpd. No. 
a 216 iPr Me 59 251 
b 218 Phenyl Me 29 252 
c 219 2-furyl Me 79 253 
d 215 -CH2OBn Me 75 250 
e 213 -CH2OBn n-Butyl 69 249 
aIsolated yield after column chromatography. 
Table 8 L-Selectride® reduction of ketone. 
Then, these conditions for the reduction of the ketone were applied to a range of THPs 
rings where different substituen group at position C2 and C6 (Scheme 80), Table 8. It can 
be seen that all ketones on THPs can be reduce by L-Selectride® with yields in between 
29-79% (entries a – e). 
 
78 
 
2.10    Lithium      aluminium hydride (LiAlH4) versus Lithium tri-sec-
butylborohydride solution (L-Selectride®). 
The reduction of cyclohexanones by reducing agents could give two possible products; 
where the hydride adds pseudo axial or pseudo equatorial depending, on the size of 
reducing agent. For example, on 4-t-butylcyclohexanone, the t-butyl group locks the 
conformation with the t-butyl group in the equatorial position. If the hydride attack on the 
same face as the t-butyl group, the hydrogen will be in axial and the hydroxyl group 
equatorial position. If the hydride attacks from the opposite face, the hydrogen will be 
equatorial and hydroxyl group will be axial (Figure 21).90-92  
 
Figure 21: The axial or equatorial attack on cyclohexanone. 
This observation can be applied to our THPs rings; large Nu attack equatorial and small 
Nu attack axially. LiAlH4 is quite small as nucleophile and the hydride is added at the 
axial position and placing the hydroxyl group equatorial. This is believed, the torsional 
effect play as a major role in the preferences for axial approach.  In the reactant 
conformation, the carbonyl group is almost eclipsed by the equatorial C(3) and C(5) C-H 
bonds. This torsional strain, is relieved by axial attack, whereas equatorial approach 
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increases strain because the oxygen atom must move through a fully eclipsed arrangement 
(Figure 22).93, 94 
 
Figure 22: The L-Selectride® versus LiAlH4 
In constrast, L-Selectride,® as a large nucleophile (bulky reducing agent), will attack 
pseudo equatorially, hence the hyride will be added at equatorial position. This is because 
steric approach control and is the result of the van der Waals repulsion with the 2,6-axial 
hydrogens. The large nucleophile encounter the 2,6-axial hydrogens on the pseudo axial 
and therefore prefer pseudo equatorial (Figure 21 and Figure 22).93, 94 
 
2.11 Synthesis of THP A ring of Lasonolide A ˗ the reduction of ester 
by lithium      aluminium hydride (LiAlH4).  
The successful installation of the stereochemistry we desired by ketone reduction with L-
Selectride®, was next followed by the reduction of the ester to a primary alcohol. To this  
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Figure 23 
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end, we looked at this reduction with lithium aluminium hydride (LiAlH4) as a final step 
for the synthesis of the THP A ring of lasonolide A 1.   
 
Scheme 81 Reagent & Conditions: i) LiAlH4, 0 °C, THF, 1 hr, 52%. 
 
 
Figure 24 1H-1H COSY NMR Correlation of 2, 6-cis THP 257  
 
The first attempt was with a methyl substituent at the C2 position and –CH2OBn 
substituent at C6 position on THPs ring 250. The reduction of the ester was a success and 
gave a 52% yield of 257 (Scheme 81). The compound 257 was elucidated by 1D and 2D 
NMR spectroscopy (Figure 23 and Figure 24). 
 
 
Scheme 82 Reagent & Conditions: i) LiAlH4, 0 °C, THF, 1hr, 52%. 
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Figure 25 
83 
 
 
Figure 26 1H-1H COSY NMR Correlation of 2, 6-cis THP 258  
 
The last step in formation of the THP A ring of lasonolides A was reduction of ester to 
primary alcohol, the reduction of ester was a success and gave a 52% yield (Scheme 82).  
The product 258 in 1H NMR spectrum showed a doublet at 3.63 ppm and another doublet 
at 3.59 ppm, both were assigned as H-11 and integrated for 2H as it has geminal coupling 
with 12.6 Hz (Figure 25). Conclusion of 1D and 2D NMR spectrum, the product 258 
showed the matching stereochemistry we desired to apply to the construction of THP A 
ring of lasonolide A 1 (Figure 26). 
 
2.12 Synthesis of dihydropyrans: amide acetal cyclisations with N, N-
dimethylformamide dimethyl acetal. 
Having successfully formed dihydropyran rings with the orthoamide methods, it was 
decided to focus on exploring this reaction. When the reaction was applied to N, N-
dimethylacetamide dimethyl acetal and a δ-hydroxy-β- ketoester, it gave a DHP with a 
methyl group at the C2 position. This product can undergo conjugate reduction to form 
2,6-cis THPs. This reaction was initially tried by Dr. Jason Hargreaves within the Clarke 
group in a model study of the C21-C32 pentasubstituted THP core of the 22-23 
phorboxazoles (Scheme 62).60, 67 
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Scheme 62 Reagent & Conditions: i) MeC(OMe)2NMe2, toluene, RT, 74 % 
 
 
Scheme 63 Reagent & Conditions: i) HC(OMe)2NMe2, toluene, RT, 65 %. 
 
 
We tried to utilise N, N-dimethylformamide dimethyl acetal with δ-hydroxy-β- ketoester 
to form the DHP ring as our next focus in this report. When N, N-dimethylformamide 
dimethyl acetal reacted with a δ-hydroxy-β- ketoester, the resultant dehydropyranone is 
unsubstituted at the C-2 position which could gave 2, 6-trans THPs following a Gilman 
cuprate conjugate addition. 
 
Based on Sellars’ thesis,78 it started with the R1 substituent as the 2-furyl group. 
Unfortunately we were unable to form the 2, 6-trans THP. When 185 treated with N, N-
dimethylformamide dimethyl acetal followed with Gilman cuprate conjugate addition, a 
product was isolated (Scheme 83), but not the desired product, instead a DHP 259 was 
isolated after flash chromatography. 
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Scheme 83 Reagent & Conditions: i) HC(OMe)2NMe2, PhMe, rt; ii) Me2CuLi, TMSCl, 
THF, ‒78 °C, 35 %. 
 
Therefore the reaction of δ-hydroxy-β-ketoesters with N, N-dimethylformamide dimethyl 
acetal was investigated. Unfortunately, the reaction showed a mixture of products by TLC 
and 1H NMR.  After chromatography the DHP 259 was actually formed, along with a 
new spot that was not in the original product mixture 261 and addition to the isolation of 
260 (Scheme 84).78 
Scheme 84 Reagent & Conditions: i) HC(OMe)2NMe2, PhMe, RT, 15% (260), 26% 
(259), 18% (261). 
 
It seemed that the Knoevenagel condensation had occurred, but there had been no oxy-
Michael cyclisation. The product of 261 were presumably formed from the acidity of the 
silica that promoted the elimination of water and together activated the enaminone to 
allow oxy-Michael addition of the hydroxyl group to form DHP 259. Even when the 
temperature was increased, this had no effect in promoting cyclisation. The Lewis acid 
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was added to make the enone more susceptible to nucleophilic attack from the hydroxyl 
group, in the presence of chlorotrimethylsilane to give 39% yield. In an attempt to 
improve, the chlorotrimethylsilane was replaced with BF3•OEt2 and reaction at room 
temperature gave 46% yield. 
 
The yield was still a disappointing 46%, further investigation into the amount of N, N-
dimethylformamide dimethyl acetal used was conducted varying the stoichiometry from 
one to ten equivalents. The solvent was changed from toluene to dicholoromethane and 
added slowly the BF3•OEt2 into reaction. Thankfully, these reactions gave the desired 
dihydropyrans in good yield and NMR purity without the need for chromatography. With 
this modified method, we could explore potential route towards 2, 6-trans THPs.78 
 
Initially, it was start with one equivalent of N, N-dimethylformamide dimethyl acetal  was 
used directly with one equivalent of δ-hydroxy-β- ketoester,  followed by addition of 
BF3•OEt2 as a Lewis acid. Gratifyingly, these reactions gave the desired dihydropyrans 
in good yield and reasonable purity (Scheme 85). 
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Scheme 85 Reagent & Conditions: i) HC(OMe)2NMe2, CH2Cl2, RT, ii) BF3•OEt2. 
Entry Starting 
material     
R1, 
eq 
N, N-
dimethylformamide 
dimethyl acetal, eq 
 
BF3.OEt2, 
eq 
Product Yield 
(%) 
a iPr 1 1 1 262 97 
b Pr 1 1 1 263 91 
c Phenyl 1 1 1 264 96 
d 2-furyl 1 1 1 259 92 
e CH2-OTIPS 1 1 1 265 87 
f 2-
methyloxazole 
1 2 2 266 77 
g -CH2OBn 1 2 2 267 - 
h E-CH=CHCH3 1 1 1 268 87 
i E-CH=CHPh 1 2 2 269 97 
j CH3 1 1 1 270 87 
 
 
Table 9 Synthesis of dihydropyrans with N, N-dimethylformamide dimethyl acetal 
 
The cyclisation with N, N-dimethylformamide dimethyl acetal gave the desired DHPs in 
good yield. Disappointingly when R1 = –CH2OBn (Table 9, entry g), an inseparable 
mixture of products was obtained even after more equivalents of acetal were added. 
 
2.13 Synthesis of 2,6-trans tetrahydropyran: conjugate addition. 
We extended our investigation towards the formationof 2,6-trans THPs using the Gilman 
cuprates. It was previously reported that for Gilman cuprates to be an effective 
nucleophile in 1, 4-conjugate additions to C-2 substituent DHPs, to give THPs with 3o 
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centres at C2. We felt this method could be extended to the construction of 2,6-trans 
THPs.95  
However when we attempted to add Gilman cuprates to DHPs, as expected it gave 
tautomeric products with enol as a major product and ketone as a minor product (Scheme 
86). To solve this problem, we formed acetates in order to convert both product to a single 
compound (Scheme 86).96 
 
Scheme 86 Reagent & Conditions: i) Me2CuLi, ii) TMSCl, ‒78 oC, 4.5 hr, THF, iii) 
Ac2O, pyridine, DMAP, 40 
oC, 40 min. 
 
It was proposed that Gilman cuprate addition works via co-ordination of the enone to a 
dimeric complex of the cuprate reagent (A). A donation/back-donation (d-π*) interaction 
between the copper and the alkene can then form a cupriocyclopropane (B), where it 
subsequently rearranges to form the open-chain CuIII intermediate C. Reductive 
elimination of C gives the enolate (silyl enol ether) product of 1,4-addition (D) (Figure 
27).97 It is believed that TMSCl promotes the 1,4-addition by participating in the enone-
cuprate complex and also can act as a Lewis base, with the Cl donating electron density 
to the Li+, where it can also have an effect on make the Si more Lewis acidic.98-100 
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Figure 27 Mechanism for Gilman cuprate addition to enones 
 
The 2,6-trans THP ring formed by conjugate addition is believed to be favoured due to 
pseudo-axial attack of Me2CuLi at C2 of the DHP when it is in a conformation that puts 
the C6 substituent in a pseudo-equatorial position (Figure 28). In order to interact with 
the π*-orbital of C2, the Me2CuLi must approach the DHP ring from a below direction to 
the double bond of C2-C3 position. First, if the Me2CuLi were to approach from the 
bottom face it would form the chair-like intermediate A which has the methyl in a pseudo-
axial position. On the other hand, if the Me2CuLi (nucleophile) were to approach from 
the top face it would form the twist-boat-like intermediate B that could ring flip to put the 
methyl in a pseudo-equatorial position. As the twist-boat intermediate would be higher in 
energy, it should be disfavoured, so pseudo-axial Me2CuLi (nucleophile) attack through 
intermediate A is favoured. Pseudo-axial quenching of enolate A at C3 position would be 
more favourable to give an all-equatorially substituted THP.101, 102 
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Figure 28 Me2CuLi (nucleophile) attack on a DHP 
 
Entry Starting material R1 Product Yielda (%) 
a 262 iPr 271 77 
b 263 Pr 272 64 
c 264 Phenyl 273 74 
d 259 2-furyl 274 82 
e 265 CH2-OTIPS 275 81 
f 268 CH=CHCH3 276 56 
aIsolated yield after column chromatography. 
Table 10 Synthesis of DHP with Me2CuLi conjugate addition. 
 
Having successfully installed a methyl group at the C2 position by Gilman cuprate 
addition, we investigated different substituents at C6 position, giving tautomeric 
mixtures. These were acetylated to simplify isolation and characterisation. The formation 
of 2, 6- trans THPs were produced in moderate yield 56-82% (Table 10, entries a-f). 
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Figure 29 
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Figure 30 1H-1H COSY NMR Correlation of 2,6-trans THP 273  
NOE Correlation of 2,6-trans THP 273  
 
For compound 273, the 1H NMR spectrum, it showed no enol peak at around 11.00-12.00 
ppm that integrated for 1H as OH, but instead here appeared a singlet  at 1.92 ppm which 
integrated as 3H implying acylation. In 1H-1H COSY spectrum (Figure 29), at 5.13 ppm 
appeared as quartet with integrated as 1H and assigned as H-2 has J-value of 6.6 Hz 
showed coupled with methyl at position C-2 at 1.39 ppm, where it was appeared as 
doublet and integrated as 3H. 
  
The H-5ax at 2.40 ppm has J-value of 9.7 Hz showed trans-diaxial coupling with the 
double of doublets at 4.83 ppm, which was integrated as 1H and assigned as H-6. Then 
H-5eq at 2.31 ppm has J-value of 4.1 Hz and showed coupled with H-6 (Figure 30). From 
the J-value of H-5ax-H-6, showed H-6 at axial position and gave the desired 2,6- trans 
THP ring stereochemistry.  
 
Based on NOE spectrum (Figure 30), a positive correlation of 2.3% between H-6 and Me-
2 and a NOE correlation between H-5eq and Me-2 of 1.86%, confirming the 
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stereochemistry which is 2,6-cis relationship that we would expect to see after axial attack 
of the organocuprate onto the DHP, supporting the assignment as a 2,6-trans DHP.  
 
Phenyl cuprate was added in a similar fashion and it gave good yields of the DHPs, but 
interestingly we could only see the enol tautomer of the conjugate addition product. It is 
believed that the enol tautomer is preferred due to minimisation of the unfavourable 
interation of having an axial phenyl substituent (Scheme 87).103 
 
Scheme 87 Reagent & Conditions: i) Ph2CuLi, ii) TMSCl, ‒78 oC, 30 min then 0 oC, 
1.5 hr, THF. 
Entry Starting material R1 Product Yielda (%) 
a 262 iPr 277 73 
b 263 Pr 278 56 
c 264 Phenyl 279 70 
d 265 CH2OTIPS 280 48 
e 268 CH=CHCH3 281 64 
f 269 CH=CHPh 282 91 
aIsolated yield after column chromatography. 
Table 11 Synthesis of DHP with Ph2CuLi conjugate addition. 
 
Having successfully installed a phenyl at the C-2 position by Gilman cuprate addition, 
we continue to investigate different substituents at C-6 position and as expected gave enol 
products more formed. The formation of 2,6-trans THPs were produced in moderate yield 
56-91% (Table 11, entries a-f). 
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Figure 31 
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Figure 32 1H-1H COSY NMR Correlation of 2,6-trans THP 282  
NOE Correlation of 2,6-trans THP 282  
 
The 1H NMR spectrum of 282, showed the enol with singlet at 12.3 ppm. A doublet of 
doublets at 6.15 ppm was assigned as H-8 and integrated as 1H with a trans alkene 
coupling of 16.1 Hz to H-9, supported by a correlation in the 1H-1H COSY spectrum. 
Proton H-8 also showed a 5.7 Hz coupling with a proton at 4.24 ppm which was assigned 
as H-6.  
 
Upon further inspection, the double double doublet was assigned as H-6 and it showed 
matching coupling with H-8. The H-6 also has a J-value of 4.1 Hz and showed coupling 
to the H-5eq and as predicted has trans-diaxial relationship with H-5ax with J-value of 
10.5 Hz. This confirmed the stereochemistry as the 2,6-trans THP that we desired (Figure 
32). 
 
NOE spectroscopy showed the H-6 at 4.24 ppm had a positive correlation of 1.4% 
between H-6 and phenyl, H-6 and H-9 of 1.35%, H-6 and H-8 1.12% and interestingly a 
small positive correlation between H-6 and H-2 with 0.27%. It showed this compound is 
2,6-trans relationship between the C-2 proton and C-6 proton (Figure 32). 
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In exploring the range of Gilman cuprates used, we tried using longer chain alkyl lithium 
reagent. nBuLi was chosen, which also gave good yields of the 1, 4-conjugate addition 
products, but again a mixture of tautomers was formed. The mixture of tautomers were 
acylated and single enol acetate products were formed in good yields (Scheme 88).104 
 
Scheme 88 Reagent & Conditions: i) nBu2CuLi, ii) TMSCl, ‒78 oC, 4 hr, THF, iii) 
Ac2O, pyridine, DMAP, 40 
oC, 40 min. 
Entry Starting material R1 Product Yielda (%) 
a 262 iPr 283 79 
b 265 CH2OTIPS 284 70 
c 263 Pr 285 62 
d 264 Phenyl 286 48 
aIsolated yield after column chromatography. 
Table 12 Synthesis of DHP with nBu2CuLi conjugate addition. 
The successfully installed n-butyl group at the C2 position by Gilman cuprate addition, 
we investigated different substituents at C6 position, giving tautomeric mixtures. These 
were acetylated to simplify isolation and characterisation. The formation of 2,6- trans 
THPs were produced in moderate yield 48-79% (Table 12, entries a-d). 
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Figure 33 
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Figure 34 1H-1H COSY NMR Correlation of 2,6-trans THP 286  
NOE Correlation of 2,6-trans THP 286  
 
Similar to the reaction of Me2CuLi, the major product in the mixture was the enol 
tautomer, and the mixture was acylated. From the 286 1H NMR spectrum showed there 
are no enol peak appeared around 11-12 ppm. The peak at 1.87 ppm integrated as 3H 
showed that acylated was form and assigned as H-13. From the 1H-1H COSY spectrum 
(Figure 33), the doublet of doublets was assigned as H-6 with integrated as 1H has J-
value of 9.0 Hz showed trans-diaxial coupling with H-5ax. The H-6 also has J-value of 
5.0 Hz showed coupled with H-5eq. From the J-value in this spectrum, it showed the 
stereochemistry of 2,6-trans THP ring that we expected as in Me2CuLi. 
Based on NOE spectrum (Figure 34), a positive correlation of 1.8% between H-6 and 
nButyl group, confirming a 2,6-cis relationship was observed between the butyl 
substituent C-2 and the C-6 proton, showing that the cuprate reagent had caused addition 
from a pseudo-axial trajectory as previously seen with methyl lithium addition. 
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2.14 Synthesis of Diospongin B. 
The development of a synthesis of 2,6-trans THP ring was achieved by using conjugate 
addition. This encouraged us to apply this method towards the synthesis of the trans-THP 
ring of a natural product. Diospongin B 4 was choosen as the diospongin B has trans-
THP ring as in basic skeleton. Diospongins B 4, isolated from the rhizomes of Dioscorea 
spongiosa by S. Kadota and co-workers in 2004, comprises a novel class of cyclic 1,7-
diarylheptanoid natural product (Figure 35).6 This compound contains a trisubstituted 
tetrahydropyran core with different stereochemistry at the C2, C4 and C6 position. 
Diospongin B 4 exhibits a potent inhibitory activity on bone desorption induced by 
parathyroid hormone in a bone organ culture system, and is regarded as a promising lead 
compound for the development of antiosteoporotic drugs.106 
                                       
                                                                Figure 35 Rhizomes of Dioscorea spongiosa 
 
A number of total syntheses of diospongin B 4 have been reported. The Tong group, used 
trans-2-aryl-6-alkyl THP 288 as a precursor for formation of diospongin B 4. Reductive 
γ-deoxygen-pyranone 287 and Heck-Matsuda coupling proceeded smoothly to deliver the 
desired trans-2-aryl-6-alkyl THP 288. The rhodium-catalyzed 1, 4-hydrosilylation of the 
enone 288 and Rubottom oxidation provided the hydroxyl ketone 289. The deoxygenation 
of the carbonyl group of 289 via tosylhydrazone produced 290, where PMB protection, 
desilylation and DMP oxidation gave the aldehyde 291. Then with phenyl Grignard 
addition to 291, DMP oxidation and DDQ deprotection of PMB group produced the total 
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synthesis of diospongin B 4 (Scheme 89).106, 107 Meanwhile, the Chandrasekhar group 
used a base catalysed conjugate addition of an α, β-unsaturated ester and an 
intramolecular oxy-Michael reaction as the key steps in synthesis of Diospongin B 4.108 
 
Scheme 89 Reagent & Conditions: i) Zn/AcOH, then PhN2BF4, Pd(0), 72% ii)Rh2(OAc)4, 
Et3SiH, then m-CPBA, 65%, iii) TsNHNH2 then  NaBH3CN, 68%, iv) PMBCl, TBAF, 
DMP,  52%, v) PhMgBr, DMP, DDQ, 62%. 
 
The Sabitha’s group synthesis of diospongin A and B, involved stereoselective reduction 
of a β-keto ester, Horner-Wadsworth-Emmons olefination and intramolecular oxy-
Michael reactions. The ester 292 was cyclised by treatment with TsOH to produce δ-
lactone 293 as an intermediate. δ-lactone 293 was reduced by DIBAL-H together with 
294 and Ba(OH)2•8H2O as a base to gave diastereomer mixture of 2,6-cis/trans THP 295 
and 4 (Scheme 90)109. In the Jennings group, they also used δ-lactone 293 as intermediate 
to synthesis diospongin A and B.110 
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Scheme 90 Reagent & Conditions: i) TsOH, CH2Cl2, ‒78 °C, 30 min, 68%, ii) DIBAL-
H, CH2Cl2, ‒78 °C, 30 min, 294, Ba(OH)2•8H2O, THF/H2O, RT, 5h, 81%. 
 
The total synthesis of diospongin B 4 by the Hall group began by epoxidation of 296 with 
m-CPBA and gave 297. Then the epoxide ring was treated with DIBAL-H and followed 
with silyl protection of the hydroxyl group using TESCl to give 299.  Mukaiyama-type 
addition onto the in situ generated oxocarbenium favoured the formation of the 2,6-trans 
THP (Scheme 91).111 
 
Scheme 91 Reagent & Conditions: i) m-CPBA, CHCl3, 0 °C to RT, 70%, ii) DIBAL-H, 
THF, 0 °C to RT, 83%, iii) TESCl, 2, 6-lutidine, CH2Cl2, 87%, iv) SnCl4, CH2Cl2, 0 °C, 
v) HF•py, THF, 0 °C, 66%. 
 
In 2010, Hashimoto group, accomplished the total synthesis of diospongin B 4 by the 
hetero-Diels-Alder (HDA) reaction between benzaldehyde 128 and Danishefsky-type 
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diene 301 with 1 mol% of [Rh2(S-BPTPI)4] and Mukaiyama-Michael reaction on 303 as 
routes into trans-THP 304 in a one-pot sequential (Scheme 92).105  
 
Scheme 92 Reagent & Conditions: i) Rh2(S-BPTPI)4 (1 mol%), CH2Cl2, 23 °C, 15 hr, ii) 
TMSOTf (10 mol%), ‒78 °C, 0.5 hr, iii) 300, 1hr, iv) TFA, ‒78 °C, 1 hr, 85%, v) K-
Selectride®, ‒78 °C, THF, 86%. 
 
The Uenishi group completed the synthesis of diospongin B 4 by using a palladium 
mediated 1, 3-chirality transfer strategy. The 1, 3-chirality transfer of the starting allylic 
alcohol to the tetrahydropyran ring is perfectly controlled in a stereospecific syn-SN2ʹ type 
PdII-promoted 6-exo-trig cyclization.  Wacker oxidation on the β-(tetrahydro-2H-pyran-
2-yl)styrenes gives the ketone 310 (Scheme 93).110 Interestingly, when 307 was subjected 
to Wacker oxidation conditions, surprisingly it gave 308 in 82%, instead of desired 
product of ketone. They assumed an intramolecular Wacker oxidation took place instead 
of intermolecular Wacker oxidation, where the nucleophilic attack of the hydroxyl group 
located at the cis position with the styryl group occurred on the Pd π-complex of 307. The 
hydroxyl group was protected as the MOM-ether to undergo Wacker oxidation.113 
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Scheme 93 Reagent & Conditions: i) PdCl2(CH3CN)2 (10 mol%), THF, 0 °C, 20 min, 
86%, ii) PdCl2 (50 mol%), CuCl, O2, DMF + H2O, 50 °C, 55%, iii) MOMCl, 
iPr2NEt, 
NaI, THF, 55 °C, 10 hr, 86%, iv) HCl aq/ THF, RT, overnight, 91%. 
 
Interestingly, when Chuzel and Bressy’s group114 synthesized (-)-diospongin A 312, 
which contains the 2,6-cis THP ring, they used modified conditions described by 
Grubbs115 for the Wacker oxidation reaction. Interestingly, in their synthesis of 
diospongin A 312 they achieve the total synthesis without the requirement of a single 
protecting group (Scheme 94).113 
 
Scheme 94 Reagent & Conditions: i) Pd(OAc)2 (5 mol%), HBF4, BQ, DMA/MeCN/H2O, 
RT, 46%. 
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Figure 36 
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2.15 Toward the synthesis of Diospongin B. 
Following the successful investigation towards the functionalization of 2,6-trans THPs 
using the Gilman cuprates, we decided to synthesise diospongin B 4. The next step is 
decarboxylation of the ester on the THP 282 by using a microwave based method 
(Scheme 95). The decarboxylation reaction reaction required only 10 minutes and 
produced one single spot on thin layer chromatography 313. 
 
 
Scheme 95 Reagent & Conditions: i) DMF/H2O, 200 Watt, μWave, 160 °C, 10 min, 
91%. 
 
 
Figure 37 1H-1H COSY NMR Correlation of 2,6-trans THP 313  
 
From the 1H NMR spectrum of 313 (Figure 36), no methoxy (OMe) peak at 3.6 ‒ 3.7 ppm 
was observed. The 1H NMR spectrum showed doublet of doublet at 5.12 ppm with 
integrated as 1H and assigned as H-2 was coupled with H-3ax and H-3eq with J-value of 
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7.7 and 4.8 Hz indicating its equatorial position. The H-6 at 4.82 ppm has trans-diaxial 
coupling to H-5ax with J-value of 10.5 Hz and H-6 coupled to H-5eq with J-value of 5.2 
Hz, indicating its axial position. From this spectrum, it showed compound 282 underwent 
successful decarboxylation reaction to yield 313 (Figure 37). 
 
The next step for construction of diospongin B 4 was the reduction of the ketone with 
sodium borohydride. Unfortunately, this did not give the desired stereochemistry at the 
C-4 alcohol required for diospongin B. When 313 was treated with NaBH4, a mixture of 
55: 45 diastereomer ratio occurred. When L-Selectride® was used, pleasantly, it did give 
secondary alcohol THP 307 as the major diastereomer (9: 1) with the correct 
stereochemistry configuration for diospongin B 4 (Scheme 96). 
 
Scheme 96 Reagent & Conditions: i) L-Selectride®, THF, ‒78 °C, 66%. 
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Figure 38 
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Figure 39 NOE NMR Correlation of 2,6-trans THP 307  
 
The 1H NMR spectrum (Figure 38) of 307 confirmed H-4 proton at 4.07 ppm has trans-
diaxial relationship to H-5ax with J-value of 9.3 Hz, and coupled to H-5eq with J-value 
of 4.5 Hz. The H-4 proton also has trans-diaxial coupling with H-3ax with J-value of 9.0 
Hz and coupled to H-3eq with J-value of 4.0 Hz. This was confirmed by NOE correlation, 
where H-2 only had NOE correlation to H-3eq of 1.33% and to H-3ax of 1.89%, H-4 had 
NOE correlations to H-6 of 1.23% and to H-3eq of 1.58% and to H-5eq of 2.59% (Figure 
39). 
 
Based on Uenishi work,113 if we proceeded with the Wacker oxidation on 307 without 
protecting the secondary alcohol group, the intramolecular Wacker oxidation reaction 
would take place instead of intermolecular Wacker oxidation. They describe a 
nucleophilic attack of the hydroxyl group located at the cis position to the styryl group 
which occurred on the Pd π-complex of 307 (Scheme 97).  
 
The secondary alcohol group was protected with chloromethyl methyl ether (MOMCl) 
before undergoing Wacker oxidation. The Wacker oxidation on 309 was very slow and it  
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Figure 40 
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took 4 days and unfortunately the yield was 35%. Compound 309, underwent Wacker 
oxidation in 3 days at 50°C. Pleasantly, the yield was 70% , but it is believed longer 
reaction times at 50 °C result in decomposition of product. Finally, the removed of MOM 
protected on compound 310 gave 58% yield of diospongin B 4 was produced (Scheme 
97). 
 
Scheme 97 Reagent & Conditions: i) PdCl2 (50 mol%), CuCl, O2, DMF + H2O, 50 °C, 
70% ii) MOMCl, iPr2NEt, NaI, THF, 55 °C, 10 hr, 60% iii) HCl aq/ THF, RT, 2 hr, 
58%. 
 
 
Figure 41 1H-1H COSY NMR Correlation of diospongin B 4  
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The 1H-1H COSY spectrum of diospongin B 4 (Figure 40), shows a double triplet at 1.51 
ppm which was integrated as 1H and assigned as H-5ax. This proton shows geminal 
coupling to H-5eq with a J-value of 12.4 Hz. The H-5ax also shows a trans-diaxial 
coupling with H-4 and H-6 both with J-value of 9.5 Hz.  
 
The two double double doublets at 2.52 and 1.92 ppm was assigned as H-3eq and H-3ax, 
showing trans-diaxial coupling between H-3ax and H-4 with J-value of 9.9 Hz. The H-
3ax has a J-value of 4.3 Hz and showed coupling to H-2, and a geminal coupling to H-3 
with a J-value of 13.4 Hz. Two doublet of doublets at 3.46 and 3.18 ppm were assigned 
as H-8 and showed matching coupling with H-6 with J-value of 7.1 and 6.0 Hz and 
geminal coupling with J-value of 15.8 Hz.  
 
There was a double double double doublet at 4.03 ppm which was assigned as H-4 and 
integrated for 1H, it showed matching coupling with both H-3, H-4 and H-5. Another 
double double double doublet at 4.23 ppm that integrated for 1H and this was assigned as 
H-6, it showed matching coupling to the both H-5, and coupled to both H-8.  
 
There was a peak at 5.19 ppm was assigned as H-2 and integrated as 1H, which coupled 
to both H-3eq and H-3ax. Lastly, the aromatic protons peak in between 7.98 -7.3 ppm 
that integrated for 10H. It showed the 1H NMR spectrum of diospongin B 4 were identical 
to those reported in the literature (Figure 41).113 
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2.16     The synthesis of 3,6-disubstituted tetrahydropyran. 
With a successful strategy developed for the synthesis of 2,6-cis THP rings and 2,6-trans-
THPs rings, we turned our intention to expand our conversions of DHPs into THPs ring 
with other substitution patterns. 
It was decided to explore the synthesis of 3,6-disubstituted THPs, where the THP can be 
formed by the conjugate reduction of the C2-C3 double bond. When DHPs were treated 
with L-Selectride® at  ̶ 78 °C and quenched, the enol tautomer was formed as a major 
product and also a minor keto-tautomer was formed. Again, in order to characterize the 
product mixture, it was converted into the enol acetate by treatment with Ac2O, pyridine 
and DMAP (Scheme 98).  
 
Scheme 98 Reagent & Conditions: i) L-Selectride®, THF, ‒78 °C, ii) Ac2O, pyridine, 
DMAP, 45 °C. 
Entry Starting 
material 
R1 Yield (%) 
314 
Ratioa,b 
enol: keto 
Yield (%) 
315 
Product 
a 259 2-Furyl 44 1: 0.4 58 316 
b 264 Phenyl 74 1: 0.2 68 317 
c 263 Pr 89 1: 0.2 51 318 
d 265 CH2-OTIPS 65 1: 0.2 65 319 
e 269 CH=CHPh 51 1: 0.4 56 320 
aAfter flash column chromatography. bDetermined by integration of the 1H NMR. 
 Table 13 Synthesis of 3,6-disubstituted THPs. 
113 
 
 
 
Figure 42 
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Then we tried with different substituent at position C6, and the reaction worked well with 
moderate yields 51-68%. From the 1H NMR spectrum. We did not detect any reduction 
of the ester or ketone in any of the examples shown (Table 13, entries a-e). 
 
Figure 43 1H-1H COSY correlation of 3,6-disubstituted THPs 316  
 
The major product in the mixture was the enol tautomer, the mixture was then acylated. 
From the 1H NMR spectrum of 316 (Figure 42), there are no enol peak signals around 11-
12 ppm, meaning acylation went to completion. The peak at 2.52 ppm integrated as 3H 
which showed that the acetyl ester was formed and assigned as H-10. From the 1H-1H 
COSY spectrum, the doublet of doublet peak was assigned as H-6 and integrated as 1H 
has J-value of 9.0 Hz showed trans-diaxial coupling with H-5ax at 2.89 ppm and H-6 also 
has J-value of 4.1 showed coupled with H-5eq (Figure 43). The 1H-1H COSY spectrum 
also showed multiplet peak at 4.51 ppm was assigned as H-2 has geminal coupling 
between H-2 only. From this spectrum, the J-value showed the stereochemistry of 3,6-
disubstituted THP ring. 
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2.17     The synthesis of 3,3,6-trisubstituted tetrahydropyran. 
The successful reduction of DHPs with L-Selectride® generated an enolate to construct 
the 3,6-disubstituted THP ring 314. We were interested to discover whether these 
reactions can work when we intercept the enolate with a carbon electrophile to construct 
the 3,3,6-trisubstituted THP ring. The stereochemistry could be determined when the 
hydride would attacked from the pseudo-axial trajectory and the electrophilic quenching 
would occur from the opposite face of the THP ring (Figure 44). Hence, the electrophile 
would gave THP products with a quaternary stereocenter at C3. Initially, this was studied 
with iodomethane (Scheme 99). 
 
Figure 44 Hydride (nucleophile) attack on a DHP, followed quenched with MeI. 
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Scheme 99 Reagent & Conditions: i) L-Selectride®, THF, ‒78 °C, ii) MeI, ‒78 °C to 
RT. 
Entry Starting 
material 
R1 Yielda (%) 
 
Product 
a 264 Phenyl 59 321 
b 263 Pr 58 322 
c 265 CH2-OTIPS 57 323 
d 269 CH=CHPh 53 324 
e 259 2-furyl 57b 325 
             aIsolated yield after column chromatography. bTotal yield of diastereomer. 
Table 14 Synthesis of 3, 3, 6-trisubstituted THPs with iodomethane. 
The reduction of the DHP ring with L-Selectride® followed with an electrophilic quench 
in all examples (Table 14, entries a-d) gave  a single product in yields between 53-59%, 
except for entry e (Table 14), where it formed a mixture of inseperable diastereomers (dr 
1 : 0.2 based on integration of the signals 1H NMR). 
 
Having successfully installed a methyl group at the C3 position using iodomethane as the 
electrophile, we expanded our interest to other alkyl halides; allyl bromide and benzyl 
bromide as the electrophile with hydrogen at C2 position. Pleasingly, in all cases a 
moderate yield of the desired product was obtained. From the 1H NMR spectrum of the 
reaction mixture, no other diastereomers was detected for entries a to d (Scheme 100, 
Table 15 and Scheme 101, Table 16), but for the entry e (Table 15 and Table 16), two 
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diastereomers were formed (dr 1 : 0.2) when we used allylbromide and benzyl bromide 
as the electrophile. 
 
Scheme 100 Reagent & Conditions: i) L-Selectride®, THF, ‒78 °C, ii) Allylbromide, 
 ‒78 °C to RT. 
Entry Starting 
material 
R1 Yielda (%) 
 
Product 
a 264 Phenyl 52 326 
b 263 Pr 52 327 
c 265 CH2-OTIPS 57 328 
d 269 E-CH=CHPh 83 329 
e 259 2-furyl 47b 330 
aIsolated yield after column chromatography. bTotal yield of diastereomer. 
Table 15 Synthesis of 3,3,6-trisubstituted THPs with allylbromide. 
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Scheme 101 Reagent & Conditions: i) L-Selectride®, THF, ‒78 °C, ii) Benzyl bromide, 
 ‒78 °C to RT. 
 
Entry Starting 
material 
R1 Yielda (%) 
 
Product 
a 264 Phenyl 65 331 
b 263 Pr 62 332 
c 265 CH2-OTIPS 62 333 
d 269 E-CH=CHPh 51 334 
e 259 2-furyl 40b 335 
aIsolated yield after column chromatography. bTotal yield of diastereomer. 
Table 16 Synthesis of 3,3,6-trisubstituted THPs with benzyl bromide. 
 
This reaction gave the desired functionalised products when alkyl halide electrophiles 
were used. However, when we tried to intercept the enolate with an aldehyde or an 
epoxide, we were unable generate any product, which could be due to stability of the β-
keto-ester’s enolate anion. The reduction with L-Selectride® does occour but when it was 
quenched with those electrophiles, only the reduction product was observed even it was 
stirred at room temperature for more than 5 days.  
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Figure 45 
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Figure 46 NOE Correlation of 3,3,6-trisubstituted THP 331  
 
The 1H-1H COSY spectrum of 331 (Figure 45) showed there were two doublet of doublets 
at 2.96 and 2.78 ppm which were assigned as H-5 and coupled with peak at 4.89 ppm 
which was assigned as H-6. The H-5ax has J-value of 10.0 Hz showed trans-diaxial 
coupling with H-6, while the H-5eq has J-value of 3.9 Hz showed coupling with H-6. 
 
Then H-9a at 3.40 ppm has J-value of 13.4 Hz showing geminal coupling with H-9b at 
3.33 ppm. Another geminal coupling between H-2 as doublet at 4.13 and 4.10 ppm with 
J-value of 12.4 Hz. 
 
The NOE correlation confirmed, there was NOE correlation between H-6 and H-5eq with 
3.6% when H-6 was irradiated. When H-5eq was irradiated a NOE to H-6 of 2.26% was 
seen. Another NOE between H-5ax and the benzyl CH2 group of 3.16% which indicating 
that these were both axial (Figure 46).  
 
From this, the 3,3,6-trisubstituted THP was characterised and the stereochemical 
configuration confirmed by 1H NMR and NOE correlations. This provide some 
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encouragement that this avenue of research could provide a useful route towards 3,3,6-
trisubstituted THPs to apply in synthesis of natural product. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
122 
 
2.18     Conclusions and Further Work. 
Conclusions. 
We have successfully developed a method to construct 2,6-cis and 2,6-trans substituted 
tetrahydropyrans from dihydropyrans. Initially we attempted the cyclisation of the δ-
hydroxy-β-ketoester with an orthoester for the formation of DHPs. Unfortunately the 
scope is limited to commercially available orthoesters. 
 
Dihydropyrans could be prepared using N, N -dimethylacetamide dimethyl acetal or N, N 
-dimethylformamide dimethyl acetal with δ-hydroxy-β-ketoesters to produce 
dihydropyrans. Pleaseingly the products were produced with modest to good yields with 
varying substitutions. 
 
Functionalisation of DHPs was achieved by reduction of DHPs using L-Selectride®. 
Quenching with iodomethane gave access to 2,6-cis THPs in good yields. With the 
successful construction of the 2,6-cis THP ring, we applied this method to the 
construction of A ring of lasonolide A 1.  
 
DHPs without substitution at C-2 were prepared enabling the synthesis of 2,6-trans 
substituted THPS via conjugate addition. The total synthesis of diospongin B was 
completed using this approach. 
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Our work in forming 3,6-disubstituted tetrahydropyrans by the conjugate reduction of the 
C-2 – C-3 double bond, by treatment with L-Selectride® followed by treatment with an 
alkyl halide has been successfully used to form 3,3,6-trisubstituted THPS. 
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Future Work. 
Our work in the formation of 2,6- cis THPs, 2,6-trans THPs, 3,6-disubstituted THPs and 
3,3,6-trisubstituted THPs has been successful. Thus the next step in our research would 
be to expand the scope of these methods in the synthesis of natural products. For example, 
the 2,6- cis THP ring method could be applied in the synthesis of cyanolide A 22, which 
exhibits significant molluscicidal activity against Biomphalaria glabrata.12 
 
The 2,6-trans THP ring method could be applied in the synthesis of dihydroisocoumarin 
derivatives 336, which has anti-inflammatory effects in lipopolysaccharide-induced BV2 
microglia. 116 
 
The 3,3,6-trisubstituted THP method could be applied in the synthesis of (-)-Bissetone 
337, which display potent anti-microbial activity.117 
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3.0      Experimental 
3.1      General experimental 
Infra-red absorbances were recorded on a ThermoNicolet Avatar 370 FT-IR spectrometer 
using NaCl plates. Nuclear magnetic resonance spectra were recorded on a Jeol ECX-
400, Jeol ECS-400 or Bruker DRX 500 spectrometer at ambient temperature; chemical 
shifts are quoted in parts per million (ppm) and were referenced as follows: chloroform-
d 7.26 ppm for 1H NMR; chloroform-d 77.0 ppm for 13C NMR. Coupling constants (J) 
are quoted in Hertz. Mass spectrometry was performed by the University of York mass 
spectrometry service using electron spray ionisation (ESI) technique. Thin layer 
chromatography was performed on glass-backed plates coated with Merck Silica gel 60 
F254. The plates were developed using ultraviolet light, basic aqueous potassium 
permanganate or ethanolic anisaldehyde. Liquid chromatography was performed using 
forced flow (flash column) with the solvent systems indicated. The stationary phase was 
silica gel 60 (220–240 mesh) supplied by Fluorochem or silica gel Merck TLC grade 
11695 supplied by Sigma-Aldrich. Dry solvents were acquired from a PureSolv PS-MD-
7 solvent tower or distilled as follows: CH2Cl2 was distilled from calcium hydride; THF 
was distilled from sodium–benzophenone ketyl; Et2O was distilled from LiAlH4; toluene 
and triethylamine were distilled from calcium hydride and methanol from CaSO4 or 
Mg/I2. All other solvents and reagents were used as received from commercial suppliers. 
All numbering on the structures below is for the benefit of characterisation and does not 
conform to IUPAC rules. 
126 
 
3.2       Experimental procedures 
Aldol reaction 
Method A: Weiler dianion 
To a slurry of sodium hydride (414 mg, 10.34 mmol) in THF (20 ml) at 0 °C was added 
methyl acetoacetate (100 mg, 8.62 mmol) slowly over 5 minutes during which time gas 
evolution was observed. The colourless solution was stirred for 10 min at 0 ºC and then 
n-butylithium (3.79 mL, 9.48 mmol, 2.5 M in hexanes) was added. The light yellow 
solution was stirred at room temperature for 20 min and was then cooled in an acetone 
dry ice bath. Once the temperature had reached ‒78 ºC the aldehyde (9.48 mmol) was 
added over a 5 min period. The solution was kept at ‒78 ºC for 5 min and was then 
warmed to room temperature over 30 min. The light yellow solution was stirred for 30 
min and then H2O (10 mL) was added. The mixture was extracted with EtOAc (50 mL) 
and washed with 5% NaHCO3 (3 x 30 mL) and brine (2 x 30 mL), dried with MgSO4, 
and concentrated in vacuo to give the crude product which was further purified by flash 
silica gel column chromatography (hexane – ethyl acetate) to give the product.  
 
Method B: Alternative Weiler dianion Procedure  
A 2.5 M n-butylithium (36.00 mL, 90 mmol) in hexanes was added to diisopropylamine 
(12.60 mL, 90 mmol) in THF at ‒78 oC, the mixture was stirred for 15 minutes at ‒78 oC 
then warm-up to room temperature for 5 minutes then the mixture was cool to ‒78 oC. 
Lithium diisopropylamide (90 mmol) was stirred in dry THF (156 mL) at ‒78 °C under a 
nitrogen atmosphere. A solution of methyl acetoacetate (4.90 mL, 45 mmol) in dry THF 
(31 mL) was added slowly over 10 minutes and the reaction mixture were stirred for 30 
minutes. Aldehyde (0.84 mL, 15 mmol) in dry THF (31 mL) was added to the reaction 
mixture at ‒50 oC and stirred for 30 min. Acetic acid (10 M in THF) (23 mL) was added 
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at ‒50 oC, and the crude reaction was extracted with EtOAc (2x50 mL) and the combined 
organic phases were washed with H2O (50 mL) and brine (50 mL). The organic phase 
was dried over MgSO4. After concentration in vacuo, the crude product was purified by 
column chromatography on silica gel (hexane – ethyl acetate). 
 
Method C: Diketene addition  
A 3.0 M solution of titanium tetrachloride in CH2Cl2 (0.50 mL, 1.50 mmol) was added to 
a stirred solution of aldehyde (1.30 mmol) and diketene (0.19 mL, 2.50 mmol) in CH2Cl2 
(6.50 mL) at ‒78 °C. After 5 minutes methanol (2 mL) was added, and the mixture stirred 
at ‒20 to ‒10 °C for 40 minutes. The mixture was poured onto ice-cooled K2CO3 solution 
(0.44 M aqueous solution, 10.00 mL, 4.4 mmol). The pale yellow precipitate formed was 
filtered, and the precipitate extracted with Et2O (2 x 20.00 mL). The organic extracts were 
combined and washed with sat. aq. NaHCO3 (2 x 20.0 mL) and brine (20.0 mL), dried 
over MgSO4 and concentrated in vacuo. Purification via flash column chromatography 
(hexane – ethyl acetate) afforded the product. 
 
Method D: Alternative Diketene Procedure  
Titanium tetraisopropoxide (2.86 mL, 9.70 mmol) was added to a stirred solution of 
aldehyde (9.70 mmol) and diketene (1.34 mL, 17.40 mmol) in CH2Cl2 (26.00 mL) at ‒78 
°C. After 5 minutes methanol (1.56 mL, 38.60 mmol) was added, and the mixture stirred 
at ‒20 to ‒10 °C for 1.5 hours. The reaction mixture was diluted with Et2O (20.00 mL), 
and washed with (20 % w/v) citric acid solution (30.00 mL). The aqueous layer was 
extracted with Et2O (2 x 20.00 mL), and the combined organic extracts washed with brine 
(2 x 20.00 mL), dried over MgSO4 and concentrated in vacuo. Flash column 
chromatography (hexane – ethyl acetate) gave the product. 
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Method E: Chan’s Diene Addition 
Titanium tetrachloride (0.63 mL, 5.70 mmol) was added to a stirred solution of aldehyde 
(5.70 mmol) in CH2Cl2 (55.00 mL) at ‒78 °C. After 5 minutes Chan’s diene in neat (2.97 
g, 11.40 mmol) was added dropwise over one minute, and the mixture stirred at ‒78 °C 
for 20 minutes before being quenched with TFA (1.69 mL, 22.80 mmol). The mixture 
was diluted with EtOAc (150 mL) then washed with sat. aq. NaHCO3 (2 x 60.00 mL) and 
brine (60.00 mL), dried over MgSO4 and concentrated in vacuo. Flash column 
chromatography (hexane – ethyl acetate) gave the product. 
 
Methyl 5-hydroxy-6-methyl-3-oxoheptanoate (182) 
 
Method C, isobutyraldehyde (0.12 mL, 1.30 mmol), diketene (0.19 mL, 2.50 mmol), 3.0 
M solution of TiCl4 in CH2Cl2 (0.50 mL, 1.50 mmol), MeOH (2.00 mL, 49.40 mmol), 
CH2Cl2 (6.50 mL); purification (hexane – ethyl acetate = 3: 2), percentage yield 0.127 g, 
52 % light yellow oil. υ max/cm-1 (film) 3474 (OH) , 2959 (C-H), 2931 (C-H), 
1741(C=O), 1710 (C=O), 1437 (CH3), 1320 (CH3), 1259 (C-O), 1151 (C-O); δH  (400 
MHz, CDCl3): δ 3.85‒3.80 (1H, m, H-5), 3.72 (3H, s, H-9), 3.51 (1H, d, J = 12.3 Hz, H-
2), 3.48 (1H, d, J = 12.3 Hz, H-2), 2.75 (1H, br s, OH), 2.71 (1H, dd, J = 16.0, 4.0 Hz, H-
4), 2.62 (1H, dd, J = 16.0, 8.0 Hz, H-4), 1.71‒1.63 (1H, m, H-6), 0.91 ( 3H, d, J = 8.0 Hz, 
H-7) and 0.89 (3H, d, J = 8.0 Hz, H-8); δC (100 MHz, CDCl3): 203.9 (C=O), 167.3 (C=O), 
72.3 (C-5), 52.5 (C-9), 49.8 (C-2), 46.9 (C-4), 33.2 (C-6), 18.4 (C-7) and 17.8 (C-8); m/z 
(ESI+) 211 (M + Na)+. (Found 211.0948 (M + Na)+. C9H16NaO4 requires 211.0946). 
NMR data were in agreement with the literature.53 
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Methyl 5-hydroxy-3-oxooctanoate (183) 
 
Method C, butyraldehyde (0.24 mL, 2.60 mmol), diketene (0.38 mL, 5.00 mmol), 3.0 M 
solution of TiCl4 in CH2Cl2 (1.00 mL, 3.00 mmol), MeOH (4.00 mL, 98.80 mmol), 
CH2Cl2 (13.00 mL); purification (hexane – ethyl acetate = 3: 2), percentage yield 0.303 
g, 62 % light yellow oil. υ max/cm-1 (film) 3395 (OH), 2914 (C-H), 2889 (C-H), 1719 
(C=O), 1687 (C=O), 1386 (CH3), 1250 (C-O), 1136 (C-O); δH  (400 MHz, CDCl3): δ 
4.07‒4.01 (1H, br m, H-5), 3.70 (3H, s, H-9), 3.44 (1H, d, J = 14.5 Hz, H-2), 3.41 (1H, 
d, J = 14.5 Hz, H-2), 2.70 (1H, br s, OH), 2.67 (1H, dd, J = 17.3, 3.3 Hz, H-4), 2.61 (1H, 
dd, J = 17.3, 8.6 Hz, H-4), 1.50‒1.28 (4H, m, H-6, H-7) and 0.90‒0.87 (3H, t, J = 8.0 Hz, 
H-8); δC (100 MHz, CDCl3): 203.7 (C=O), 167.5 (C=O), 67.3 (C-5), 52.5 (C-9), 49.8 (C-
2), 49.7 (C-4), 38.7 (C-6), 18.7 (C-7) and 13.9 (C-8); m/z (ESI+) 211 (M + Na)+. (Found 
211.0944 (M + Na)+. C9H16NaO4 requires 211.0946). NMR data were in agreement with 
the literature.53 
 
Methyl 6-(benzyloxy)-5-hydroxy-3-oxohexanoate (184) 
 
Method D, Benzyloxyacetaldehyde (1.36 mL, 9.70 mmol), diketene (1.34 mL, 17.40 
mmol), Ti(OiPr)4 (2.86 mL, 9.70 mmol), MeOH ( 1.56 mL, 38.60 mmol), CH2Cl2 (26.00 
mL): purification (hexane – ethyl acetate = 3: 2), percentage yield 0.593 g, 23 % oil. 
Method E, Benzyloxyacetaldehyde (0.80 mL, 5.7 mmol), Chan’s diene (2.97 g, 11.4 
mmol), TiCl4 (0.63 mL, 5.7 mmol), TFA (1.69 mL, 22.8 mmol), CH2Cl2 (55.0 mL): 
purification (hexane – ethyl acetate = 3: 2), percentage yield 1.152 g, 76 % light yellow 
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oil. υ max/cm-1 (film) 3452 (OH), 2861 (C-H), 1741 (C=O), 1712 (C=O), 1252 (C-O), 
1203 (C-O), 1096 (C-O), 738 (Ar), 698 (Ar), 481 (Ar);  δH  (400 MHz, CDCl3): δ 7.38‒
7.27 (5H, m, Ar), 4.58 (1H, d, J = 12.1 Hz, H-7), 4.52 (1H, d, J = 12.1 Hz, H-7), 4.32‒ 
4.24 (1H, m, H-5), 3.73 (3H, s, H-9), 3.11 (1H, d, J = 12.1 Hz, H-2), 3.08 (1H, d, J = 12.1 
Hz, H-2), 3.49 (1H, dd, J = 9.6, 4.6 Hz, H-4), 3.44 (1H, dd, J = 9.6, 6.12 Hz, H-4), 2.78 
(1H, dd, J = 17.1, 6.5 Hz, H-6) and 2.73 (1H, dd, J = 17.1, 3.9 Hz, H-6);δC (100 MHz, 
CDCl3): 202.7 (C=O), 167.8 (C=O), 138.1 (C-10), 128.6 (Ar), 127.9 (Ar), 127.8 (Ar), 
73.5 (C-4), 73.1 (C-7), 66.8 (C-5), 52.5 (C-9), 49.9 (C-2), 46.5 (C-6); m/z (ESI+) 289 (M 
+ Na)+. (Found 289.1058 (M + Na)+. C14H18NaO5 requires 289.1052). NMR data were in 
agreement with the literature.53 
 
Methyl 5-hydroxy-3-oxo-5-phenylpentanoate (138)  
 
Method D, Benzaldehyde ( 1.97 mL, 19.40 mmol), diketene (5.36 mL, 34.80 mmol), 
Ti(OiPr)4  (5.74 mL, 19.40 mmol), MeOH (3.12 mL, 77.20 mmol), CH2Cl2 (52.00 mL); 
purification (hexane – ethyl acetate = 3: 2), percentage yield 2.239 g, 52 % light yellowoil. 
υ max/cm-1 (film) 3452 (OH), 2953 (C-H), 1739 (C=O), 1710 (C=O), 1475 (Ar), 1264 
(C-O), 1196 (C-O), 750 (Ar), 700 (Ar), 538 (Ar); δH  (400 MHz, CDCl3): δ 7.32‒7.24 
(5H, m, Ar), 5.14 (1H, dd, J = 8.0, 4.0 Hz, H-5), 3.69 (3H, s, H-9),  3.46 (2H, s, H-2), 
3.36 (1H, br s, OH),  2.96 (1H, dd, J = 16.0, 10.0 Hz, H-4), 2.84 (1H, dd, J = 16.0, 4.0 
Hz, H-4); δC (100 MHz, CDCl3): 202.7 (C=O), 167.6 (C=O), 142.7 (C-10), 128.7 (Ar), 
127.9 (Ar), 125.7 (Ar), 69.9 (C-5), 52.6 (C-9), 51.7 (C-2) and 49.7 (C-4); m/z (ESI+) 245 
(M + Na)+. (Found 245.0784 (M + Na)+. C12H14NaO4 requires 245.0790). NMR data were 
in agreement with the literature.53 
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Methyl 5-(furan-2-yl)-5-hydroxy-3-oxopentanoate (185) 
 
 
Method D, Furfural (0.80 mL, 9.70 mmol), diketene (1.34 mL, 17.40 mmol), Ti (OiPr) 4 
(2.86 mL, 9.70 mmol), MeOH (1.56 mL, 38.60 mmol), CH2Cl2 (26.00 mL); purification 
(hexane – ethyl acetate = 3: 2), percentage yield 1.275 g, 62 % light yellow oil. υ max/cm-
1 (film) 3407 (OH), 1704 (C=O), 1711 (C=O), 1618 (C=C), 1208 (C-O), 1248 (C-O), 
1148 (C-O), 1011 (C-O); δH  (400 MHz, CDCl3): δ 7.37 (1H, dd, J = 1.8, 0.8 Hz, H-8), 
6.33 (1H, dd, J = 3.2, 1.8 Hz, H-7), 6.28 (1H, dd, J = 3.2, 0.7 Hz, H-6), 5.20 (1H, dd, J = 
8.8, 3.4 Hz,  H-5), 3.75 (3H, s, H-9), 3.55 (1H, d, J = 12.2 Hz, H-2), 3.51 (1H, d, J = 12.2 
Hz, H-2), 3.17 (1H, dd, J = 17.6, 8.8 Hz, H-4), 3.04 (1H, dd, J = 17.6, 3.4 Hz, H-4); δC 
(100 MHz, CDCl3): 202.2 (C=O), 167.5 (C=O), 154.7 (C-10), 142.7 (C-7), 110.5 (C-8), 
106.4 (C-6), 63.7 (C-5), 52.3 (C-9), 49.9 (C-2), and 48.1 (C-4); m/z (ESI+) 235 (M + Na)+. 
(Found 235.0577 (M + Na)+. C10H12NaO5 requires 235.0582).
 NMR data were in 
agreement with the literature.119 
 
Methyl 5-hydroxy-5-(2-nitrophenyl)-3-oxopentanoate (186) 
 
Method D, 2-nitrobenzaldehyde (1.47g, 9.70 mmol), diketene (1.34 mL, 17.40 mmol), 
Ti(OiPr) 4 (2.86 mL, 9.70 mmol), MeOH (1.56 mL, 38.60 mmol), CH2Cl2 (26.00 mL); 
purification (hexane – ethyl acetate = 4: 1), percentage yield 1.321 g, 51 % yellow solid. 
υ max/cm-1 (film) 3496 (OH), 2942 (C-H), 1734 (C=O), 1695 (C=O), 1524 (C=C), 1350 
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(N=O), 1299 (C-N), 1128 (C-O), 1078 (C-O), 788 (Ar), 737 (Ar), 689 (Ar); δH  (400 MHz, 
CDCl3): δ 7.87 (1H, dd, J = 8.4, 1.2 Hz, H-6), 7.82 (1H, dd, J = 7.7, 1.2 Hz, H-9), 7.60 
(1H, ddd, J = 7.7, 7.0, 1.2 Hz, H-8), 7.38 (1H, ddd, J = 8.4, 7.0, 1.4 Hz, H-7), 5.63 (1H, 
dd, J = 9.3, 2.1 Hz,  H-5), 3.75 (1H, OH) 3.66 (3H, s, H-10), 3.52 (1H, d, J = 14.6 Hz, H-
2), 3.49 (1H, d, J = 14.6 Hz, H-2), 3.09 (1H, dd, J = 17.4, 2.3 Hz, H-4) and 2.83 (1H, dd, 
J = 17.4, 9.3 Hz, H-4); δC (100 MHz, CDCl3): 202.2 (C=O), 167.5 (C=O), 147.0 (C-12), 
138.5 (C-11), 133.9 (Ar), 128.5 (Ar), 128.2 (Ar), 124.5 (Ar), 65.5 (C-5), 52.6 (C-10), 50.9 
(C-4) and 49.3 (C-2); m/z (ESI+) 290 (M + Na)+. (Found 290.0635 (M + Na)+. 
C12H13NaO6 requires 290.0641).
 NMR data were in agreement with the literature.120 
 
Methyl 5-hydroxy-3-oxo-6-((triisopropylsilyl)oxy)hexanoate (194) 
 
Method A, 2-((triisopropylsilyl)oxy) acetaldehyde (1.06 g, 4.90 mmol), 
methylacetoacetate (5.40 mmol), NaH (0.26 g, 6.40 mmol), 1.8 M n-BuLi in hexanes 
(3.27 mL) in THF (10 mL); purification (hexane – ethyl acetate = 4: 1), percentage yield 
0.569 g, 35 % light yellow oil. υ max/cm-1 (film) 3453 (OH) , 2943 (C-H), 2866 (C-H), 
1746 (C=O), 1715 (C=O), 1462 (CH3), 1237 (C-O), 1114 (C-O), 1064 (C-O); δH  (400 
MHz, CDCl3): δ 4.12‒4.05 (1H, dddd, J = 7.5, 6.0, 4.9, 4.8 Hz, H-5), 3.54 (1H, dd, J = 
9.8, 4.9 Hz, H-6), 3.48 (1H, dd, J = 9.8, 6.0 Hz, H-6), 3.26 (3H, s, H-7), 3.09 (2H, s, H-
2), 2.67 (1H, br s, OH), 2.48 (1H, dd, J = 16.6, 7.5 Hz, H-4), 2.42 (1H, dd, J = 16.6, 4.8 
Hz, H-4) and 1.03 (21H, m, OTIPS); δC (100 MHz, CDCl3): 204.4 (C=O), 167.0 (C=O), 
68.3 (C-5), 66.6 (C-6), 51.4 (C-7), 49.4 (C-2), 45.8 (C-4), 17.8 (C-OTIPS) and 11.9 (C-
OTIPS); m/z (ESI+) 355 (M + Na)+. (Found 355.1905 (M + Na)+. C16H32NaO5Si requires 
355.1917). NMR data were in agreement with the literature.121 
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Methyl 5-hydroxy-5-(2-methyloxazol-4-yl)-3-oxopentanoate (187) 
 
Method E, 2-methyloxazole-4-carbaldehyde (0.25 g, 2.30 mmol), Chan’s diene (1.20 g, 
4.50 mmol), 3.0 M solution of TiCl4 in CH2Cl2 (0.25 mL, 2.30 mmol), TFA (0.70 mL, 
9.00 mmol) in dicholoromethane (22.00 mL); purification (hexane – ethyl acetate = 1: 4), 
percentage yield 0.151 g, 30 % light yellow oil. υ max/cm-1 (film) 3337 (OH), 2955 (C-
H), 2920 (C-H), 1741 (C=O), 1713 (C=O), 1600 (C=C), 1267 (C-N), 1092 (C-O), 865 
(C=C), 657 (C=C); δH  (400 MHz, CDCl3): δ 7.47 (1H, s, H-6), 5.13‒5.10 (1H, m, H-5), 
3.73 (3H, s, H-8), 3.52 (2H, s, H-2), 3.08‒3.06 (2H, m, H-4) and 2.42 (3H, s, H-7); δC 
(100 MHz, CDCl3): 202.6 (C=O), 167.5 (C=O), 161.6 (C-9), 142.1 (C-10), 134.9 (C-6), 
63.4 (C-5), 52.6 (C-8), 49.7 (C-2), 48.6 (C-4) and 13.9 (C-7); m/z (ESI+) 250 (M + Na)+. 
(Found 250.0682 (M + Na)+. C10H13NaO5 requires 250.0691).
  
 
Methyl 5-hydroxy-3-oxooct-6-enoate (188) 
 
Method D, crotonaldehyde (1.61 g, 19.40 mmol), diketene (2.68 mL, 34.80 mmol), 
Ti(OiPr)4 (5.70 mL, 19.40 mmol), MeOH (3.12 mL), CH2Cl2 (52.00 mL); purification 
(hexane – ethyl acetate = 3: 2), percentage yield 2.346 g, 65 % light yellow oil. υ max/cm-
1 (film) 3424 (OH) , 2955 (C-H), 2920 (C-H), 1741 (C=O), 1710 (C=O), 1450 (CH3), 
1262 (C-O), 1151 (C-O), 967 (C=C); δH  (400 MHz, CDCl3): δ 5.52 (1H, m, H-7), 5.33 
(1H, m, H-6), 4.40 (1H, m, H-5),  3.28 (3H, s, H-7), 3.10 (1H, d, J = 15.7 Hz, H-2), 3.06 
(1H, d, J = 15.7 Hz, H-2), 2.41 (1H, dd, J = 16.5, 8.5 Hz, H-4), 2.26 (1H, dd, J = 16.5, 
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3.7 Hz, H-4) and 1.49 (3H, d, J = 6.5 Hz, H-8); δC (100 MHz, CDCl3): 201.8 (C=O), 
167.0 (C=O), 133.0 (C-6), 125.7 (C-7), 69.3 (C-5), 52.4 (C-9), 51.4 (C-4), 49.6 (C-2), 
17.4 (C-8); m/z (ESI+) 209 (M + Na)+. (Found 209.0784 (M + Na)+. C9H14NaO4 requires 
209.0784). 
 
 (E)-Methyl 5-hydroxy-3-oxo-7-phenylhept-6-enoate (189) 
 
Method D, cinnamaldehyde (5.00 g, 38.80 mmol), diketene (5.37 mL, 69.60 mmol), 
Ti(OiPr)4 (11.50 mL, 38.80 mmol), MeOH (6.24 mL), CH2Cl2 (104.00 mL); purification 
(hexane – ethyl acetate = 3: 2), percentage yield 7.313 g, 76 % light yellow oil. υ max/cm-
1 (film) 3423 (OH) , 3050 (Ar), 2953 (C-H), 1740 (C=O), 1710 (C=O), 1266 (C-O), 1149 
(C-O), 967 (Ar), 747 (Ar), 694 (Ar); δH  (400 MHz, CDCl3): δ 7.28‒7.05 (5H, m, H-8), 
6.57 (1H, d, J = 16.0 Hz,  H-7), (1H, dd, J = 16.0, 5.4 Hz, H-6), 4.62 (1H, m, H-5),  3.30 
(3H, s, H-9), 3.20 (1H, d, J = 16.0 Hz, H-2), 3.16 (1H, d, J = 16.0 Hz, H-2),  2.49 (1H, 
dd, J = 16.8, 8.9 Hz, H-4), 2.31 (1H, dd, J = 16.8, 3.6 Hz, H-4); δC (100 MHz, CDCl3): 
201.8 (C=O), 167.0 (C=O), 136.9 (C-10), 130.8 (C-7), 129.9 (C-6), 128.6 (Ar), 127.8 
(Ar), 126.6 (Ar), 68.3 (C-5), 51.5 (C-9), 50.5 (C-2), 49.2 (C-4); m/z (ESI+) 271 (M + 
Na)+. (Found 271.0937 (M + Na)+. C14H16NaO4 requires 271.0941).
  
 
 Methyl 5-hydroxy-3-oxohexanoate (197) 
 
Method B, methyl acetoacetate (4.90 mL, 45 mmol), acetaldehyde (0.84 mL, 15 mmol), 
2.5 M n-BuLi (36.00 mL, 90 mmol), diisopropylamine (12.60 mL, 90 mmol), THF (216 
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mL); purification (hexane – ethyl acetate = 3: 2), percentage yield 1.728 g, 72 % orange 
oil. υ max/cm-1 (film)  3417 (OH), 2970 (C-H), 1738 (C=O), 1709 (C=O), 1375 (CH3), 
1263 (C-O), 1139 (C-O); δH  (400 MHz, CDCl3): δ 4.25 (1H, m, H-5), 3.72 (3H, s, H-7), 
3.47 (2H, s, H-2), 2.89 (1H, bs, OH), 2.70 (1H, dd, J = 17.6, 3.6 Hz, H-4), 2.64 (1H, dd, 
J = 17.6, 8.4 Hz, H-4) and 1.18 (1H, d, J = 6.4 Hz, H-6); δC (100 MHz, CDCl3): 203.4 
(C=O), 167.4 (C=O), 63.7 (C-5), 52.4 (C-7), 51.0 (C-4), 49.5 (C-2), 22.4 (C-6); m/z (ESI+) 
183 (M + Na)+. (Found 183.0620 (M + Na)+. C7H12NaO4 requires 183.0628). NMR data 
were in agreement with the literature.68 
 
3-Trimethylsilanyloxy-but-2-enoic acid methyl ester (192) 
 
To a solution of methyl acetoacetate (5.00 mL, 0.046 mol) in hexane (200 mL) stirring at 
room temperature under a N2 atmosphere was added triethylamine (5.70 g, 0.056 mol) 
and the reaction was stirred for 30 minutes. The reaction was treated with 
chlorotrimethylsilane (7.00 g, 0.064 mol) and stirred for 17 hours. The mixture was 
filtered through a pad of celite with hexane (200 mL) and the filtrate was concentrated in 
vacuo to give a pale yellow oil. Purification by Kugelrhor distillation (RT - 50 °C, 10-1 
mbar) gave a colourless oil (3.00 g, 35 %). The 1H NMR data were found to be in 
agreement with the literature. δH  (400 MHz, CDCl3): δ 5.05 (1H, s, H-2), 3.58 (3H, s, H-
5), 2.25 (3H, s, H-4) and 0.20 (9H, s, H-6). 1H NMR data were in agreement with the 
literature.122 
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1- Methoxy-1,3-bis-trimethylsilanyloxy-buta-1,3-diene (141) 
 
To a solution of diisopropylamine (1.90 g, 19 mmol) in THF (30 mL) stirring under a N2 
atmosphere at ‒78 °C was added a 2.5 M solution of n-BuLi in hexanes (7.00 mL, 17 
mmol). After 5 minutes the mixture was warmed to room temperature and stirred for 15 
minutes then cooled to ‒78 °C. The reaction was treated with a solution of 189 (3.00 g, 
16 mmol) in THF (20 mL) over a 10 minutes period and was stirred for a further 20 
minutes. The reaction was treated with chlorotrimethylsilane (2.30 g, 21 mmol) and was 
warmed to 0 °C and left to stir for 1 hour. The resulting yellow solution was concentrated 
in vacuo. The salts were removed by filtration through a pad of celite and washed with 
hexane (100 mL). The filtrate was concentrated in vacuo to give a crude yellow oil which 
was purified by Kugelrhor distillation (RT - 50 °C, 10-1 mbar) to give a colourless oil 
(51%). The 1H NMR data were found to be in agreement with the literature. δH  (400 
MHz, CDCl3): δ 4.47 (1H, s, H-2), 4.14 (1H, s, H-4), 3.93 (1H, s, H-4), 3.55 (3H, s, H-
5), 0.27 (9H, s, H-6/H-7), 0.25 (9H, s, H-6/H-7). 1H NMR data were in agreement with 
the literature.122 
 
General procedure for orthoester cyclisations:  
A mixture of δ-hydroxy-β-ketoester (0.30 mmol), trimethyl orthoester (0.05 mL, 0.30 
mmol) and acetic anhydride (0.05 mL, 0.50 mmol) in toluene (2.00 mL) was run under 
microwave for 15 minute. The mixture was then cooled and the solvent removed in vacuo. 
Flash column chromatography (petroleum ether – ethyl acetate) gave the product. 
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Methyl 6-phenyl-2-butyl-4-oxo-5,6-dihydro-2H-pyran-3-carboxylate (199)   
 
δ-Hydroxy-β-ketoester 138 (0.035 g, 0.15 mmol), trimethyl orthovalerate (0.05 mL, 0.30 
mmol), Ac2O (0.05 mL, 0.50 mmol), PhMe (1.00 mL); purification (petroleum ether – 
ethyl acetate = 4:1), percentage yield 0.039 g, 90 %, light yellow oil. υ max/cm-1 (film) 
2961(C-H), 2924 (C-H), 2863 (C-H), 1722 (C=O), 1592 (C=C), 1260 (C-O), 1219 (C-
O), 1158 (C-O), 756, (Ar), 698 (Ar); δH (400MHz, CDCl3) 7.44‒7.34 (5H, m, Ar), 5.41 
(1H, dd, J = 16.0, 4.0 Hz, H-6), 3.84 (3H, s, H-9), 2.88 (1H, dd, J = 16.0, 12.0 Hz, H-
5ax), 2.71 (1H, dd, J = 16.0, 4.0 Hz, H-5eq), 2.55 (2H, t, J = 8.0 Hz, H-7), 1.68- 1.60 (2H, 
m, H-10), 1.42‒1.33 (2H, m, H-11) and 0.91 (3H, t, J = 8.0 Hz, H-12); δC (100 MHz, 
CDCl3) 188.4 (C=O), 180.6 (C=O), 166.7 (C-2), 137.4 (C-8), 128.7 (Ar), 127.6 (Ar), 
126.8 (Ar), 111.1 (C-3), 80.0 (C-6), 52.4 (C-9), 42.4 (C-5), 33.6 (C-7), 29.7 (C-10), 17.6 
(C-11) and 13.8 (C-12); m/z (ESI+) 311 (M + Na)+, 289 (M + H)+. (Found 311.1256 (M 
+ Na)+. C17H20NaO4 requires 311.13).
  
 
Methyl 6-(benzyloxymethyl)-2-butyl-4-oxo-5,6-dihydro-2H-pyran-3-carboxylate 
(200)   
 
δ-Hydroxy-β-ketoester 184 (0.045 g, 0.15 mmol), trimethyl orthovalerate (0.05 mL, 0.30 
mmol), Ac2O (0.05 mL, 0.50 mmol), PhMe (1.00 mL); purification (petroleum ether – 
ethyl acetate = 4:1), percentage yield 0.025 g, 51 %, light yellow oil. υ max/cm-1 (film) 
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2955 (C-H), 2926 (C-H), 2869 (C-H), 1718 (C=O),1680 (C=C), 1375 (CH3), 1341 (C-
O), 1208 (C-O), 1066 (C-O), 804 (Ar), 737 (Ar), 698 (Ar); δH (400MHz, CDCl3) 7.31‒
7.24 (5H, m, Ar), 4.62 (1H, d, J = 12.12 Hz, H-8), 4.58 (1H, d, J = 12.12 Hz, H-8), 4.57‒ 
4.53 (1H, m, H-6), 3.80 (3H, s, H-10), 3.73 (1H, dd, J = 10.9, 3.7 Hz, H-7), 3.68 (1H, dd, 
J = 10.9, 5.0 Hz, H-7), 2.72 (1H, dd, J = 16.7, 13.6 Hz, H-5ax), 2.51 (1H, dd, J = 16.7, 
3.5 Hz, H-5eq), 2.49 (2H, d, J = 7.6 Hz, H-11), 1.65‒1.57 (2H, m, H-12), 1.42- 1.32 (2H, 
m, H-13) and 0.92 (3H, t, J = 8.0 Hz, H-14); δC (100 MHz, CDCl3) 188.4 (C=O), 179.8 
(C=O), 166.7 (C-2), 137.4 (C-10), 128.5 (Ar), 127.8 (Ar), 127.1 (Ar), 112.3 (C-3), 78.1 
(C-6), 73.5 (C-8), 70.4 (C-7), 52.2 (C-10), 37.5 (C-5), 33.4 (C-11), 29.1 (C-12), 22.50 
(C-13) and 13.8 (C-14); m/z (ESI+) 355 (M + Na)+, 333 (M + H)+. (Found 355.1515 (M 
+ Na)+. C19H24NaO5 requires 355.1521). 
 
 
Methyl 2-isopropyl-6-methyl-4-oxo-3,4-dihydro-2H-pyran-5-carboxylate (205) 
 
δ-Hydroxy-β-ketoester 182 (0.031 g, 0.15 mmol), trimethyl orthoacetate (0.04 mL, 0.30 
mmol), Ac2O (0.05 mL, 0.50 mmol), PhMe (1.00 mL); purification (petroleum ether – 
ethyl acetate = 4:1), percentage yield 0.010 g, 32 %, light yellow oil. υ max/cm-1 (film) 
2955 (C-H), 2926 (C-H), 2869 (C-H), 1718 (C=O), 1672 (C=C), 1375 (CH3), 1208 (C-
O), 1066 (C-O), 804 (C=C), 737 (C=C); δH (400MHz, CDCl3) 3.66 (3H, s, H-9), 3.46 
(1H, m, H-6), 2.07 (1H, dd, J = 9.24, 7.12 Hz, H-5ax), 2.04 (1H, dd, J = 9.24, 1.88 Hz, 
H-5eq), 1.93 (3H, s, H-10), 1.43 (1H, m, H-7), 0.68 (3H, d, J = 6.8 Hz, H-8) and 0.68 
(3H, d, J = 6.8 Hz, H-8); δC (100 MHz, CDCl3) 188.8 (C=O), 175.2 (C=O), 166.3 (C-2), 
111.9 (C-3), 83.9 (C-6), 52.20 (C-9), 38.1 (C-5), 31.7 (C-7), 20.67 (C-10), 17.6 (C-8) and 
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16.9 (C-8); m/z (ESI+) 235 (M + Na)+, 213 (M + H)+. (Found 235.0952 (M + Na)+. 
C11H16NaO4 requires 235.09).  
 
Methyl 2-(furan-2-yl)-6-methyl-4-oxo-3,4-dihydro-2H-pyran-5-carboxylate (204)   
 
δ-Hydroxy-β-ketoester 185 (0.032 g, 0.15 mmol), trimethyl orthoacetate (0.04 mL, 0.30 
mmol), Ac2O (0.05 mL, 0.50 mmol), PhMe (1.00 mL); purification (petroleum ether – 
ethyl acetate = 4:1), percentage yield 0.012 g, 34 %, light yellow oil. υ max/cm-1 (film) 
2950 (C-H), 2925 (C-H), 1705 (C=O), 1667 (C=C), 1381 (CH3), 1039 (C-O); δH 
(400MHz, C6D6) 6.86 (1H, dd, J = 1.8, 0.8 Hz, H-13), 5.86 (1H, d, J = 3.3 Hz, H-11), 
5.84 (1H, dd, J = 3.3, 1.8 Hz, H-12), 4.56 (1H, dd, J = 12.5, 3.9 Hz, H-6), 3.48 (3H, s, H-
9), 2.51 (1H, dd, J = 16.6, 12.5 Hz, H5ax), 2.13 (1H, dd, J = 16.6, 3.9 Hz, H-5eq) and 
1.78 (3H, s, H-7); δC (100 MHz, C6D6) 185.6 (C=O), 174.4 (C=O), 165.9 (C-2), 150.0 
(C-12), 143.2 (C-8), 113.3 (C-3), 110.3 (C-10), 109.5 (C-9), 72.8 (C-6), 51.4 (C-11), 38.4 
(C-5) and 19.3 (C-7); m/z (ESI+) 259 (M + Na)+, 237 (M + H)+, 205 (M - CH3OH)+.  
(Found 259.0577 (M + Na)+.  C12H12NaO5 requires 259.0577).
  
 
Synthesis of dihydropyrans: amide acetal cyclisations 
General procedure for the synthesis of 2-methyl dihydropyrans: 
N,N-Dimethylacetamide dimethyl acetal (0.06 mL, 0.40 mmol) was added to a stirred 
solution of δ-hydroxy- β-ketoester (0.20 mmol) in dry CH2Cl2 (2.00 mL) at room 
temperature. After the mixture was stirred for 45 minute, then BF3.OEt2 (0.05 mL, 0.40 
mmol) was added into mixture. The solution was stirred at room temperature and 
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monitored by TLC. Upon completion of the reaction, the mixture was diluted with EtOAc 
(40.0 mL) and washed with sat. aq. NaHCO3 (10.0 mL). The aqueous layer was extracted 
with EtOAc (15.0 mL) and the combined organic extracts were washed with brine (10.0 
mL), dried over MgSO4 and concentrated in vacuo to give the DHP. Flash column 
chromatography (hexane – ethyl acetate) gave the product. 
 
 
Methyl 6-isopropyl-2-methyl-4-oxo-5,6-dihydro-2H-pyran-3-carboxylate (205) 
 
δ-Hydroxy-β-ketoester 182 (0.086 g, 0.46 mmol), N,N-dimethylacetamide dimethyl 
acetal (0.13 mL, 0.92 mmol), BF3.OEt2 ( 0.11 mL, 0.92 mmol), CH2Cl2 (4.00 mL), 
purification (hexane – ethyl acetate = 4:1): percentage yield 0.071 g, 73%, light yellow 
oil. υ max/cm-1 2964 (C-H), 2882 (C-H), 1715 (C=O), 1673 (C=C), 1396 (CH3), 1217 
(C-O), 1082 (C-O), 1053 (C-O), 800 (C=C), 597 (C=C); δH (400MHz, C6D6) 3.52 (3H, s, 
H-10), 3.30 (1H, m, H-6), 1.92 (1H, dd, J = 9.24, 7.12 Hz, H-5ax), 1.92 (1H, dd, J = 9.24, 
1.88 Hz, H-5eq) 1.84 (3H, s, H-7), 1.30 (1H, m, H-8), 0.53 (3H, d, J = 6.8 Hz, H-9) and 
0.47 (3H, d, J = 6.8 Hz, H-9); δC (100 MHz, C6D6) 187.0 (C=O), 175.1 (C=O), 166.3 (C-
2), 113.0 (C-3), 83.1 (C-6), 51.4 (C-10), 37.8 (C-5), 31.2 (C-8), 19.3 (C-7), 17.2 (C-9) 
and 16.9 (C-9); m/z (ESI+) 235 (M + Na)+, 213 (M + H)+, (Found 235.0945 (M + Na)+. 
C11H16NaO4 requires; 235.0941.
  
 
 
 
141 
 
Methyl 6-(furan-2-yl)-2-methyl-4-oxo-5,6-dihydro-2H-pyran-3-carboxylate (204) 
 
δ-Hydroxy-β-ketoester 185 (0.14 g, 0.65 mmol), N,N-dimethylacetamide dimethyl acetal 
(0.19 mL, 1.30 mmol), BF3.OEt2 ( 0.16 mL, 1.30 mmol), CH2Cl2 (4.00 mL), purification 
(hexane – ethyl acetate = 4:1): percentage yield 0.027 g, 18%, light orange oil . υ max/cm-
1 2951 (C-H), 2920 (C-H), 1714 (C=O), 1663 (C=C), 1337 (CH3), 1204 (C-O), 777 
(C=C), 700 (C=C); δH (400MHz, C6D6) 6.86 (1H, dd, J = 1.8, 0.8 Hz, H-8), 5.86 (1H, d, 
J = 3.3 Hz, H-9), 5.84 (1H, dd, J = 3.3, 1.8 Hz, H-10), 4.56 (1H, dd, J = 12.5, 3.9 Hz, H-
6), 3.48 (3H, s, H-11), 2.51 (1H, dd, J = 16.6, 12.5 Hz, H-5ax), 2.13 (1H, dd, J = 16.6, 
3.9 Hz, H-5eq) and 1.78 (3H, s, H-7); δC (100 MHz, C6D6) 185.6 (C=O), 174.4 (C=O), 
165.9 (C-2), 150.0 (C-12), 143.2 (C-8), 113.3 (C-3), 110.3 (C-10), 109.5 (C-9), 72.8 (C-
6), 51.4 (C-11), 38.4 (C-5), and 19.3 (C-7); m/z (ESI+) 259 (M + Na)+, 237 (M + H)+, 
(Found 259.0577 (M + Na)+. C12H12NaO5 requires; 259.0577.
  
 
Methyl 2-methyl-4-oxo-6-propyl-5,6-dihydro-2H-pyran-3-carboxylate (208)    
 
δ-Hydroxy-β-ketoester 183 (0.13 g, 0.70 mmol), N,N-dimethylacetamide dimethyl acetal 
(0.20 mL, 1.40 mmol), BF3.OEt2 ( 0.16 mL, 1.40 mmol), CH2Cl2 (5.00 mL), purification 
(hexane – ethyl acetate = 4:1): percentage yield 0.074 g, 50%, light yellow oil. υ max/cm-
1 2957 (C-H), 2849 (C-H), 1715 (C=O), 1675 (C=C), 1397 (CH3), 1205 (C-O), 1081 (C-
O), 1043 (C-O), 802 (C=C), 579 (C=C); δH (400MHz, C6D6) 3.50 (1H, m, H-6), 3.47 (3H, 
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s, H-11), 1.88 (1H, dd, J = 16.5, 3.7 Hz, H-5ax), 1.80 (3H, s, H-7), 1.79 (1H, dd, J = 16.5, 
13.1 Hz, H-5eq), 1.14‒0.77 (4H, m, H-8, H-9) and 0.54 (3H, t, J = 7.3 Hz, H-10); δC (100 
MHz, C6D6) 187.0 (C=O), 175.2 (C=O), 166.5 (C-2), 113.3 (C-3), 78.8 (C-6), 51.6 (C-
11), 40.9 (C-5), 36.1 (C-8), 19.6 (C-7), 18.0 (C-9) and 13.7 (C-10); m/z (ESI+) 235 (M + 
Na)+, 213 (M + H)+, (Found 235.0937 (M + Na)+. C11H16NaO4 requires; 235.0941.
  
 
2-Methyl-4-oxo-6-phenyl-5,6-dihydro-4H-pyran-3-carboxylic acid methyl ester 
(207) 
 
δ-Hydroxy-β-ketoester 138 (0.13 g, 0.52 mmol), N,N-dimethylacetamide dimethyl acetal 
(0.16 mL, 1.00 mmol), BF3.OEt2 (0.12 mL, 1.00 mmol), CH2Cl2 (4.00 mL), purification 
(hexane – ethyl acetate = 4:1): percentage yield 0.083 g, 65%, light yellow solid. υ 
max/cm-1 2951 (C-H), 2920 (C-H), 1714 (C=O), 1663 (C=C), 1394 (CH3), 1204 (C-O), 
777 (C=C), 700 (C=C); δH (400MHz, C6D6) 7.44‒7.34 (5H, m, Ar), 5.41 (1H, dd, J = 
14.3, 3.3 Hz, H-6), 3.82 (3H, s, H-9), 2.88 (1H, dd, J = 16.6, 14.3 Hz, H-5ax), 2.67 (1H, 
dd, J = 16.6, 3.3 Hz, H-5eq), 2.28 (3H, s, H-7); δC (100 MHz, C6D6) 186.1 (C=O), 176.9 
(C=O), 166.0 (C-2), 137.9 (C-8), 128.6 (Ar), 128.4 (Ar), 125.8 (Ar), 113.6 (C-3), 80.2 
(C-6), 51.4 (C-9), 42.1 (C-5), and 19.3 (C-7); m/z (ESI+) 269 (M + Na)+, 247 (M + H)+, 
(Found 269.0772 (M + Na)+. C14H14NaO4 requires; 269.0784.
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Methyl 6-(benzyloxymethyl)-2-methyl-4-oxo-5,6-dihydro-2H-pyran-3-carboxylate 
(209) 
 
δ-Hydroxy-β-ketoester 184 (0.40 g, 1.52 mmol), N,N-dimethylacetamide dimethyl acetal 
(0.67 mL, 4.60 mmol), BF3.OEt2 (0.67 mL, 4.60 mmol), CH2Cl2 (15.00 mL), purification 
(hexane – ethyl acetate = 4:1): percentage yield 0.242 g, 55%, light yellow oil. υ max/cm-
1 2952 (C-H), 2865 (C-H), 1715 (C=O), 1672 (C=C), 1396 (CH3), 1208 (C-O), 1078 (C-
O), 1055 (C-O), 738 (C=C), 698 (C=C); δH (400MHz, C6D6) 7.36‒7.06 (5H, m, Ar), 4.16 
(1H, d, J = 12.0 Hz, H-9), 4.11 (1H, d, J = 12.0 Hz, H-9), 3.79 (1H, dddd, J = 13.5, 5.0, 
3.5, 3.5 Hz,  H-6), 3.54 (3H, s, H-11), 3.03 (1H, dd, J = 10.5, 3.5 Hz, H-8), 2.97 (1H, dd, 
J = 10.5, 5.0 Hz, H-8), 2.26 (1H, dd, J = 16.5, 13.5 Hz, H-5ax), 1.99 (1H, dd, J = 16.5, 
3.5 Hz, H-5eq), 1.87 (3H, s, H-7); δC (100 MHz, C6D6) 186.6 (C=O), 175.1 (C=O), 166.4 
(C-2), 138.2 (C-12), 128.6 (Ar), 128.1 (Ar), 127.9 (Ar), 113.3 (C-3), 78.0 (C-6), 73.2 (C-
9), 70.4 (C-8), 51.7 (C-11), 37.4 (C-5), and 19.6 (C-7); m/z (ESI+) 313 (M + Na)+, 291 
(M + H)+, (Found 313.1038 (M + Na)+. C16H18NaO5 requires; 313.1046.
  
 
General procedure for the synthesis of 2-H dihydropyrans: 
N,N-Dimethylformamide dimethyl acetal (0.03 mL, 0.20 mmol) was added to a stirred 
solution of δ-hydroxy-β-ketoester (0.20 mmol) in dry CH2Cl2 (2.00 mL) at room 
temperature. After the mixture was stirred for 45 minute, then BF3.OEt2 (0.03 mL, 0.20 
mmol) was added into mixture.  The solution was stirred at room temperature and 
monitored by TLC (hexane – ethyl acetate = 4: 1). Upon completion of the reaction, the 
mixture was diluted with EtOAc (40.0 mL) and washed with sat. aq. NaHCO3 (10.0 mL). 
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The aqueous layer was extracted with EtOAc (15.0 mL) and the combined organic 
extracts were washed with brine (10.0 mL), dried over MgSO4 and concentrated in vacuo 
to give the DHP. No further purification was carried out on the product. 
 
 
Methyl 2-isopropyl-4-oxo-3,4-dihydro-2H-pyran-5-carboxylate (262) 
 
δ-Hydroxy-β-ketoester 182 (0.06 g, 0.30 mmol), N,N-dimethylformamide dimethyl acetal 
(0.04 mL, 0.30 mmol), BF3.OEt2 (0.04 mL, 0.30 mmol), CH2Cl2 (3.00 mL), yielded 0.057 
g, 97%, light yellow oil. υ max/cm-1 2962 (C-H), 1741 (C=O), 1699 (C=O), 1633 (C=C), 
1435 (CH3), 1383 (CH3), 1295 (C-O), 1122 (C-O), 1047 (C-O), 771 (C=C), 593 (C=C); 
δH (400MHz, CDCl3) 8.33 (1H, s, H-2), 4.28–4.22 (1H, m, H-6), 3.76 (3H, s, H-10), 2.55 
(1H, dd, J = 16.3, 13.6 Hz, H-5ax), 2.46 (1H, dd, J = 16.3, 3.8 Hz, H-5eq), 2.05–1.97 
(1H, m, H-9), 0.97 (3H, d, J = 6.8 Hz, H-7) and 0.99 (3H, d, J = 6.8 Hz, H-8); δC (100 
MHz, CDCl3) 187.8 (C=O), 171.8 (C-2), 164.2 (C=O), 110.6 (C-3), 85.7 (C-6), 51.9(C-
10), 39.0 (C-5), 31.7 (C-9), 17.8 (C-7) and 17.6 (C-8); m/z (ESI+) 221 (M + Na)+, 199 (M 
+ H)+, (Found 221.0786 (M + Na)+. C10H14NaO4 requires; 221.0790).
  
 
Methyl 4-oxo-2-propyl-3,4-dihydro-2H-pyran-5-carboxylate (263) 
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δ-Hydroxy-β-ketoester 183 (0.05 g, 0.27 mmol), N,N-dimethylformamide dimethyl acetal 
(0.04 mL, 0.27 mmol), BF3.OEt2 (0.04 mL, 0.27 mmol), CH2Cl2 (3.00 mL), yielded 0.049 
g, 91%, light yellow oil. υ max/cm-1 2958 (C-H), 2874 (C-H), 1741 (C=O), 1700 (C=O), 
1589 (C=C), 1435 (CH3), 1380 (CH3), 1300 (C-O), 1147 (C-O), 1074 (C-O), 799 (C=C), 
506 (C=C); δH (400MHz, C6D6) 7.97 (1H, s, H-2), 3.71‒3.64 (1H, m, H-6), 3.52 (3H, s, 
H-10), 1.97 (1H, dd, J = 16.2, 4.1 Hz, H-5eq), 1.89 (1H, dd, J = 16.2, 12.4 Hz, H-5ax), 
1.24–0.98 (2H, m, H-7), 0.98–0.86 (2H, m, H-8) and 0.64 (3H, t, J = 7.2 Hz, H-9); δC 
(100 MHz, C6D6) 187.6 (C=O), 171.5 (C-2), 164.5 (C=O), 116.9 (C-3), 81.3 (C-6), 51.9 
(C-10), 41.6 (C-5), 36.0 (C-7), 17.9 (C-8) and 13.7 (C-9); m/z (ESI+) 221 (M + Na)+, 199 
(M + H)+, (Found 221.0782 (M + Na)+. C10H14NaO4 requires; 221.0790).
  
 
Methyl 4-oxo-2-phenyl-3,4-dihydro-2H-pyran-5-carboxylate (264) 
 
δ-Hydroxy-β-ketoester 138 (0.05 g, 0.20 mmol), N,N-dimethylformamide dimethyl acetal 
(0.03 mL, 0.20 mmol), BF3.OEt2 (0.03 mL, 0.20 mmol), CH2Cl2 (2.00 mL), yielded 0.045 
g, 96 %, orange solid. υ max/cm-1 2955 (C-H), 1738 (C=O), 1572 (C=C), 1472 (Ar), 1290 
(C-O), 1244 (C-O), 1146 (C-O), 845 (Ar), 761 (Ar), 698 (C=C); δH (400MHz, CDCl3) 
8.43 (1H, s, H-2), 7.43–7.36 (5H, m, Ar), 5.54 (1H, dd, J = 12.0, 4.0 Hz, H-6), 3.81 (3H, 
s, H-9), 2.96 (1H, dd, J = 16.0, 4.0 Hz, H-5ax) and 2.76 (1H,d, J = 16.0, 4.0 Hz, H-5eq); 
δC (100 MHz, CDCl3) 186.8 (C=O), 171.3 (C-2), 164.2 (C=O), 136.9 (Ar), 129.4 (Ar), 
129.0 (Ar), 126.2 (Ar), 111.2 (C-3), 82.3 (C-6), 52.1 (C-9) and 43.1 (C- 5); m/z (ESI+) 
255 (M + Na)+, 233 (M + H)+, (Found 255.0631 (M + Na)+. C13H12NaO4 requires; 
255.0633.  
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Methyl 2-(furan-2-yl)-4-oxo-3,4-dihydro-2H-pyran-5-carboxylate (259) 
 
δ-Hydroxy-β-ketoester 185 (0.69 g, 3.29 mmol), N,N-dimethylformamide dimethyl acetal 
(0.44 mL,  3.30 mmol), BF3.OEt2 (0.44 mL, 3.30 mmol), CH2Cl2 (33.00 mL), yielded 
0.674 g, 92 %, light yellow oil . υ max/cm-1 2953 (C-H), 1738 (C=O), 1704 (C=O), 1579 
(C=C), 1296 (C-O), 1133 (C-O), 1013 (C-O), 816 (C=C), 732 (C=C); δH (400MHz, 
CDCl3) 8.27 (1H, s, H-2), 7.44 (1H, dd, J = 1.8, 0.6 Hz, H-7), 6.45 (1H, d, J = 3.3 Hz, H-
8), 6.36 (1H, dd, J = 3.3, 1.8 Hz, H-9), 5.58 (1H, dd, J = 11.5, 4.3 Hz, H-6), 3.74 (3H, s, 
H-10), 3.07 (1H, dd, J = 16.6, 11.5 Hz, H-5ax) and 2.79 (1H, dd, J = 16.6, 4.3 Hz, H-
5eq); δC (100 MHz, CDCl3) 186.8 (C=O), 170.5 (C-2), 170.4 (C=O), 163.8 (C-11), 148.7 
(C-8), 143.9 (C-7), 110.8 (C-3), 110.6 (C-9), 74.7 (C-6), 51.9 (C-10) and 39.3 (C-5); m/z 
(ESI+) 245 (M + Na)+, 223 (M + H)+, (Found 245.0423 (M + Na)+. C11H10NaO5 requires; 
245.0426).  
 
Methyl 4-oxo-2-(((triisopropylsilyl)oxy)methyl)-3,4-dihydro-2H-pyran-5-
carboxylate (265) 
 
δ-Hydroxy-β-ketoester 194 (0.03 g, 0.09 mmol), N,N-dimethylformamide dimethyl acetal 
(0.02 mL, 0.09 mmol), BF3.OEt2 (0.02 mL, 0.09 mmol), CH2Cl2 (1.00 mL), yielded 0.029 
g, 88%, light orange oil . υ max/cm-1 2953 (C-H), 1738 (C=O), 1704 (C=O), 1579 (C=C), 
1465 (CH2), 1296 (C-O), 1133 (C-O), 1013 (C-O), 816 (C=C), 732 (C=C); δH (400MHz, 
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C6D6) 7.99 (1H, s, H-2), 3.81–3.75 (1H, m, H-6), 3.49 (3H, s, H-8), 3.29–3.25 (1H, m, 
H-7), 2.42 (1H, dd, J = 16.2, 13.0 Hz, H-5ax), 2.07 (1H, dd, J = 16.2, 3.8 Hz, H-5eq) and 
1.10‒9.94 (21H, m, OTIPS); δC (100 MHz, C6D6) 187.4 (C=O), 171.4 (C-2), 164.3 
(C=O), 110.6 (C-3), 81.5 (C-6), 64.2 (C-7), 52.0 (C-8), 38.2 (C-5), 17.9 (C-OTIPS) and 
11.9 (C-OTIPS); m/z (ESI+) 365 (M + Na)+ (Found 365.1741 (M + Na)+. C17H30NaO5Si 
requires; 365.1760).  
 
Methyl 2-(2-methyloxazol-4-yl)-4-oxo-3,4-dihydro-2H-pyran-5-carboxylate (266) 
 
δ-Hydroxy-β-ketoester 187 (0.08 g, 0.34 mmol),  N,N-dimethylformamide dimethyl 
acetal (0.04 mL, 0.34 mmol), BF3.OEt2 (0.04 mL, 0.34 mmol), CH2Cl2 (2.00 mL),  
yielded 0.062 g, 77%, light yellow oil . υ max/cm-1 2953 (C-H), 1738 (C=O), 1704 (C=O), 
1579 (C=C), 1465 (CH2), 1383 (CH3), 1296 (C-N), 1133 (C-O), 1013 (C-O), 816 (C=C), 
732 (C=C); δH (400MHz, CDCl3) 8.34 (1H, s, H-2), 7.61 (1H, s, H-7), 5.55 (1H, dd, J = 
12.0, 4.0 Hz, H-6), 3.80 (3H, s, H-9), 3.10 (1H, dd, J = 16.7, 12.0 Hz, H-5ax), 2.81 (1H, 
dd, J = 16.7, 4.0 Hz, H-5eq) and 2.48 (3H, s, H-8); δC (100 MHz, CDCl3) 198.7 (C=O), 
167.7 (C-2), 160.1 (C=O), 137.2 (C-3), 63.0 (C-10), 52.6 (C-6), 49.6 (C-9), 45.5 (C-5), 
31.5 (C-11), 30.1 (C-7) and 14.2 (C-8); m/z (ESI+) 260 (M + Na)+ (Found 260.0523 (M 
+ Na)+. C11H11NNaO5 requires; 260.0535).
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Methyl 4-oxo-2-(prop-1-en-1-yl)-3,4-dihydro-2H-pyran-5-carboxylate (268) 
 
δ-Hydroxy-β-ketoester 188 (0.30 g, 1.61 mmol), N,N-dimethylformamide dimethyl acetal 
(0.21 mL, 1.61 mmol), BF3.OEt2 (0.21 mL, 1.61 mmol), CH2Cl2 (16.10 mL), yielded  
0.274 g, 87%, light orange oil. υ max/cm-1 2952 (C-H), 2919 (C-H), 1740 (C=O), 1701 
(C=O), 1579 (C=C), 1435 (CH2), 1380 (CH3), 1297 (C-O), 1135 (C-O), 1053 (C-O), 965 
(C=C); δH (400MHz, CDCl3) 8.01 (1H, s, H-2), 5.28 (1H, m, H-7), 5.08 (1H, m, H-8), 
4.20 (1H, ddd, J = 8.6, 7.0, 7.0 Hz, H-6), 3.51 (3H, s, H-10), 2.08 (2H, m, H-5) and 1.31 
(3H, d, J = 6.5, H-9); δC (100 MHz, CDCl3) 181.2 (C=O), 169.9 (C-2), 164.3 (C=O), 
131.5 (C-7), 127.0 (C-8), 111.5 (C-3), 80.9 (C-6), 51.3 (C-10), 41.8 (C-5) and 17.5 (C-
9); m/z (ESI+) 219 (M + Na)+ (Found 219.0629 (M + Na)+. C10H12NaO4 requires; 
219.0628).  
 
Methyl 4-oxo-2-styryl-3,4-dihydro-2H-pyran-5-carboxylate (269) 
 
δ-Hydroxy-β-ketoester 189 (0.11 g, 0.43 mmol), N,N-dimethylformamide dimethyl acetal 
(0.11 mL, 0.85 mmol), BF3.OEt2 (0.11 mL, 0.85 mmol), CH2Cl2 (4.00 mL),  yielded 0.107 
g, 97%, orange solid. υ max/cm-1 2951 (C-H), 1693 (C=O), 1569 (C=C), 1436 (CH2), 
1260 (C-O), 1295 (C-O),  1060 (C-O), 966 (C=C), 747 (Ar), 692 (Ar); δH (400MHz, 
CDCl3) 8.04 (1H, s, H-2), 7.10‒7.03 (5H, m, Ar), 6.19 (1H, dd, J = 16.0, 1.1 Hz, H-8), 
5.73 (1H, dd, J = 16.0, 6.8 Hz, H-7),  4.26 (1H, ddd, J = 9.1, 6.9, 6.8 Hz, H-6), 3.53 (3H, 
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s, H-10) and 2.12 (2H, m, H-5); δC (100 MHz, CDCl3) 193.2 (C=O), 184.9 (C=O), 169.9 
(C-2), 164.9 (C-11)), 135.6 (C-Ar), 134.3 (C-8), 128.9 (Ar), 127.1 (Ar), 124.2 (C-7), 
111.8 (C-3), 81.0 (C-6), 51.5 (C-10) and 42.0 (C-5); m/z (ESI+) 281 (M + Na)+ (Found 
281.0781 (M + Na)+. C15H14NaO4 requires; 281.0784).
  
 
Methyl 2-methyl-4-oxo-3,4-dihydro-2H-pyran-5-carboxylate (270) 
 
δ-Hydroxy-β-ketoester 197 (0.08 g, 0.51 mmol), N,N-dimethylformamide dimethyl acetal 
(0.07 mL, 0.51 mmol), BF3.OEt2 (0.07 mL, 0.51 mmol), CH2Cl2 (5.00 mL), yield 0.061 
g, 70 %, light yellow oil. υ max/cm-1 2962 (C-H), 1741 (C=O), 1699 (C=O), 1637 (C=C), 
1430 (CH3), 1383 (CH3), 1296 (C-O), 1122 (C-O), 1047 (C-O), 771 (C=C), 593 (C=C); 
δH (400MHz, C6D6) 7.81 (1H, s, H-2), 3.55 (1H, ddd, J = 12.5, 6.4, 3.8 Hz, H-6), 3.36 
(3H, s, H-8), 1.74 (1H, dd, J = 16.2, 3.8 Hz, H-5eq), 1.64 (1H, dd, J = 16.2, 12.5 Hz, H-
5ax), and 0.56 (3H, d, J = 6.4 Hz, H-7); δC (100 MHz, C6D6) 186.2 (C=O), 169.7 (C-2), 
164.2 (C=O), 110.9 (C-3), 76.9 (C-6), 51.3 (C-8), 42.3 (C-5) and 19.1 (C-7); m/z (ESI+) 
193 (M + Na)+, 171 (M + H)+, (Found 193.0476 (M + Na)+, (Found 171.0651 (M + H)+. 
C8H10NaO4 requires; 193.0471). C8H11O4 requires; 171.0652).
  
 
General Procedure for L-Selectride® reduction of dihydropyrans: 
A 1.0 M solution of L-Selectride® in THF (0.04 mL, 0.19 mmol) was added to a stirred 
solution of DHP (0.04 mmol) in THF (1.00 mL) at ‒78 °C. The mixture was stirred for 1 
hour and monitor by TLC until completion, when it was partitioned between Et2O (10.0 
mL) and sat. aq. NHCl4 (10.0 mL). The aqueous layer was washed with Et2O (10.0 mL) 
and the combined organic extracts were washed with brine (20.0 mL), dried over MgSO4 
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and concentrated in vacuo. Purification by flash column chromatography (hexane – ethyl 
acetate) afforded the product. 
 
 (2R*,3R*,6R*)-Methyl 6-((benzyloxy)methyl)-2-butyl-4-oxotetrahydro-2H-pyran-
3-carboxylate (214) 
 
Dihydropyran 200 (0.04 g, 0.12 mmol), L-Selectride® solution 1.0M in THF (0.12 mL, 
0.56 mmol), THF (3.00 mL), purification (hexane – ethyl acetate = 4:1): percentage yield 
0.038 g, 95 %, light yellow oil. υ max/cm-1 (film) 2955 (C-H), 2928 (C-H), 2861 (C-H), 
1744 (C=O), 1716 (C=O), 1600 (Ar), 1375 (CH3), 1263 (C-O), 1112 (C-O), 1029 (C-O), 
831 (Ar), 736 (Ar); δH (400MHz, C6D6) 7.27‒7.17 (4H, m, Ar), 7.11‒7.06 (1H, m, Ar), 
4.27 (1H, d, J = 12.7 Hz, H-8), 4.24 (1H, d, J = 12.7 Hz, H-8), 3.94 (1H, m, H-6), 3.43 
(3H, s, H-9), 3.40 (1H, m, H-2), 3.14 (1H, s, H-3), 3.15 (1H, dd, J = 15.4, 3.8 Hz, H-7), 
3.12 (1H, dd, J = 15.4, 7.7 Hz, H-7), 2.18 (1H, dd, J = 14.2, 2.7 Hz, H-5eq), 2.04 (1H, 
dd, J = 14.2, 11.5 Hz, H-5ax), 1.58‒1.50 (2H, m, H-13), 1.44‒1.29 (2H, m, H-12), 1.27‒ 
1.15 (2H, m, H-11) and 0.83 (3H, t, J = 7.32 Hz, H-14); δC (100 MHz, C6D6) 193.3 (C=O), 
168.5 (C=O), 138.5 (Ar), 128.3 (Ar), 127.6 (Ar), 127.4 (Ar), 78.5 (C-6), 76.2 (C-2), 72.9 
(C-8), 71.9 (C-7), 62.9 (C-3), 51.1 (C-9), 43.3 (C-5), 34.7 (C-13), 27.4 (C-12), 22.6 (C-
11) and 13.9 (C-14); m/z (ESI+) 357 (M + Na)+, 335 (M + H)+. (Found 357.1659 (M + 
Na)+. C19H26NaO5 requires 357.1672).
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General Procedure for L-Selectride reduction of dihydropyrans with 
electrophile quench:  
A 1.0 M solution of L-Selectride® in THF (0.04 mL, 0.19 mmol) was added to a stirred 
solution of DHP (0.04 mmol) in THF (1.00 mL) at -78 °C. The mixture was stirred for 1 
hour, after which time the electrophile (0.40 mmol) was added. The reaction mixture was 
stirred at room temperature until complete, when it was partitioned between Et2O (10.0 
mL) and sat. aq. NHCl4 (10.0 mL). The aqueous layer was washed with Et2O (10.0 mL) 
and the combined organic extracts were washed with brine (20.0 mL), dried over MgSO4 
and concentrated in vacuo. Purification by flash column chromatography (hexane – ethyl 
acetate or cyclohexane – ethyl acetate) afforded the product. 
 
 (2R*,3R*,6R*)-Methyl 6-isopropyl-2,3-dimethyl-4-oxotetrahydro-2H-pyran-3 
carboxylate (216) 
 
Dihydropyran 205 (0.07 g, 0.34 mmol), L-Selectride® solution 1.0M in THF (0.34 mL, 
1.59 mmol), MeI (0.42 mL, 6.73 mmol), THF (9.00 mL); purification (hexane – ethyl 
acetate = 7: 3); Percentage yield 0.074 g, 96%, light yellow oil; υ max/cm-1 2960 (C-H), 
2878 (C-H), 1740 (C=O), 1712 (C=O), 1267 (C-O), 1096 (C-O); δH (400MHz, C6D6) 
4.15 (1H, q, J = 6.3 Hz, H-2), 3.43 (3H, s, H-10), 2.99‒2.94 (1H, m, H-6), 2.03 (1H, dd, 
J = 14.8, 9.6 Hz, H-5ax), 1.98 (1H, dd, J = 14.8, 4.4 Hz, H-5eq), 1.48‒1.40 (1H, m, H-8), 
1.28 (3H, s, H-11), 1.03 (3H, d, J = 6.3 Hz, H-7), 0.77 (3H, d, J = 6.8 Hz, H-9) and 0.65 
(3H, d, J = 6.8 Hz, H-9); δC (100 MHz, C6D6) 205.6 (C=O), 193.2 (C=O), 171.1 (C-3), 
81.3 (C-6), 75.9 (C-2), 51.6 (C-10), 39.8 (C-5), 32.8 (C-8), 17.6 (C-9), 17.4 (C-9), 15.7 
152 
 
(C-7) and 13.5 (C-11) ppm; m/z (ESI+) 251 (M + Na)+, 229 (M + H)+, (Found 251.1260 
(M + Na)+. C12H20NaO4 requires; 251.1254).
  
 
 (2R*,3R*,6S*)-Methyl 2,3-dimethyl-4-oxo-6-propyltetrahydro-2H-pyran-3-
carboxylate (217) 
 
Dihydropyran 208 (0.09 g, 0.47 mmol), L-Selectride® solution 1.0M in THF (0.46 mL, 
2.20 mmol), MeI (0.57 mL, 9.30 mmol), THF (12.00 mL); purification (hexane – ethyl 
acetate = 7: 3); Percentage yield 0.051 g, 48%, light yellow oil; υ max/cm-1 2957 (C-H), 
2874 (C-H), 1739 (C=O), 1712 (C=O), 1263 (C-O), 1095 (C-O); δH (400MHz, C6D6) 
4.16 (1H, q, J = 6.2 Hz, H-2), 3.42 (3H, s, H-9), 3.28‒3.18 (1H, m, H-6), 1.99 (1H, dd, J 
= 14.8, 4.5 Hz, H-5), 1.94 (1H, dd, J = 14.8, 2.6 Hz, H-5), 1.29 (3H, s, H-10), 1.83‒1.26 
(2H, m, H-11), 1.19‒1.05 (1H, m, H12), 1.03 (3H, d, J = 6.2 Hz, H-7) and 0.75 (3H, t, J 
= 7.2 Hz, H- 13); δC (100 MHz, C6D6)  198.3 (C=O), 171.1 (C=O), 76.4 (C-6), 76.0 (C-
2), 62.3 (C-3), 51.5 (C-9), 43.0 (C-5), 38.1 (C-11), 18.2 (C12), 15.8 (C-7), 13.7 (C-13) 
and 13.5 (C-10); m/z (ESI+) 251 (M + Na)+, 229 (M + H)+, (Found 251.1255 (M + Na)+. 
C12H20NaO4 requires; 251.1254).
  
 
 (2R*,3R*,6R*)-Methyl 2,3-dimethyl-4-oxo-6-phenyltetrahydro-2H-pyran-3-
carboxylate (218) 
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Dihydropyran 207 (0.13 g, 0.54 mmol), L-Selectride® solution 1.0M in THF (0.53 mL, 
2.50 mmol), MeI (0.67 mL, 10.80 mmol), THF (14.00 mL); purification (hexane – ethyl 
acetate = 7: 3); Percentage yield 0.102 g, 72%, light yellow solid; υ max/cm-1 2985 (C-
H), 2951 (C-H), 1737 (C=O), 1710 (C=O), 1245 (C-O), 1266 (C-O), 1094 (C-O), 761 
(Ar), 698 (Ar), 563 (Ar); δH (400MHz, C6D6) 7.19‒7.17 (3H, m, Ar), 7.14‒7.13 (2H, m, 
Ar), 4.35 (1H, q, J = 6.2 Hz, H-2), 4.32‒4.28 (1H, m, H-6), 3.48 (3H, s, H-9), 2.34 (1H, 
dd, J = 15.0, 9.2 Hz, H-5ax), 2.30 (1H, dd, J = 15.0, 3.3 Hz, H-5eq), 1.37 (3H, s, H-10) 
and 1.12 (3H, d, J = 6.2 Hz, H-7); δC (100 MHz, C6D6) 193.2 (C=O), 170.9 (C=O), 141.0 
(Ar), 128.4 (Ar), 127.6 (Ar), 125.6 (Ar), 78.3 (C-2), 76.3 (C-6), 62.3 (C-3), 51.6 (C-9), 
44.9 (C-5), 15.8 (C-7) and 13.6 (C-10); m/z (ESI+) 285 (M + Na)+, 262 (M + H)+, (Found 
285.1095 (M + Na)+. C15H18NaO4 requires; 285.1097).
  
 
 (2R*,3R*,6R*)-Methyl 6-(furan-2-yl)-2,3-dimethyl-4-oxotetrahydro-2H-pyran-3-
carboxylate (219) 
 
Dihydropyran 204 (0.04 g, 0.19 mmol), L-Selectride® solution 1.0M in THF (0.19 mL, 
0.89 mmol), MeI (0.23 mL, 3.71 mmol), THF (5.00 mL); purification (hexane – ethyl 
acetate = 7: 3); Percentage yield 0.025 g, 53%, light yellow oil; υ max/cm-1 2985 (C-H), 
2952 (C-H), 1737 (C=O), 1713 (C=O), 1271 (C-O), 1260 (C-O), 1088 (C-O), 743 (C=C), 
558 (C=C); δH (400MHz, C6D6) 7.01‒6.99 (1H, m, H-14), 5.99 (1H, m, H-13), 5.96 (1H, 
m, H-12), 4.30 (1H, dd, J = 12.1, 3.1 Hz, H-6), 4.25 (1H, q, J = 6.3 Hz, H-2), 3.39 (3H, 
s, H-9), 2.71 (1H, dd, J = 15.1, 12.1 Hz, H-5ax), 2.23 (1H, dd, J = 15.1, 3.1 Hz, H-5eq), 
1.32 (3H, s, H-10) and 1.02 (3H, d, J = 6.3 Hz, H-7); δC (100 MHz, C6D6)  204.0 (C=O), 
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170.1 (C=O), 152.1 (C-15), 142.6 (C-14), 109.8 (C-13), 107.7 (C-12), 75.9 (C-2), 71.2 
(C-6), 62.5 (C-3), 51.9 (C-9), 40.3 (C-5), 15.9 (C-7) and 13.2 (C-10); m/z (ESI+) 275 (M 
+ Na)+, 253 (M + H)+, (Found 275.0891 (M + Na)+. C13H16NaO5 requires; 275.0890).
  
 
 (2R*,3R*,6R*)-Methyl 6-((benzyloxy)methyl)-2,3-dimethyl-4-oxotetrahydro-2H-
pyran-3-carboxylate (215) 
 
Dihydropyran 209 (0.15 g, 0.51 mmol), L-Selectride® solution 1.0M in THF (0.51 mL, 
2.39 mmol), MeI (0.31 mL, 5.12 mmol), THF (13.00 mL); purification (hexane – ethyl 
acetate = 7:3), Percentage yield 0.095 g, 61%, light yellow oil; υ max/cm-1 (film) 2955 
(C-H), 2913 (C-H), 2849 (C-H), 1738 (C=O), 1712 (C=O), 1454 (CH3), 1260 (C-O), 1089 
(C-O), 1016 (C-O), 795 (Ar), 736 (Ar), 697 (Ar); δH (400MHz, C6D6) 7.24‒7.17 (2H, m, 
Ar), 7.15‒7.06 (3H, m, Ar), 4.29 (1H, d, J = 12.2 Hz, H-11), 4.25 (1H, d, J = 12.2 Hz, H-
11), 4.18 (1H, q, J = 6.3 Hz, H- 2), 3.51‒3.46 (1H, m, H-6), 3.39 (3H, s, H-9), 3.19‒3.12 
(2H, m, H-10), 2.36 (1H, dd, J = 15.1, 11.8 Hz, H-5ax), 2.07 (1H, dd, J = 15.1, 3.1 Hz, 
H-5eq), 1.28 (3H, s, H-12) and 1.02 (3H, d, J = 6.3 Hz, H-7); NOE H6 – H2 2.84%, H6 
– H8 2.60% and H6 – H5 1.12%, H2 – H6 2.83%, Me-2 – H5ax 0.82%; δC (100 MHz, 
C6D6) 204.0 (C=O), 170.9 (C=O), 138.4 (Ar), 128.3 (Ar), 127.9 (Ar), 127.1 (Ar), 76.2 
(C-2), 75.9 (C-6), 73.1 (C-11), 71.9 (C-10), 62.6 (C-3), 51.5 (C-9), 39.4 (C-5), 15.8 (C-
7) and 13.4 (C-12); m/z (ESI+) 329 (M + Na)+. (Found 329.1361 (M + Na)+. C17H22 NaO5 
requires 329.1359).  
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 (2R*,3R*,6R*)-Methyl 6-((benzyloxy)methyl)-2-butyl-3-methyl-4 oxotetrahydro-
2H-pyran-3-carboxylate (213) 
 
Dihydropyran 200 (0.05 g, 0.17 mmol), L-Selectride® solution 1.0M in THF (0.16 mL, 
0.79 mmol), MeI (0.20 mL, 3.30 mmol), THF (4.00 mL); purification (hexane – ethyl 
acetate = 7:3), Percentage yield 0.033 g, 57%, light yellow oil; υ max/cm-1 (film) 2913 
(C-H), 2849 (C-H), 1738 (C=O), 1712 (C=O), 1454 (CH3), 1260 (C-O), 1089 (C-O), 1016 
(C-O), 795 (Ar), 736 (Ar), 697 (Ar); δH (400MHz, C6D6) 7.27‒7.17 (4H, m, Ar), 7.14‒
7.08 (1H, m, Ar), 4.31 (1H, d, J = 12.3 Hz, H-8), 4.27 (1H, d, J = 12.3 Hz, H-8), 4.08 
(1H, dd, J = 9.5, 2.2 Hz, H-2), 3.51‒3.45 (1H, m, H-6), 3.43 (3H, s, H-9), 3.17 (2H, m, 
H-7), 2.37 (1H, dd, J = 15.1, 11.8 Hz, H-5ax), 2.10 (1H, dd, J = 15.1, 3.1 Hz, H-5eq), 
1.63‒1.50 (2H, m, H-11), 1.34 (3H, s, H-10), 1.27‒1.15 (4H, m, H-12, H-13) and 0.84 
(3H, t, J = 8.3 Hz, H-14); δC (100 MHz, C6D6) 204.9 (C=O), 171.0 (C=O), 138.6 (Ar), 
128.3 (Ar), 127.8 (Ar), 126.5 (Ar), 80.2 (C-2), 76.2 (C-6), 72.7 (C-8), 71.9 (C-7), 62.2 
(C-3), 51.3 (C-9), 39.9 (C-5), 30.6 (C-11), 28.5 (C-12), 22.6 (C-13), 14.05 (C-14) and 
13.8 (C-10); m/z (ESI+) 371 (M + Na)+. (Found 371.1828 (M + Na)+. C20H28 NaO5 
requires 371.1829).  
 
General Procedure for L-Selectride reduction of ketone on 
tetrahydropyrans:  
A 1.0 M solution of L-Selectride® in THF (0.36 mL, 1.68 mmol) was added to a stirred 
solution of THP (0.14 mmol) in THF (2.00 mL) at ‒78 °C. The mixture was stirred for 1 
hour at ‒78 °C and followed with stirring at room temperature until completion. The 
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reaction mixture was stirred at room temperature until completion. Then it was partitioned 
between Et2O (10.0 mL) and sat. aq. NHCl4 (10.0 mL). The aqueous layer was washed 
with Et2O (10.0 mL) and the combined organic extracts were washed with brine (20.0 
mL), dried over MgSO4 and concentrated in vacuo. Purification by flash column 
chromatography (toluene – methanol) afforded the product. 
 
 
(2R*,3S*,4S*,6R*)-M-ethyl4-hydroxy-6-isopropyl-2,3-dimethyl-tetrahydro-2H-
pyran-3-carboxylate (251) 
 
Tetrahydropyrans 216 (0.07 g, 0.33 mmol), L-Selectride® solution 1.0M in THF (0.85 
mL, 4.00 mmol), THF (4.00 mL); purification (toluene – methanol = 49 : 1), Yield 0.044 
g, 59%, light yellow oil; υ max/cm-1 (film) 3376 (OH), 2953 (C-H), 2931 (C-H), 2877 
(C-H), 1735 (C=O), 1465 (CH2), 1379 (CH3), 1246 (C-O), 1090 (C-O), 1028 (C-O); δH 
(400MHz, C6D6) 4.39 (1H, q , J = 6.3 Hz, H-2), 3.87 (1H, dd, J = 6.0, 3.0 Hz, H- 4), 3.61 
(1H, ddd, J = 9.5, 6.2, 3.3 Hz, H-6), 3.24 (3H, s, H-11), 2.74 (1H, br s, OH), 1.66‒1.58 
(1H, m, H-8), 1.42 (1H, ddd, J = 16.0, 9.5, 3.0 Hz, H-5ax), 1.37 (1H, ddd, J = 16.0, 6.0, 
3.3 Hz, H-5eq), 1.23 (3H, d, J = 6.3 Hz, H-7), 1.13 (3H, s, H-10), 0.98 (3H, d, J = 6.8 Hz, 
H-9) and 0.87 (3H, d, J = 6.8 Hz, H-9); δC (100 MHz, C6D6) 193.1 (C=O), 76.2 (C-6), 
71.7 (C-4), 70.7 (C-2), 50.1 (C-11), 41.9 (C-3), 32.7 (C-8), 30.6 (C-5), 18.2 (C-9), 18.0 
(C-9), 16.9 (C-7) and 14.0 (C-10); m/z (ESI+) 253 (M + Na)+. (Found 253.1408 (M + 
Na)+. C12H22 NaO4 requires 253.1410). 
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(2R*,3S*,4S*,6R*)-Methyl4-hydroxy-2,3-dimethyl-6-phenyl-tetrahydro-2H-pyran-
3-carboxylate (252). 
 
Tetrahydropyrans 218 (0.10 g, 0.39 mmol), L-Selectride® solution 1.0M in THF (0.98 
mL, 4.63 mmol), THF (8.00 mL); purification (toluene – methanol = 49 : 1), Percentage 
yield 0.029 g, 29%, light yellow oil; υ max/cm-1 (film) 3462 (OH), 2923 (C-H), 2856 (C-
H), 1733 (C=O), 1453 (CH3), 1262 (C-O), 1091 (C-O), 1082 (C-O), 735 (Ar), 697 (Ar); 
δH (400MHz, C6D6) 7.41‒7.34 (3H, m, Ar), 7.12‒7.08 (2H, m, Ar), 4.99 (1H, dd, J = 
11.1, 3.4 Hz, H-6), 4.58 (1H, q, J = 6.3 Hz, H-2), 3.84 (1H, dd, J = 6.4, 3.0 Hz, H- 4), 
3.25 (3H, s, H-9), 2.82 (1H, br s, OH), 1.71 (1H, ddd, J = 14.0, 11.1, 3.0 Hz, H-5ax), 1.64 
(1H, ddd, J = 14.0, 6.4, 3.4 Hz, H-5eq), 1.29 (3H, d, J = 6.3 Hz, H-7) and 1.18 (3H, s, H-
10); δC (100 MHz, C6D6) 193.0 (C=O), 143.3 (Ar), 128.2 (Ar), 127.1 (Ar), 125.9 (Ar), 
73.8 (C-6), 71.7 (C-4), 71.1 (C-2), 51.1 (C-9), 49.1 (C-3), 36.6 (C-5), 17.0 (C-7), and 14.1 
(C-10); m/z (ESI+) 287 (M + Na)+. (Found 287.1247 (M + Na)+. C15H20NaO4 requires 
287.1254). 
 
(2R*,3S*,4S*,6R*)-Methyl 6-(furan-2-yl)-4-hydroxy-2,3-dimethyl-tetrahydro-2H-
pyran-3-carboxylate (253). 
 
Tetrahydropyrans 219 (0.03 g, 0.10 mmol), L-Selectride® solution 1.0M in THF (0.25 
mL, 1.20 mmol), THF (3.00 mL); purification (toluene – methanol = 49 : 1), Percentage 
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yield 0.020 g, 79%, light yellow oil; υ max/cm-1 (film) 3463 (OH), 2976 (C-H), 2952 (C-
H), 1723 (C=O), 1251 (C-O), 1144 (C-O), 1066 (C-O), 1033 (C-O), 961 (C=C), 738 
(C=C); δH (400MHz, C6D6) 7.08 (1H, dd, J = 1.8, 0.8 Hz, H-10), 6.14 (1H, d, J = 3.2 Hz, 
H-8), 6.06 (1H, dd, J = 3.2, 1.8 Hz, H-9), 5.07 (1H, dd, J = 12.0, 3.0 Hz, H-6), 4.56 (1H, 
q , J = 6.3 Hz, H-2), 3.86 (1H, dd, J = 5.5, 2.1 Hz, H- 4), 3.22 (3H, s, H-12), 2.74 (1H, br 
s, OH), 2.09 (1H, ddd, J = 14.0, 12.0, 2.6, Hz, H-5ax), 1.63 (1H, ddd, J = 14.0, 5.6, 3.0 
Hz, H-5eq), 1.23 (3H, d, J = 6.3 Hz, H-7) and 1.17 (3H, s, H-11); δC (100 MHz, C6D6) 
179.0 (C=O), 155.3 (C-13), 141.7 (C-10), 110.0 (C-8), 106.6 (C-9), 71.3 (C-2), 71.1(C-
4), 67.5 (C-6), 51.1 (C-12), 49.1 (C-3), 32.3 (C-5), 16.9 (C-7) and 14.0 (C-11); m/z (ESI+) 
277 (M + Na)+. (Found 277.1038 (M + Na)+. C13H18 NaO5 requires 277.10465). 
 
(2R*,3S*,4S*,6R*)-Methyl 6-(benzyloxymethyl)-4-hydroxy-2,3-dimethyl-
tetrahydro-2H-pyran-3-carboxylate (250) 
 
Tetrahydropyrans 215 (0.04 g, 0.14 mmol), L-Selectride® solution 1.0M in THF (0.35 
mL, 1.68 mmol), THF (2.00 mL); purification (toluene – methanol = 49 : 1), Percentage 
yield 0.032 g, 75%, light orange oil; υ max/cm-1 (film) 3462 (OH), 2923 (C-H), 2856 (C-
H), 1733 (C=O), 1453 (CH3), 1262 (C-O), 1091 (C-O), 1082 (C-O), 735 (Ar), 697 (Ar); 
δH (400MHz, C6D6) 7.36‒7.28 (3H, m, Ar), 7.19‒7.05 (2H, m, Ar), 4.46 (1H, q, J = 6.3 
Hz, H-2), 4.40 (1H, d, J = 12.1 Hz, H-9), 4.37 (1H, d, J = 12.1 Hz, H-9), 4.19‒4.13 (1H, 
m, H-6), 3.87 (1H, dd, J = 5.7, 3.0 Hz, H- 4), 3.44 (1H, dd, J = 10.1, 5.1 Hz, H-8), 3.36 
(1H, dd, J = 10.1, 4.6 Hz, H-8), 3.23 (3H, s, H-12), 2.64 (1H, br s, OH), 1.66 (1H, ddd, J 
= 14.0, 11.9, 3.0 Hz, H-5ax), 1.46 (1H, ddd, J = 14.0, 5.7, 2.8 Hz, H-5eq), 1.25 (3H, d, J 
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= 6.4 Hz, H-7) and 1.14 (3H, s, H-11); δC (100 MHz, C6D6) 193.1 (C=O), 138.0 (Ar), 
128.2 (Ar), 127.8 (Ar), 127.3 (Ar), 73.3 (C-9), 73.1 (C-8), 71.4 (C-2), 71.2 (C-4), 70.7 
(C-6), 50.9 (C-12), 41.2 (C-3), 30.1 (C-5), 16.9 (C-7), and 14.1 (C-11); m/z (ESI+) 331 
(M + Na)+. (Found 331.1502 (M + Na)+. C17H24 NaO5 requires 331.1516). 
  
 
(2R*,3S*,4S*,6R*)-Methyl 6-(benzyloxymethyl)-2-butyl-4-hydroxy-3-methyl-
tetrahydro-2H-pyran-3-carboxylate (249) 
 
 
Tetrahydropyrans 213 (0.06 g, 0.18 mmol), L-Selectride® solution 1.0M in THF (0.46 
mL, 2.19 mmol), THF (9.00 mL); purification (toluene – methanol = 49 : 1), Percentage 
yield 0.044 g, 69%, light yellow oil; υ max/cm-1 (film) 3462 (OH), 2953 (C-H), 2926 (C-
H), 2856 (C-H), 1731 (C=O), 1454 (CH3), 1264 (C-O), 1101 (C-O), 1042 (C-O), 734 
(Ar), 697 (Ar) ; δH (400MHz, C6D6) 7.32‒7.30 (2H, m, Ar), 7.20‒7.18 (2H, m, Ar), 7.11‒
7.07 (1H, m, Ar), 4.42 (1H, d, J = 12.9 Hz, H-9), 4.39 (1H, d, J = 12.9 Hz, H-9), 4.30 
(1H, dd, J = 6.9, 4.4 Hz, H-2), 4.19‒4.13 (1H, m, H-6), 3.84 (1H, dd, J = 5.7, 2.7 Hz, H- 
4), 3.44 (1H, dd, J = 10.1, 5.2 Hz, H-8), 3.37 (1H, dd, J = 10.1, 4.5 Hz, H-8), 3.26 (3H, 
s, H-11), 2.69 (1H, br s, OH), 1.79‒1.72 (1H, m, H-7), 1.48‒44 (1H, m, H-7), 1.66 (1H, 
ddd, J = 14.0, 12.0, 2.7 Hz, H-5ax), 1.46 (1H, ddd, J = 14.0, 5.7, 2.4 Hz, H-5eq), 1.55‒
1.50 (2H, m, H-13), 1.38‒1.29 (2H, m, H-14), 1.17 (3H, s, H-12) and 0.90 (3H, t, J = 7.3 
Hz, H-15); δC (100 MHz, C6D6) 195.0 (C=O), 139.1 (Ar), 128.2 (Ar), 127.3 (Ar), 127.0 
(Ar), 75.2 (C-2), 73.4 (C-9), 73.1 (C-8), 71.6 (C-6), 71.4 (C-4), 51.1 (C-11), 49.5 (C-3), 
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31.2 (C-7), 31.0 (C-5), 29.1 (C-13), 22.8 (C-14), 14.6 (C-12) and 14.0 (C-15); m/z (ESI+) 
373 (M + Na)+. (Found 373.1980 (M + Na)+. C20H30NaO5 requires 373.1985).
  
 
General Procedure for lithium aluminium hydride reduction of ketone 
and ester on tetrahydropyran:  
All apparatus are oven dried and flushed with N2 gas. A round bottom flasked was 
charged with N2 gas and LiAlH4 (0.01 g, 0.33 mmol). Dried THF (3.00 mL) was added 
slowly so that the LiAlH4 was a grey suspension. The reaction was cooled to 0
oC and the 
tetrahydropyran (0.05 g, 0.17 mmol) in dried THF (3.00 mL) was added drop wise. The 
reaction was stirred at 0oC and monitored by TLC until it was shown to be complete. The 
reaction mixture was quenched by the drop wise addition of 5 mL of H2O, 15 mL of 15% 
of NaOH solution followed with 3 x 5 mL of H2O. It was then dried over MgSO4 and 
concentrated in vacuo. Purification by flash column chromatography (hexane – ethyl 
acetate) afforded the product. 
 
 (2R*,3S*,4R*,6R*)-6-((Benzyloxy)methyl)-3-(hydroxymethyl)-2,3-
dimethyltetrahydro-2H-pyran-4-ol (248) 
 
Tetrahydropyrans 215 (0.05 g, 0.17 mmol), LiAlH4 (0.01 g, 0.33 mmol), THF (2.00 mL); 
purification (hexane – ethyl acetate = 1:1), Percentage yield 0.026 g, 56%, light yellow 
oil; υ max/cm-1 (film) 3379 (OH), 2925 (C-H), 2860 (C-H), 1465 (CH2), 1453 (CH3), 
1375 (CH3), 1255 (C-O), 1091 (C-O), 1027 (C-O), 735 (Ar), 697 (Ar), 654 (Ar); δH 
(400MHz, CDCl3) 7.29-7.27 (2H, m, Ar), 7.23‒7.18 (3H, m, Ar), 4.53 (1H, d, J = 12.2 
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Hz, H-9), 4.47 (1H, d, J = 12.2 Hz, H-9), 3.85 (1H, dd, J = 12.0, 4.8 Hz, H- 4), 3.55 (1H, 
d, J = 10.0 Hz, H-11), 3.39 (1H, d, J = 10.0 Hz, H-11), 3.59‒3.57 (1H, m, H-6), 3.46 (1H, 
dd, J = 10.1, 6.1 Hz, H-8), 3.35 (1H, dd, J = 10.1, 4.0 Hz, H-8), 3.18 (1H, q, J = 6.4 Hz, 
H-2), 2.64 (1H, br s, OH), 1.64 (1H, ddd, J = 12.6, 4.8, 2.4 Hz, H-5eq), 1.40 (1H, dd, J = 
12.6, 12.0, 12.1 Hz, H-5ax), 1.02 (3H, d, J = 6.4 Hz, H-7) and 0.86 (3H, s, H-12); δC (100 
MHz, CDCl3) 138.5 (Ar), 128.5 (Ar), 127.8 (Ar), 127.7 (Ar), 75.6 (C-2), 75.3 (C-6), 74.0 
(C-4), 73.5 (C-9), 73.2 (C-8), 69.8 (C-11), 42.9 (C-3), 33.2 (C-5), 15.1 (C-7), and 8.55 
(C-12); m/z (ESI+) 303 (M + Na)+. (Found 303.1564 (M + Na)+. C16H24 NaO4 requires 
303.1567). 
 
(2R*,3S*,4R*,6R*)-6-(Benzyloxymethyl)-2-butyl-3-(hydroxymethyl)-3-methyl-
tetrahydro-2H-pyran-4-ol (247) 
 
Tetrahydropyrans 213 (0.03 g, 0.09 mmol), LiAlH4 (0.01 g, 0.24 mmol), THF (3.00 mL); 
purification (hexane – ethyl acetate = 1:1), Percentage yield 0.015 g, 51%, colourless oil; 
υ max/cm-1 (film) 3369 (OH), 2927 (C-H), 2857 (C-H), 1453 (CH3), 1375 (CH3), 1113 
(C-O), 1086 (C-O), 1025 (C-O), 733 (Ar), 696 (Ar), 665 (Ar); δH (400MHz, CDCl3) 7.34‒
7.22 (4H, m, Ar), 7.31‒7.27 (1H, m, Ar), 4.60 (1H, d, J = 12.0 Hz, H-9), 4.56 (1H, d, J = 
12.0 Hz, H-9), 3.93 (1H, dd, J = 11.5, 4.8 Hz, H- 4), 3.69 (1H, d, J = 10.4 Hz, H-11), 3.52 
(1H, d, J = 10.4 Hz, H-11), 3.61‒3.58 (1H, m, H-6), 3.55 (1H, dd, J = 12.0, 6.5 Hz, H-8), 
3.48 (1H, dd, J = 12.0, 6.5 Hz, H-8), 3.02 (1H, dd, J = 10.2, 1.4 Hz, H-2), 2.41 (1H, br s, 
OH), 1.75 (1H, ddd, J = 12.4, 4.8, 2.0 Hz, H-5eq), 1.48 (1H, dd, J = 12.4, 12.0, 11.5 Hz, 
H-5ax), 1.42‒1.35 (2H, m, H-7), 1.33‒1.25 (2H, m, H-14), 0.94 (3H, s, H-12) and 0.89 
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(3H, t, J = 7.1 Hz, H-15); δC (100 MHz, CDCl3) 138.5 (Ar), 128.4 (Ar), 127.7 (Ar), 127.4 
(Ar), 80.3 (C-2), 75.6 (C-6), 74.3 (C-4), 73.4 (C-9), 73.2 (C-8), 69.8 (C-11), 42.8 (C-3), 
33.3 (C-5), 29.8 (C-13), 22.8 (C-14), 20.9 (C-7) 14.2 (C-15) and 9.1 (C-12); (m/z (ESI+) 
345 (M + Na)+. (Found 345.2042 (M + Na)+. C19H30NaO4 requires 345.2036).
  
 
(2R*,3S*,4S*,6R*)-6-(Benzyloxymethyl)-3-(hydroxymethyl)-2,3-dimethyl-
tetrahydro-2H-pyran-4-ol (257) 
 
Tetrahydropyrans 250 (0.02 g, 0.08 mmol), LiAlH4 (0.006 g, 0.16 mmol), THF (2.00 
mL); purification (hexane – ethyl acetate = 1:1), Percentage yield 0.011 g, 52%, light 
yellow oil; υ max/cm-1 (film) 3368 (OH), 2923 (C-H), 2856 (C-H), 1452 (CH3), 1375 
(CH3), 1088 (C-O), 1029 (C-O), 736 (Ar), 697 (Ar), 597 (Ar); δH (400MHz, CDCl3) 7.34‒
7.33 (4H, m, Ar), 7.29‒7.27 (1H, m, Ar), 4.61 (1H, d, J = 12.2 Hz, H-9), 4.55 (1H, d, J = 
12.2 Hz, H-9), 4.16 (1H, q, J = 6.6 Hz, H-2), 4.05 (1H, dddd, J = 12.0, 6.0, 4.2, 5.6 Hz, 
H-6), 3.96 (1H, dd, J = 5.6, 2.8 Hz, H- 4), 3.61 (1H, d, J = 10.0 Hz, H-11), 3.58 (1H, d, J 
= 10.0 Hz, H-11), 3.63 (1H, dd, J = 10.2, 6.0 Hz, H-8), 3.43 (1H, dd, J = 10.2, 4.2 Hz, H-
8), 2.83 (1H, br s, OH), 1.80 (1H, ddd, J = 14.2, 12.0, 5.6 Hz, H-5ax), 1.49 (1H, ddd, J = 
14.2, 5.6, 2.8 Hz, H-5eq), 1.15 (3H, d, J = 6.6 Hz, H-7) and 0.79 (3H, s, H-12); δC (100 
MHz, CDCl3) 138.4 (Ar), 128.4 (Ar), 127.8 (Ar), 127.7 (Ar), 74.8 (C-4), 73.4 (C-9), 73.3 
(C-8), 71.4 (C-6), 70.6 (C-2), 70.2 (C-11), 40.5 (C-3), 33.4 (C-5), 15.1 (C-7), and 15.0 
(C-12); m/z (ESI+) 303 (M + Na)+. (Found 303.1570 (M + Na)+. C16H24 NaO4 requires 
303.1567). 
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(2R*,3S*,4S*,6R*)-6-(Benzyloxymethyl)-2-butyl-3-(hydroxymethyl)-3-methyl-
tetrahydro-2H-pyran-4-ol (258) 
 
Tetrahydropyrans 249 (0.027 g, 0.08 mmol), LiAlH4 (0.006 g, 0.15 mmol), THF (6.00 
mL); purification (hexane – ethyl acetate = 1:1), Percentage yield 0.011 g, 52%, colorless 
oil; υ max/cm-1 (film) 3351 (OH), 2924 (C-H), 2857 (C-H), 1453 (CH3), 1377 (CH3), 
1092 (C-O), 1028 (C-O), 732 (Ar), 697 (Ar), 613 (Ar); δH (400MHz, CDCl3) 7.34‒7.33 
(4H, m, Ar), 7.31‒7.27 (1H, m, Ar), 4.61 (1H, d, J = 12.4 Hz, H-9), 4.58 (1H, d, J = 12.4 
Hz, H-9), 3.99 (1H, dddd, J = 12.0, 5.6, 4.4, 3.0 Hz, H-6), 3.93 (1H, dd, J = 5.6, 3.0 Hz, 
H- 4), 3.91 (1H, dd, J = 8.0, 3.6 Hz, H-2), 3.63 (1H, d, J = 12.6 Hz, H-11), 3.59 (1H, d, J 
= 12.6 Hz, H-11), 3.56 (1H, dd, J = 10.4, 5.6 Hz, H-8), 3.48 (1H, dd, J = 10.4, 4.4 Hz, H-
8), 2.86 (2H, br s, OH), 1.80 (1H, ddd, J = 14.4, 12.0, 3.0 Hz, H-5ax), 1.50 (1H, ddd, J = 
14.4, 5.6, 2.8 Hz, H-5eq), 1.63‒1.58 (2H, m, H-14), 1.43‒1.25 (4H, m, H-7, H-13), 0.90 
(3H, t, J = 7.0 Hz, H-15) and 0.78 (3H, s, H-12); δC (100 MHz, CDCl3) 138.6 (Ar), 128.4 
(Ar), 127.7 (Ar), 127.6 (Ar), 75.3 (C-2), 75.1 (C-4), 73.4 (C-9), 73.3 (C-8), 71.6 (C-6), 
70.1 (C-11), 40.5 (C-3), 33.5 (C-5), 29.0 (C-13), 28.7 (C-14), 22.9 (C-7), 15.7 (C-12) and 
14.3 (C-15); (m/z (ESI+) 345 (M + Na)+. (Found 345.2044 (M + Na)+. C19H30 NaO4 
requires 345.2036).  
 
 
General Procedure for the Synthesis 2,6-trans-tetrahydropyran-4-ones 
from dihydropyrans by conjugate addition 
Addition of Ph2CuLi: 
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Phenyl lithium 1.9M in dibutyl ether solution (0.58 mL, 0.90 mmol) was added to a 
suspension of copper iodide (86.30 mg, 0.45 mmol) in THF (3.00 mL) at 0 °C. The 
mixture was stirred at this temperature for 20 minutes then cooled to ‒78 °C. Addition of 
chlorotrimethylsilane (0.18 mL, 1.40 mmol) was followed by addition of DHP (0.28 
mmol) in THF (2.00 mL) at ‒78 °C. The reaction mixture was stirred at this temperature 
for 30 minutes then at 0 °C for 1.5 hours. The reaction was quenched with sat. aq. NH4Cl 
(2.50 mL) and allowed to warm to rt with vigorous stirring. The mixture was diluted with 
sat. aq. NH4Cl (10.0 mL) and extracted with EtOAc (5 x 15.0 mL). The combined organic 
extracts were washed with H2O (15.0 mL) and brine (15.0 mL), then dried over MgSO4 
and concentrated in vacuo. Flash column chromatography (hexane – ethyl acetate) 
afforded the product. 
 
(2R*,6S*)-Methyl 4-hydroxy-2,6-diphenyl-5,6-dihydro-2H-pyran-3-carboxylate 
(279) 
 
Dihydropyran 264 (0.08 g, 0.37 mmol), phenyl lithium 1.9 M in dibutyl ether (0.79 ml, 
1.22 mmol), copper iodide (0.11 g, 0.61 mmol), cholorotrimethylsilane (0.24 ml, 1.90 
mmol), THF (6.80 ml); purification (hexane – ethyl acetate = 4: 1), Percentage yield 0.082 
g, 70%, light brown oil. υ max/cm-1 (film) 2955 (C-H), 2931 (C-H), 2872 (C-H), 1768 
(C=O), 1465 (CH2), 1177 (C-O), 1149 (C-O), 1055 (C-O), 875 (Ar), 480 (Ar); δH (400 
MHz, CDCl3) 12.4 (1H, s, OH), 7.41‒7.24 (10H, m, Ar1, Ar2), 5.80 (1H, s, H-2), 4.56 
(1H, dd, J =10.8, 4.0 Hz, H-6), 3.66 (3H, s, H-9), 2.73 (1H, dd, J = 18.1, 10.8 Hz, H-5ax), 
2.59 (1H, dd, J = 18.1, 4.0 Hz, H-5eq); δC (100 MHz, CDCl3) 193.0 (C=O), 171.2 (C-3), 
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140.7 (C-4), 128.6 (Ar), 128.3 (Ar), 128.0 (Ar), 127.9 (Ar), 126.0 (Ar), 125.8 (Ar), 98.6 
(Ar), 73.3 (C-2), 68.4 (C-6), 51.8 (C-9), 41.1 (C-11), and 35.6 (C-5); m/z (ESI+) 333 (M 
+ Na)+ (Found 333.1108 (M + Na)+. C19H18NaO4 requires; 333.1103).
  
 
 
(2R*,6S*)-Methyl 4-hydroxy-6-isopropyl-2-phenyl-5,6-dihydro-2H-pyran-3-
carboxylate (277) 
 
Dihydropyran 262 (0.06 g, 0.30 mmol), phenyl lithium 1.9M in dibutyl ether (0.49 ml, 
0.72 mmol), copper iodide (0.06, 0.36 mmol), cholorotrimethylsilane (0.06 ml, 0.54 
mmol), THF (5 ml); purification (hexane – ethyl acetate = 4: 1), Percentage yield 0.060 
g, 73%, light yellow oil. υ max/cm-1 (film) 2924 (C-H), 2852 (C-H), 1739 (C=O), 1661 
(Ar), 1365 (CH3), 1268 (C-O), 1222 (C-O), 1060 (C-O), 841 (Ar); δH (400 MHz, CDCl3) 
12.30 (1H, s, OH), 7.37‒7.27 (5H, m, Ar), 5.62 (1H, s, H-2), 3.63 (3H, s, H-11), 3.10 
(1H, dd, J =10.8, 3.9 Hz, H-6), 2.36 (1H, dd, J = 18.0, 10.8 Hz, H-5ax), 2.23 (1H, dd, J 
= 18.0, 3.9 Hz, H-5eq), 1.64‒1.56 (1H, m, H-8), 0.80 (3H, d, J = 6.8 Hz, H-9) and 0.77 
(3H, d, J = 6.8 Hz, H-10); δC (100 MHz, CDCl3) 193.2 (C=O), 171.5 (C-3), 141.5 (C-4), 
128.6 (Ar), 128.0 (Ar), 127.7 (Ar), 98.5 (Ar), 72.6 (C-2), 71.6 (C-6), 51.2 (C-11), 32.8 
(C-5), 32.3 (C-7), 18.4 (C-9) and 17.8 (C-10); m/z (ESI+) 299 (M + Na)+ (Found 299.1245 
(M + Na)+. C16H20NaO4 requires; 299.1254).
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(2R*,6S*)-Methyl 4-hydroxy-2-phenyl-6-(((triisopropylsilyl)oxy)methyl)-5,6-
dihydro-2H-pyran-3-carboxylate (280) 
 
Dihydropyran 265 (0.07 g, 0.21 mmol), phenyl lithium 1.9M in dibutyl ether (0.40 ml, 
0.70 mmol), copper iodide (0.08 g, 0.44 mmol), cholorotrimethylsilane (0.13 ml, 1.10 
mmol), THF (2.00 ml); purification (hexane – ethyl acetate = 4: 1), Percentage yield 0.043 
g, 48%, light yellow oil. υ max/cm-1 (film) 2941 (C-H), 2861 (C-H), 1660 (C=C), 1600 
(Ar), 1465 (CH2), 1280 (C-O), 1264 (C-O), 1215 (C-O), 1095 (C-O), 880 (Ar), 681 (Ar); 
δH (400 MHz, C6D6) 12.90 (1H, s, OH), 7.38‒7.36 (2H, m, Ar), 7.18‒7.08 (3H, m, Ar) 
5.79 (1H, s, H-2), 3.65‒3.60 (1H, m, H-6), 3.55‒3.46 (2H, m, H-7), 3.05 (3H, s, H-9), 
2.59 (1H, dd, J = 18.1, 10.8 Hz, H-5ax), 2.18 (1H, dd, J = 18.1, 2.8 Hz, H-5eq) and 1.01 
(21H, m, OTIPS); δC (100 MHz, C6D6) 172.3 (C=O), 170.5 (C-3), 141.5 (C-4), 128.9 
(Ar), 128.4 (Ar), 127.9 (Ar), 99.0 (Ar), 73.1 (C-2), 67.9 (C-6), 66.3 (C-7), 51.0 (C-9), 
31.4 (C-5), 18.1 (C-OTIPS) and 12.2 (C-OTIPS); m/z (ESI+) 443 (M + Na)+ (Found 
443.2209 (M + Na)+. C23H36NaO5Si requires; 443.2224).
  
 
(2R*,6R*)-Methyl 4-hydroxy-2-phenyl-6-propyl-5,6-dihydro-2H-pyran-3-
carboxylate (278) 
 
Dihydropyran 263 (0.04g, 0.22 mmol), phenyl lithium 1.9M in dibutyl ether (0.40 ml, 
0.74 mmol), copper iodide (0.07 g, 0.37 mmol), cholorotrimethylsilane (0.14 ml, 1.15 
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mmol), THF (2.00 ml); purification (hexane – ethyl acetate = 4: 1), percentage yield 0.035 
g, 56%, light yellow oil. υ max/cm-1 (film) 2955 (C-H), 2927 (C-H), 2875 (C-H), 1658 
(C=O), 1621 (Ar), 1441 (CH3), 1262 (C-O), 1216 (C-O), 1043 (C-O), 775 (Ar), 698 (Ar); 
δH (400 MHz, CDCl3) 12.29 (1H, s, OH), 7.37‒7.27 (5H, m, Ar), 5.59 (1H, s, H-2), 3.63 
(3H, s, H-11), 3.47‒3.41 (1H, m, H-6), 2.32 (1H, dd, J = 18.0, 10.0 Hz, H-5ax), 2.23 (1H, 
dd, J = 18.0, 4.2 Hz, H-5eq), 1.05‒1.43 (2H, m, H-7), 1.37‒1.28 (2H, m, H-8) and 0.72 
(3H, t, J = 7.2 Hz, H-9); δC (100 MHz, CDCl3) 171.7 (C=O), 171.2 (C-3), 141.1 (C-4), 
128.5 (Ar), 128.1 (Ar), 127.8 (Ar), 98.6, 72.2 (C-2), 66.3 (C-6), 51.7 (C-11), 37.8 (C-7), 
35.0 (C-5), 18.3 (C-8) and 13.8 (C-9); m/z (ESI+) 299 (M + Na)+ (Found 299.1255 (M + 
Na)+. C16H20NaO4 requires; 299.1254).
  
 
(2R*,6S*)-Methyl 4-hydroxy-2-phenyl-6-((E)-prop-1-en-1-yl)-5,6-dihydro-2H-
pyran-3-carboxylate (281) 
 
Dihydropyran 268 (0.05 g, 0.28 mmol), phenyl lithium 1.9M in dibutyl ether (0.58 ml, 
0.90 mmol), copper iodide (0.08 mg, 0.45 mmol), cholorotrimethylsilane (0.17 ml, 1.40 
mmol), THF (5.00 ml); purification (hexane – ethyl acetate = 4: 1), percentage yield 0.049 
g, 64%, light yellow oil. υ max/cm-1 (film) 2952 (C-H), 2896 (C-H), 1618 (C=C), 1437 
(CH3), 1325 (CH3), 1243 (C-O), 1205 (C-O), 1181 (C-O), 1051 (C-O), 958 (Ar), 740 
(Ar), 690 (Ar); δH (400 MHz, CDCl3) 12.30 (1H, s, OH), 7.40-7.27 (5H, m, Ar), 5.62 (1H, 
s, H-2), 5.56 (1H, d, J = 16.0, 4.0 Hz, H-8), 5.44 (1H, dd, J = 16.0, 4.0 Hz, H-9),  3.97 
(1H, ddd, J = 12.0, 4.0, 4.0 Hz, H-6) , 3.62 (3H, s, H-11), 2.47 (1H, dd, J = 16.0, 12.0 Hz, 
H-5ax), 2.32 (1H, dd, J = 16.0, 4.0 Hz, H-5eq) and 1.65 (1H, d, J = 4.0 Hz, H-10); δC 
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(100 MHz, CDCl3) 171.1 (C=O), 168.5 (C-3), 140.9 (C-4), 130.4 (C-9), 128.5 (C-8), 
128.2 (Ar), 127.9 (Ar), 127.1 (Ar), 98.6 (Ar), 73.0 (C-2), 67.1 (C-6), 51.6 (C-11), 34.4 
(C-5), and 17.9 (C-10); m/z (ESI+) 297 (M + Na)+ (Found 297.1091 (M + Na)+. 
C16H18NaO4 requires; 297.1097).
  
 
(2R*,6S*)-Methyl 4-hydroxy-2-phenyl-6-((E)-styryl)-5,6-dihydro-2H-pyran-3-
carboxylate (282) 
 
Dihydropyran 269 (0.98 g, 3.82 mmol), phenyl lithium 1.9M in dibutyl ether (8.12 ml, 
12.60 mmol), copper iodide (1.16 g, 6.10 mmol), cholorotrimethylsilane (2.41 ml, 19.00 
mmol), THF (68.00 ml); purification (hexane – ethyl acetate = 4: 1), percentage yield 
1.170 g, 91 %, light yellow oil. υ max/cm-1 (film) 2952 (C-H), 2896 (C-H), 1662 (C=C), 
1618 (C=C), 1437 (CH2), 1205 (C-O), 1181 (C-O), 1051 (C-O), 958 (Ar), 740 (Ar), 690 
(Ar); δH (400 MHz, CDCl3) 12.32 (1H, s, OH), 7.46‒7.20 (10H, m, Ar), 6.49 (1H, d, J = 
16.1 Hz, H-9), 6.15 (1H, dd, J = 16.1, 5.7 Hz, H-8), 5.70 (1H, s, H-2), 4.24 (1H, ddd, J = 
10.5, 5.7, 4.1 Hz, H-6) , 3.64 (3H, s, H-11), 2.58 (1H, dd, J = 18.0, 10.5 Hz, H-5ax) and 
2.46 (1H, dd, J = 18.0, 4.1 Hz, H-5eq); NOE C2 (Phenyl) – H6 1.4%, H6 – H9 1.35% 
and H6 – H8 1.12%; δC (100 MHz, CDCl3) 171.1 (C=O), 170.9 (C-3), 140.8 (C-4), 136.4 
(Ar), 131.4 (C-9), 128.6 (Ar), 128.5 (Ar), 128.3 (C-8), 128.0 (Ar), 127.9 (Ar), 126.6 (Ar), 
115.4 (Ar), 98.3 (Ar), 73.0 (C-2), 67.4 (C-6), 51.8 (C-11), 34.5 (C-5); m/z (ESI+) 359 (M 
+ Na)+ (Found 359.1249 (M + Na)+. C21H20NaO4 requires; 359.1254).
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Addition of Me2CuLi: 
Methyl lithium 1.6M in Et2O (0.56 ml, 0.72 mmol) was added to a suspension of copper 
iodide (0.069g, 0.36 mmol) in THF (2.00 mL) at 0 °C. The mixture was stirred at this 
temperature for 20 minutes after which chlorotrimethylsilane (0.14 ml, 0.54 mmol) then 
DHP (0.10 mmol) in THF (2.00 mL) were added at ‒78 °C. The reaction mixture was 
stirred at this temperature for 4.5 hours then sat. aq. NH4Cl (1.70 mL) was added to the 
mixture, which was stirred rapidly for 30 minutes at rt. The mixture was diluted with H2O 
(10.0 mL) extracted with Et2O (2 x 20.0 mL) and washed with H2O (20.0 mL) and brine 
(20.0 mL). The organic layer was dried over MgSO4 and concentrated in vacuo. Flash 
column chromatography (hexane:ethyl acetate 7:1 to 3:1) afforded the products as an 
inseparable mixture of enol and ketone tautomers which were then subjected to acylation. 
The THP mixture (0.03 mmol), acetic anhydride (0.10 mL, 0.10 mmol) and DMAP (2 
mg) were stirred in pyridine (0.47 mL) at 40 °C for 40 minutes. The mixture was cooled 
to rt, concentrated in vacuo, then partitioned between Et2O (30.00 mL) and H2O (10.00 
mL). The organic layer was washed with H2O (10.00 mL) and brine (10.00 mL), then 
dried over MgSO4 and concentrated in vacuo. Flash column chromatography (hexane- 
ethyl acetate) gave the product. 
 
(2R*,6S*)-Methyl 4-acetoxy-2-methyl-6-phenyl-5,6-dihydro-2H-pyran-3-
carboxylate (273) 
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Dihydropyran 264 (0.25 g, 1.09 mmol), methyl lithium 1.6M in Et2O (0.47 ml, 0.61 
mmol), copper iodide (0.05g, 0.31 mmol), cholorotrimethylsilane (0.11 ml, 0.92 mmol), 
THF (1.70 ml). Then, THP (0.10 g, 0.40 mmol), Ac2O (1.33 mL, 1.33 mmol), DMAP (2 
mol %), pyridine (6.70 mL); purification (hexane – ethyl acetate = 4: 1), percentage yield 
0.149 g, (47 % after 2 steps), light yellow oil. υ max/cm-1 (film) 2945 (C-H), 2931 (C-H), 
1766 (C=O), 1720 (C=O), 1664 (C=C), 1365 (CH3), 1247 (C-O), 1174 (C-O), 1053 (C-
O), 758 (Ar), 698 (Ar); δH (400 MHz, C6D6) 7.30‒7.23 (2H, m, Ar), 7.17‒7.16 (1H, 
m,Ar), 7.14‒7.05 (2H, m, Ar), 5.13 (1H, q, J = 6.6 Hz, H-2), 4.83 (1H, dd, J = 9.7, 4.1 
Hz, H-6), 3.26 (3H, s, H-9), 2.40 (1H, dd, J =17.9, 9.7 Hz, H-5ax), 2.31 (1H, dd, J = 17.9, 
4.1 Hz, H-5eq), 1.88 (3H, s, H-10) and 1.39 (3H, d, J = 6.6 Hz, H-7); NOE C2(Me) – H6 
2.3% and C2(Me) – H5eq 1.86%; δC (100 MHz, C6D6) 193.5 (C=O), 167.8 (C=O), 163.9 
(C-3), 154.1 (C-4), 141.0 (Ar), 128.6 (Ar), 126.7 (Ar), 121.7 (Ar), 69.5 (C-2), 68.8 (C-6), 
51.1 (C-9), 36.9 (C-5), 20.5 (C-10) and 19.5 (C-7); m/z (ESI+) 313 (M + Na)+ (Found 
313.1040 (M + Na)+. C16H18NaO5 requires; 313.1052).
  
 
(2R*,6S*)-Methyl 4-acetoxy-2-methyl-6-(((triisopropylsilyl)oxy)methyl)-5,6-
dihydro-2H-pyran-3-carboxylate (275) 
 
Dihydropyran 265 (0.05 g, 0.16 mmol), methyl lithium 1.6M in Et2O (0.47 ml, 0.61 
mmol), copper iodide (0.06 g, 0.31 mmol), cholorotrimethylsilane (0.11 ml, 0.92 mmol), 
THF (1.70 ml). Then, THP (0.03 g, 0.09 mmol), Ac2O (0.30 mL, 0.30 mmol), DMAP (2 
mol%), pyridine (1.41 mL); purification (hexane – ethyl acetate = 4: 1), percentage yield 
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0.040 g, (61 % after 2 steps), light yellow oil. υ max/cm-1 (film) 2941 (C-H), 2866 (C-H), 
1771 (C=O), 1725 (C=O), 1365 (CH3), 1246 (C-O), 1177 (C-O), 1149 (C-O), 1055 (C-
O); δH (400 MHz, C6D6) 5.04 (1H, q, J = 6.5 Hz, H-2), 4.03‒3.97 (1H, m, H-6), 3.76 (1H, 
dd, J =10.2, 5.1 Hz, H-8), 3.63 (1H, dd, J =10.2, 5.2 Hz, H-8), 3.23 (3H, s, H-9), 2.44 
(1H, dd, J =17.8, 10.0 Hz, H-5ax), 2.25 (1H, dd, J = 17.8, 3.8 Hz, H-5eq), 1.87 (3H, s, H-
10), 1.39 (3H, d, J =6.5 Hz, H-7) and 1.09 (21H, m, OTIPS); δC (100 MHz, C6D6) 168.0 
(C=O), 163.8 (C=O), 154.4 (C-3), 121.8 (C-4), 69.1 (C-2), 68.1 (C-6), 66.4 (C-8), 51.1 
(C-9), 32.0 (C-5), 20.6 (C-10) 19.4 (C-7), 18.3 (C-OTIPS) and 12.2 (C-OTIPS); m/z 
(ESI+) 423 (M + Na)+ (Found 423.2160 (M + Na)+. C20H36NaO6Si requires; 423.2179).
  
 
(2R*,6S*)-Methyl4-acetoxy-6-(furan-2-yl)-2-methyl-5,6-dihydro-2H-pyran-3-
carboxylate (274) 
 
Dihydropyran 259 (0.03 g, 0.12 mmol), methyl lithium 1.6M in Et2O (0.40 ml, 0.36 
mmol), copper iodide (0.04 g, 0.23 mmol), cholorotrimethylsilane (0.08 ml, 0.70 mmol), 
THF (3.00 ml). Then, THP (0.02 g, 0.06 mmol), Ac2O (0.21 mL, 0.21 mmol), DMAP (2 
mol%), pyridine (1.00 mL); purification (hexane – ethyl acetate = 4: 1), percentage yield 
0.015 g, (42 % after 2 steps), light yellow oil. υ max/cm-1 (film) 2955 (C-H), 2924 (C-H), 
2854 (C-H), 1766 (C=O), 1720 (C=O), 1435 (CH3), 1364 (CH3), 1253 (C-O), 1176 (C-
O), 1144 (C-O), 1052 (C-O); δH (400 MHz, CDCl3) 7.41 (1H, s, H-10), 6.37-6.35 (2H, 
m, H-8, H-9), 5.04 (1H, dd, J = 9.2, 4.2 Hz, H-6), 4.85 (1H, q, J = 6.5 Hz, H-2), 3.74 (3H, 
s, H-11), 2.79 (1H, dd, J =17.9, 9.2 Hz, H-5ax), 2.53 (1H, dd, J = 17.9, 4.2 Hz, H-5eq), 
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2.22 (3H, s, H-12) and 1.48 (3H, d, J = 6.5 Hz, H-7); δC (100 MHz, CDCl3) 168.5 (C=O), 
164.0 (C=O), 157.5 (C-3), 152.6 (C-4), 142.9 (C-10), 121.6 (C-13), 110.4 (C-8), 108.0 
(C-9), 69.0 (C-2), 63.4 (C-6), 51.9 (C-11), 32.6 (C-5), 21.1 (C-12) and 19.3 (C-7) ppm; 
m/z (ESI+) 303 (M + Na)+ (Found 303.0827 (M + Na)+. C14H16NaO6 requires; 303.0845).
  
 
(2R*,6S*)-Methyl 4-acetoxy-6-isopropyl-2-methyl-5,6-dihydro-2H-pyran-3-
carboxylate (271) 
 
Dihydropyran 262 (0.04 g, 0.20 mmol), methyl lithium 1.6M in Et2O (0.28 ml, 0.36 
mmol), copper iodide (0.03 g, 0.18 mmol), cholorotrimethylsilane (0.06 ml, 0.54 mmol), 
THF (2.00 ml). Then, THP (0.01 g, 0.06 mmol), Ac2O (0.21 mL, 0.21 mmol), DMAP (2 
mol%), pyridine (1.00 mL); purification (hexane – ethyl acetate = 4: 1), percentage yield 
0.019 g, (37 % after 2 steps), light yellow oil. υ max/cm-1 (film) 2959 (C-H), 2927 (C-H), 
2875 (C-H), 1768 (C=O), 1723 (C=O), 1435 (CH3), 1367 (CH3), 1249 (C-O), 1177 (C-
O), 1142 (C-O), 1058 (C-O); δH (400 MHz, C6D6) 5.00 (1H, q, J = 6.5 Hz, H-2), 3.45‒
3.40 (1H, m, H-6), 3.24 (3H, s, H-10), 2.17 (1H, dd, J =17.7, 10.1 Hz, H-5ax), 2.02 (1H, 
dd, J = 17.7, 3.4 Hz, H-5eq), 1.92 (3H, s, H-11), 1.60‒1.53 (1H, m, H-8), 1.34 (3H, d, J 
= 6.5 Hz, H-7), 0.93 (3H, d, J =6.5 Hz, H-9) and 0.73 (3H, d, J = 6.5 Hz, H-9); δC (100 
MHz, C6D6) 193.5 (C=O), 168.3 (C=O), 164.1 (C-3), 155.0 (C-4), 121.8 (C-8), 71.4 (C-
6), 69.0 (C-2), 50.8 (C-10), 33.0 (C-5), 20.6 (C-11), 19.3 (C-7), 18.4 (C-9) and 18.0 (C-
9); m/z (ESI+) 279 (M + Na)+ (Found 279.1199 (M + Na)+. C13H20NaO5 requires; 
279.1208).  
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(2R*,6R*)-Methyl 4-acetoxy-2-methyl-6-propyl-5,6-dihydro-2H-pyran-3-
carboxylate (272) 
 
Dihydropyran 263 (0.03 g, 0.15 mmol), methyl lithium 1.6M in Et2O (0.28 ml, 0.36 
mmol), copper iodide (0.034 g, 0.18 mmol), cholorotrimethylsilane (0.06 ml, 0.54 mmol), 
THF (2.00 ml). Then, THP (0.02 g, 0.10 mmol), Ac2O (0.33 mL, 0.33 mmol), DMAP (2 
mol%), pyridine (1.60 mL); purification (hexane – ethyl acetate = 4: 1), percentage yield 
0.015 g, (40 % after 2 steps), light yellow oil. υ max/cm-1 (film) 2955 (C-H), 2931 (C-H), 
2872 (C-H), 1768 (C=O), 1723 (C=O), 1435 (CH3), 1363 (CH3), 1254 (C-O), 1177 (C-
O), 1149 (C-O), 1055 (C-O); δH (400 MHz, C6D6) 5.02 (1H, q, J = 6.5 Hz, H-2), 3.73‒
3.67 (1H, m, H-6), 3.25 (3H, s, H-11), 2.09‒2.02 (2H, m, H-5), 1.90 (3H, s, H-12), 1.50-
1.39 (2H, m, H-8), 1.35 (3H, d, J =6.5 Hz, H-7), 1.31-1.12 (2H, m, H-9) and 0.82 (3H, t, 
J = 7.2 Hz, H-10); δC (100 MHz, C6D6) 193.8 (C=O), 168.0 (C=O), 163.9 (C-3), 154.4 
(C-4), 68.9 (C-2), 66.4 (C-6), 51.0 (C-11), 37.6 (C-8), 35.4 (C-5), 20.7 (C-12), 19.0 (C-
9), 18.8 (C-7) and 14.0 (C-10); m/z (ESI+) 279 (M + Na)+ (Found 279.1202 (M + Na)+. 
C13H20NaO5 requires; 279.1208).
  
 
 
 
 
 
174 
 
(2R*,6S*)-Methyl 4-acetoxy-2-methyl-6-((E)-prop-1-en-1-yl)-5,6-dihydro-2H-
pyran-3-carboxylate (276) 
 
Dihydropyran 268 (0.05 g, 0.25 mmol), methyl lithium 1.6M in Et2O (0.72 ml, 0.92 
mmol), copper iodide (0.089 g, 0.47 mmol), cholorotrimethylsilane (0.17 ml, 1.40 mmol), 
THF (5.20 ml). Then, THP (0.03 g, 0.14 mmol), Ac2O (0.46 mL, 0.46 mmol), DMAP (2 
mol%), pyridine (2.20 mL); purification (hexane – ethyl acetate = 4: 1), percentage yield 
0.019 g, (29 % after 2 steps), light yellow oil. υ max/cm-1 (film) 2952 (C-H), 2930 (C-H), 
1767 (C=O), 1721 (C=O), 1664 (C=C), 1436 (CH3), 1366 (CH3), 1245 (C-O), 1212 (C-
O), 1176 (C-O), 1046 (C-O), 1050 (C-O); δH (400 MHz, CDCl3) 5.78 (1H, dd, J = 16.0, 
4.0 Hz, H-8), 5.52 (1H, dq, J = 16.0, 4.0 Hz, H-9), 4.85 (1H, q, J = 8.0 Hz, H-2), 4.37 
(1H, ddd, J = 8.0, 4.0, 4.0 Hz, H-6), 3.72 (3H, s, H-11), 2.30 (2H, m, H-5), 2.20 (3H, s, 
H-12), 1.71 (2H, d, J = 4.0 Hz , H-10) and 1.42 (3H, d, J = 8.0 Hz, H-7); δC (100 MHz, 
CDCl3) 168.7 (C=O), 164.1 (C=O), 153.3 (C-3), 130.2 (C-4), 129.2 (C-8), 121.3 (C-9), 
68.8 (C-2), 67.9 (C-6), 51.9 (C-11), 34.8 (C-5), 21.0 (C-12), 19.6 (C-7) and 17.9 (C-10); 
m/z (ESI+) 277 (M + Na)+ (Found 277.1047 (M + Na)+. C13H18NaO5 requires; 277.1046).
  
 
General method for n-Bu2CuLi:  
nButyl lithium 2.5M in hexane solution (0.26 mL, 0.60 mmol) was added to a suspension 
of copper iodide (57.20 mg, 0.30 mmol) in THF (1.70 mL) at 0 °C. The mixture was 
stirred at this temperature for 20 minutes. After this time the mixture was cooled to ‒78 
°C and chlorotrimethylsilane (0.12 mL, 0.90 mmol) was added followed by addition of 
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DHP (0.20 mmol) in THF (1.80 mL) at ‒78 °C. The reaction mixture was stirred at ‒78 
°C for 4 hours, then quenched with sat. aq. NH4Cl (1.50 mL) and allowed to warm to rt 
with vigorous stirring. The mixture was diluted further with sat. aq. NH4Cl (10.0 mL) and 
extracted with EtOAc (5 x 15.0 mL). The combined organic extracts were washed with 
H2O (15.0 mL) and brine (15.0 mL), then dried over MgSO4 and concentrated in vacuo. 
Flash column chromatography (hexane – ethyl acetate) afforded the products as an 
inseparable mixture of enol and ketone tautomers, which were then subjected to acylation. 
The THP mixture (0.03 mmol), acetic anhydride (0.10 mL, 0.10 mmol) and DMAP (2 
mol%) were stirred in pyridine (0.47 mL) at 40 °C for 40 minutes. The mixture was cooled 
to rt, concentrated in vacuo, then partitioned between Et2O (30.00 mL) and H2O (10.00 
mL). The organic layer was washed with H2O (10.00 mL) and brine (10.00 mL), then 
dried over MgSO4 and concentrated in vacuo. Flash column chromatography (hexane- 
ethyl acetate) gave products. 
 
(2R*,6S*)-Methyl 4-acetoxy-2-butyl-6-isopropyl-5,6-dihydro-2H-pyran-3-
carboxylate (283) 
 
Dihydropyran 262 (0.04 g, 0.18 mmol), n-butyl lithium 2.5M in hexane (0.26 ml, 0.60 
mmol), copper iodide (0.05 g, 0.30 mmol), cholorotrimethylsilane (0.11 ml, 0.90 mmol), 
THF (1.82 ml). Then, THP (0.02 g, 0.10 mmol), Ac2O (0.33 mL, 0.33 mmol), DMAP (2 
mol%), pyridine (1.60 mL); purification (Hex: EA = 4.0: 1.0), percentage yield 0.020 g, 
(37 % after 2 steps), light yellow oil. υ max/cm-1 (film) 2955 (C-H), 2929 (C-H), 1767 
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(C=O), 1724 (C=O), 1435 (CH3), 1365 (CH3), 1249 (C-O), 1202 (C-O), 1177 (C-O), 1056 
(C-O); δH (400 MHz, C6D6) 4.89 (1H, d, J = 10.0 Hz, H-2), 3.43‒3.38 (1H, m, H-6), 3.28 
(3H, s, H-15), 2.15 (1H, dd, J = 17.7, 9.6 Hz, H-5ax), 2.07 (1H, dd, J = 17.7, 4.3 Hz, H-
5eq), 1.92 (3H, s, H-14), 1.74‒1.53 (2H, m, H-10), 1.48‒1.39 (1H, m, H-7), 1.37‒1.24 
(4H, m, H-11, H-12), 0.96 (3H, d, J = 6.7 Hz, H-9), 0.88 (3H, t, J = 7.3 Hz, H-13) and 
0.74 (3H, d, J = 6.8 Hz, H-8); δC (100 MHz, C6D6) 167.9 (C=O), 164.0 (C=O), 154.4 (C-
3), 121.4 (C-4), 72.8 (C-2), 71.4 (C-6), 51.0 (C-15), 32.9 (C-10), 32.2 (C-5), 28.7 (C-7), 
22.6 (C-14), 20.6 (C-12, C-11), 18.6 (C-9), 18.3 (C-8) and 14.2 (C-13); m/z (ESI+) 321 
(M + Na)+ (Found 321.1669 (M + Na)+. C16H26NaO5 requires; 321.1672).
  
 
(2R*,6S*)-Methyl 4-acetoxy-2-butyl-6-(((triisopropylsilyl)oxy)methyl)-5,6-dihydro-
2H-pyran-3-carboxylate (284) 
 
Dihydropyran 265 (0.05 g, 0.16 mmol), n-butyl lithium 2.5M in hexane (0.28 ml, 0.51 
mmol), copper iodide (0.049g, 0.26 mmol), cholorotrimethylsilane (0.10 ml, 0.80 mmol), 
THF (3.00 ml). Then, THP (0.03 g, 0.08 mmol), Ac2O (0.26 mL, 0.26 mmol), DMAP (2 
mol%), pyridine (1.25 mL); purification (Hex: EA = 4.0: 1.0), percentage yield 0.012 g, 
(70 % after 2 steps), light yellow oil. υ max/cm-1 (film) 2941 (C-H), 2865 (C-H), 1770 
(C=O), 1725 (C=O), 1364 (CH3), 1247 (C-O), 1192 (C-O), 1177 (C-O), 1146 (C-O), 1094 
(C-O); δH (400 MHz, C6D6) 4.89 (1H, d, J = 9.6 Hz, H-2), 3.99‒3.93 (1H, m, H-6), 3.75 
(1H, dd, J = 10.3, 5.6 Hz, H-7), 3.61 (1H, dd, J = 10.3, 4.8 Hz, H-7), 3.27 (3H, s, H-12), 
2.35 (1H, dd, J = 17.9, 10.0 Hz, H-5ax), 2.21 (1H, dd, J = 17.9, 3.9 Hz, H-5eq), 1.87 (3H, 
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s, H-13), 1.73‒1.59 (2H, m, H-8), 1.49‒1.39 (2H, m, H-9), 1.38‒1.23 (2H, m, H-10), 1.10 
(21H, m, OTIPS) and 0.89 (3H, t, J = 7.3 Hz, H-11); δC (100 MHz, C6D6) 167.9 (C=O), 
163.9 (C=O), 154.0 (C-3), 121.5 (C-4), 72.8 (C-2), 67.9 (C-6), 66.5 (C-7), 51.0 (C-12), 
32.4 (C-8), 31.8 (C-5), 28.5 (C-9), 22.6 (C-10), 20.6 (C-13), 18.2 (OTIPS), 14.2 (C-11) 
and 12.2 (OTIPS); m/z (ESI+) 465 (M + Na)+ (Found 465.2625 (M + Na)+. C23H42NaO6Si 
requires; 465.2643).  
 
 
(2R*,6S*)-Methyl 4-acetoxy-2-butyl-6-phenyl-5,6-dihydro-2H-pyran-3-carboxylate 
(286) 
(prepared by Alejandra M. Peter) 
 
Dihydropyran 264 (0.10 g, 0.43 mmol), n-butyl lithium 2.5M in hexane (0.60 ml, 1.29 
mmol), copper iodide (0.12 g, 0.65 mmol), cholorotrimethylsilane (0.25 ml, 1.94 mmol), 
THF (8.00 ml). Then, THP (0.10 g, 0.36 mmol), Ac2O (1.20 mL, 1.20 mmol), DMAP (2 
mol%), pyridine (5.64 mL); purification (hexane – ethyl acetate = 4: 1), percentage yield 
0.056 g, (39 % after 2 steps), light yellow oil. υ max/cm-1 (film) 2953 (C-H), 2860 (C-H), 
1764 (C=O), 1721 (C=O), 1248 (C-O), 1174 (C-O), 1055 (C-O); δH (400 MHz, CDCl3) 
7.40‒7.29 (5H, m, Ar), 4.92 (1H, dd, J = 9.0, 5.0 Hz, H-6), 4.79 (1H, d, J = 10.1 Hz, H-
2), 3.75 (3H, s, H-12), 2.69‒2.47 (2H, m, H-5), 2.21 (3H, s, H-13), 1.88‒1.24 (6H, m, H-
8, H-9, H-10), and 0.89 (3H, t, J = 7.3 Hz, H-11); δC (100 MHz, CDCl3) 168.9 (C=O), 
164.1 (C=O), 153.2 (C-3), 141.0 (C-4), 128.6 (Ar), 128.0 (Ar), 126.0 (Ar), 121.2 (Ar), 
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73.2 (C-2), 68.4 (C-6), 51.8 (C-12), 36.0 (C-5), 32.2 (C-8), 28.3 (C-9), 22.4 (C-13), 21.0 
(C-10) and 14.0 (C-11); m/z (ESI+) 355 (M + Na)+ (Found 355.1509 (M + Na)+. 
C19H24NaO5 requires; 355.1516).
  
 
 
(2R*,6R*)-Methyl 4-acetoxy-2-butyl-6-propyl-5,6-dihydro-2H-pyran-3-carboxylate 
(285) 
(prepared by Alejandra M. Peter) 
 
Dihydropyran 263 (0.070g, 0.35 mmol), n-butyl lithium 2.5M in hexane (0.48 ml, 1.10 
mmol), copper iodide (0.10 g, 0.54 mmol), cholorotrimethylsilane (0.20 ml, 1.62 mmol), 
THF (6.00 ml). Then, THP (0.06 g, 0.24 mmol), Ac2O (0.80 mL, 0.80 mmol), DMAP (2 
mol%), pyridine (4.00 mL); purification (hexane – ethyl acetate = 4: 1), percentage yield 
0.037 g, (35 % after 2 steps), light yellow oil. υ max/cm-1 (film) 2956 (C-H), 2932 (C-H), 
2872 (C-H), 1767 (C=O), 1722 (C=O), 1241 (C-O), 1177 (C-O), 1053 (C-O); δH (400 
MHz, CDCl3) 4.61 (1H, d, J = 10.3 Hz, H-2), 2.84 (1H, m, H-6), 3.71 (3H, s, H-14), 2.22‒
2.16 (2H, m, H-5), 2.18 (3H, s, H-15), 1.74‒1.25 (10H, m, H-7, H-8, H-10, H-11, H-12), 
and 0.95‒0.88 (6H, m, H-9, H-13); δC (100 MHz, CDCl3) 168.6 (C=O), 164.3 (C=O), 
153.9 (C-3), 121.1 (C-4), 77.3 (C-2), 66.2 (C-6), 51.8 (C-14), 37.7 (C-7), 35.0 (C-5), 32.0 
(C-8), 28.2 (C-10), 22.3 (C-11), 21.0 (C-15), 18.8 (C-12) and 14.1 (C-9, C-13); m/z (ESI+) 
321 (M + Na)+ (Found 321.1681 (M + Na)+. C16H26NaO5 requires; 321.1672).
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 (2S*,6S*)-2-Phenyl-6-((E)-styryl)dihydro-2H-pyran-4(3H)-one (313) 
 
A solution of THP 282 (0.06 g, 0.17 mmol) in DMF (0.92 mL) and H2O (0.02 mL) was 
submitted to 200 W microwave radiation in a sealed tube at 160 °C for 10 minutes. The 
solution was cooled to rt and taken up in EtOAc (30.0 mL). The mixture was washed with 
H2O (2 x 20.0 mL). The aqueous layer was extracted with EtOAc (30.0 mL) and the 
combined organic extracts were washed with brine (20.0 mL), dried over MgSO4 and 
concentrated in vacuo to give  (0.044 g, 91 %) as a pale yellow solid. υ max/cm-1 (film) 
2978 (C-H), 2881 (C-H), 1721 (C=O), 1230 (C-O), 1047 (C-O), 966 (Ar), 753 (Ar), 737 
(Ar), 695 (Ar); δH (400 MHz, CDCl3) 7.34‒7.17 (10H, m, Ar), 6.53 (1H, dd, J = 16.3, 1.3 
Hz, H-9), 6.23 (1H, dd, J = 16.3, 5.1 Hz, H-8), 5.12 (1H, dd, J = 7.7, 4.8 Hz, H-2), 4.82 
(1H, ddd, J = 10.5, 5.2, 5.1 Hz, H-6),and 2.78‒2.68 (4H, m H-3, H-5); δC (100 MHz, 
CDCl3) 205.9 (C=O), 140.5 (Ar), 135.7 (Ar), 133.5 (C-9), 128.8 (Ar), 128.7 (Ar), 128.3 
(Ar), 128.2 (Ar), 127.9 (Ar), 126.7 (C-8), 126.5 (Ar), 73.6 (C-2), 72.9 (C-6), 47.8 (C-3), 
45.4 (C-5); m/z (ESI+) 301 (M + Na)+. (Found 301.1196 (M + Na)+. C19H18NaO2 requires 
301.1199).  
 
 (2S*,4S*,6S*)-2-Phenyl-6-((E)-styryl)tetrahydro-2H-pyran-4-ol (307) 
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The NaBH4 (0.009g, 0.26 mmol) was added to a stirred solution of crude decarboxylated 
product 313 (0.03 g, 0.13 mmol) in MeOH (2.00 mL) at 0 oC. The mixture was stirred at 
this temperature for 30 minutes and warm to room temperature for 1 hour, the reaction 
mixture was stirred at this this temperature until completion. The mixture was diluted 
with Et2O (20 mL) and washed with sat. aq. NH4Cl (20 mL). The aqueous layer was 
washed with Et2O (20 mL) and the combined organic extracts were washed with brine 
(20 mL), dried MgSO4 and concentrated in vacuo to give 301 0.024g (69%), light yellow 
oil. Diastereomers (55: 45, OH eq: OH ax). υ max/cm-1 (film) 3374 (OH), 2925 (C-H), 
1448 (C=C), 1052 (C-O), 695 (Ar); δH (400 MHz, CDCl3) OH eq 7.47‒7.22 (10H, m, 
Ar), 6.64 (1H, dd, J = 16.0, 1.9 Hz, H-9), 6.37 (1H, dd, J = 16.0, 5.2 Hz, H-8), 5.30 (1H, 
t, J = 4.4 Hz, H-2), 4.98 (1H, t, J = 5.64 Hz, H-6), 4.20 (1H, m, H-4 ), 2.51 (1H, m, H-
3eq), 2.04 (1H, m, H-5eq), 1.97 (1H, m, H-3ax), 1.67 (1H, m, H-5ax), and 1.64 (1H, bs, 
OH eq); δH (400 MHz, CDCl3) OH ax 7.47-7.22 (10H, m, Ar ), 6.64 (1H, dd, J = 16.0, 
1.9 Hz, H-9), 6.37 (1H, dd, J = 16.0, 5.2 Hz, H-8), 4.74 (1H, J = 11.3, 2.1 Hz, H-2), 4.27 
(1H, m, H-6), 4.06 (1H, m, H-4), 2.30 (1H, m, H-3eq), 2.17 (1H, m, H-5eq), 1.92 (1H, m, 
H-3ax), 1.59 (1H, m, H-5ax), and 1.64 (1H, bs, OH ax); δC (100 MHz, CDCl3) 140.6 (Ar), 
136.9 (Ar), 130.6 (C-9), 129.9 (C-8), 128.7 (Ar), 128.6 (Ar), 127.7 (Ar), 127.3 (Ar), 126.6 
(Ar), 126.4 (Ar), 72.3 (C-2), 70.5 (C-6), 64.8 (C-4), 40.6 (C-5) and 36.9 (C-3); m/z (ESI+) 
303 (M + Na)+. (Found 303.1349 (M + Na)+. C19H20NaO2 requires 303.1356). 
 
(2S*,4S*,6S*)-2-Phenyl-6-((E)-styryl)tetrahydro-2H-pyran-4-ol (307) 
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The 1.0 M solution of L-Selectride® in THF (0.73 mL) was added to a stirred solution of 
crude decarboxylated product 313 (0.079g, 0.28 mmol) in THF (3.50 mL) at ‒78 oC. The 
mixture was stirred at this temperature for 15 minutes and warm to room temperature for 
1 hour, the reaction mixture was stirred at this this temperature until completion. The 
mixture was diluted with Et2O (20 mL) and washed with sat. aq. NH4Cl (20 mL). The 
aqueous layer was washed with Et2O (20 mL) and the combined organic extracts were 
washed with brine (20 mL), dried MgSO4 and concentrated in vacuo to give 307 0.052g 
(66%), light yellow oil. Diastereomers (9: 1, OH eq: OH ax (minor)). υ max/cm-1 (film) 
3374 (OH), 2925 (C-H), 1448 (C=C), 1052 (C-O), 695 (Ar); δH (400 MHz, CDCl3) 7.47‒
7.22 (10H, m, Ar), 6.64 (1H, dd, J = 16.1, 1.1 Hz, H-9), 6.37 (1H, dd, J = 16.1, 5.8 Hz, 
H-8), 5.31 (1H, t, J = 4.4 Hz, H-2), 4.98 (1H, m, H-6 minor), 4.74 (1H, m, H-2 minor), 
4.27 (1H, dddd, J = 9.1, 5.8, 5.0, 1.1 Hz, H-6), 4.19 (1H, m, H-4 minor), 4.07 (1H, dddd, 
J = 9.3, 9.0, 4.5, 4.0 Hz, H-4), 2.54 (1H, ddd, J = 13.5, 4.4, 4.0 Hz, H-3eq), 2.31 (1H, m, 
H-3 minor), 2.19 (1H, m, H-5 minor), 2.08 (1H, ddd, J = 12.6, 5.0, 4.5 Hz, H-5eq), 1.96 
(1H, ddd, J = 13.5, 9.0, 4.4 Hz, H-3ax), 1.89 (1H, m, H-5 minor), 1.64 (1H, ddd, J = 12.6, 
9.3, 9.1 Hz, H-5ax) and 1.64 (1H, bs, OH); δC (100 MHz, CDCl3) 140.7 (Ar), 136.8 (Ar), 
130.6 (C-9), 129.9 (C-8), 128.8 (Ar), 128.7 (Ar), 127.8 (Ar), 127.3 (Ar), 126.6 (Ar), 126.4 
(Ar), 72.2 (C-2), 70.6 (C-6), 64.7 (C-4), 40.5 (C-5) and 37.0 (C-3); m/z (ESI+) 303 (M + 
Na)+. (Found 303.1361 (M + Na)+. C19H20NaO2 requires 303.1356). NMR data were in 
agreement with the literature.113 
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(2S*,4S*,6S*)-4-(Methoxymethoxy)-2-phenyl-6-((E)-styryl)tetrahydro-2H-pyran 
(309) 
 
To the stirred solution of THP 307 (0.08 g, 0.28 mmol) in THF (5.00 mL) was added 
N,N-diisopropylethylamine (0.60 mL, 3.36 mmol), MOMCl (0.34 mL, 4.48 mmol), and 
sodium iodide (0.10 g, 0.67 mmol) at room temperature. The mixture was heated at 50 oC 
for 10 hours. After the solvent was removed under vacuum, the reaction mixture was 
diluted with H2O (20 mL x 7) and extracted with EtOAc (20 mL). The extract was washed 
with brine and dried over MgSO4 and concentrated in vacuo to give the product 309 0.054 
g (60 %) as a light yellow oil. υ max/cm-1 (film) 2923 (C-H), 2854 (C-H), 1145 (C-O), 
1033 (C-O), 695 (Ar); δH (400 MHz, CDCl3) 7.47‒7.22 (10H, m), 6.62 (1H, d, J = 16.0 
Hz), 6.38 (1H, dd, J = 16.0, 6.0 Hz), 5.29 (1H, t, J = 4.4 Hz), 4.74, (2H, s), 4.26 (1H, 
dddd, J = 9.2, 6.0, 4.6 Hz), 3.96 (1H, dddd, J = 9.4, 9.2, 5.0, 4.0 Hz), 3.41, (3H, s), 2.54 
(1H, dddd, J = 13.4, 4.4, 4.0, 1.5 Hz), 2.09 (1H, ddd, J = 12.8, 5.0, 4.6, 1.5 Hz), 2.03 (1H, 
ddd, J = 13.4, 9.4, 4.4 Hz), and 1.67 (1H, dt, J = 12.8, 9.2, 9.2 Hz); δC (100 MHz, CDCl3) 
140.6 (Ar), 136.9 (Ar), 130.5 (C-9), 129.9 (C-8), 128.7 (Ar), 128.6 (Ar), 127.7 (Ar), 127.3 
(Ar), 126.6 (Ar), 126.4 (Ar), 94.9 (C-11), 72.3 (C-2), 70.8 (C-6), 69.8 (C-4), 55.4 (C-12), 
37.9 (C-5) and 34.6 (C-3); m/z (ESI+) 347 (M + Na)+. (Found 347.1618 (M + Na)+. 
C21H24NaO3 requires 347.1618). NMR data were in agreement with the literature.
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2-((2S*,4S*,6S*)-4-(Methoxymethoxy)-6-phenyltetrahydro-2H-pyran-2-yl)-1-
phenylethanone (310) 
 
To the stirred solution of THP MOM-protected alcohol 309 (0.014g, 0.04 mmol) in DMF 
(0.50 mL) and H2O (0.50 mL) was added PdCl2 (0.004g, 0.02 mmol), Copper chloride 
(0.006g, 0.06 mmol) at room temperature. The mixture was heated at 50 oC for 3 days 
under oxygen atmosphere. After the solvent was removed under vacuum to give 310 
0.010 g (70 %) as a light yellow oil. υ max/cm-1 (film) 2921 (C-H), 1682 (C=O), 1445 
(C=C), 1036 (C-O), 690 (Ar); δH (400 MHz, CDCl3) 7.97 (2H, dd, J = 7.0, 1.0 Hz), 7.57 
(1H, tt, J = 7.4, 1.2 Hz), 7.47 (2H, t, J = 7.3 Hz), 7.35-7.29 (5H, m), 5.16 (1H, t, J = 4.3 
Hz), 4.70 (2H, s), 4.24 (1H, dddd, J = 9.3, 7.0, 5.9, 3.0 Hz), 3.91 (1H, dddd, J = 9.8, 9.3, 
4.2, 4.1 Hz), 3.42 (1H, dd, J = 15.9, 7.0 Hz), 3.38, (3H, s), 3.18 (1H, dd, J = 15.9, 5.9 
Hz), 2.52 (1H, ddd, J = 13.5, 4.3, 4.1 Hz), 2.08 (1H, ddd, J = 12.6, 4.2, 3.0 Hz), 1.98 (1H, 
ddd, J = 13.5, 9.8, 4.3 Hz), and 1.67 (1H, dt, J = 12.6, 9.3, 9.3 Hz); δC (100 MHz, CDCl3) 
198.1 (C-O), 140.4 (Ar), 137.2 (Ar), 133.2 (Ar), 128.7 (Ar), 128.3 (Ar), 127.2 (Ar), 126.4 
(Ar), 98.6 (Ar), 95.2 (C-11), 72.4 (C-2), 69.5 (C-6), 67.5 (C-4), 55.4 (C-12), 44.4 (C-O), 
38.1 (C-5), and 34.7 (C-3); m/z (ESI+) 363 (M + Na)+. (Found 363.1559 (M + Na)+. 
C21H24NaO4 requires 363.1567). NMR data were in agreement with the literature.
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Diospongin B  
2-((2S*,4S*,6S*)-4-Hydroxy-6-phenyltetrahydro-2H-pyran-2-yl)-1-phenylethanone 
(4) 
 
A solution of THP 310 (0.013 mg, 0.04 mmol) and 30% HCl (0.68 mL) was stirred in 
THF (2.10 mL) at room temperature for 2 hours. Then, water was added to the mixture 
and the reaction mixture was neutralized with NaHCO3 and extracted with EtOAc (30.0 
mL) and the organic extracts were washed with H2O (20.0 mL), dried over MgSO4 and 
concentrated in vacuo to give diospongin B, 0.006 g (58%) as a light yellow oil. υ 
max/cm-1 (film) 3375 (OH), 2916 (C-H), 2846 (C-H), 1702 (C=O), 1411 (C-O), 1129 (C-
O); δH (400 MHz, CDCl3)  7.98 (2H, dd, J = 8.0, 1.7 Hz, Ar), 7.58 (1H, tt, J = 7.1, 1.3 
Hz, Ar), 7.47 (2H, td, J = 7.6, 2.2 Hz, Ar), 7.37-7.3 (5H, m, Ar), 5.19 (1H, t, J = 4.3 Hz, 
H-2), 4.23 (1H, dddd, J = 9.5, 7.1, 6.0, 3.0 Hz, H-6), 4.03 (1H, dddd, J = 9.9, 9.5, 5.5, 4.5 
Hz, H-4), 3.46 (1H, dd, J = 15.8, 7.1 Hz, H-8), 3.18 (1H, dd, J = 15.8, 6.0 Hz, H-8), 2.52 
(1H, ddd, J = 13.4, 5.5, 4.3 Hz, H-3eq), 2.06 (1H, ddd, J = 12.4, 4.5, 3.0 Hz, H-5eq), 1.92 
(1H, ddd, J = 13.4, 9.9, 4.3 Hz, H-3ax), and 1.51 (1H, dt, J = 12.4, 9.5, 9.5 Hz, H-5ax); 
δC (100 MHz, CDCl3) 198.5 (C=O), 140.4 (Ar), 137.2 (Ar), 133.3 (Ar), 128.7 (Ar), 128.6 
(Ar), 128.4 (Ar), 127.2 (Ar), 126.4 (Ar), 72.5 (C-2), 67.0 (C-6), 64.3 (C-4), 44.7 (C-O), 
40.3 (C-5) and 36.8 (C-3); m/z (ESI+) 319 (M + Na)+. (Found 319.1300 (M + Na)+. 
C19H20NaO3 requires 319.1305). NMR data were in agreement with the literature.
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General Procedure for the Synthesis of 3,6-disubstituted-
tetrahydropyran-4-ones. 
A 1.0 M solution of L-Selectride® in THF (0.04 mL, 0.04 mmol) was added to a stirred 
solution of DHP (0.04 mmol) in THF (1.00 mL) at ‒78 °C. The mixture was stirred for 1 
hour at ‒78 °C until completion. Then it was diluted with Et2O (10.0 mL) and quench 
with sat. aq. NHCl4 (10.0 mL). The aqueous layer was washed with Et2O (10.0 mL) and 
the combined organic extracts were washed with brine (20.0 mL), dried over MgSO4 and 
concentrated in vacuo. Purification by flash column chromatography (hexane – ethyl: 
acetate with 4:1) afforded the tautomer product. 
 
Methyl 6-(furan-2-yl)-4-hydroxy-5,6-dihydro-2H-pyran-3-carboxylate (338) 
 
Dihydropyran 259 (0.09 g, 0.43 mmol), L-Selectride® (0.44 mL, 0.44 mmol), THF (11 
mL); purification (hexane – ethyl acetate = 4: 1), percentage yielded 0.043 g, 44 %, light 
yellow oil. υ max/cm-1 (film) 2954 (C-H), 2927 (C-H), 2868 (C-H), 1737 (C=O), 1667 
(C=O), 1627 (C=O), 1442 (C=C), 1275 (C-O), 1066 (C-O), 1011 (C-O), 739 (C=C), 598 
(C=C); δH  (400 MHz, CDCl3): δ 11.81 (OH, s), 7.42 (1H, m, H-7), 7.38 (1H, m, keto H-
7) 6.37‒6.33 (2H, m, H-8, H-9), 6.28‒6.27 (2H, m, keto H-8, H-9), 5.08 (1H, dd, J = 11.6, 
2.9 Hz, keto H-6), 4.88 (1H, dd, J = 10.0, 3.6 Hz, keto H-3), 4.73 (1H, dd, J = 9.9, 3.9 Hz, 
H-6), 4.50 (2H, m, H-2), 4.44 (1H, d, J = 14.0, H-2ax), 4.37 (1H, d, J = 14.0 Hz, H-2eq), 
3.77 (3H, s, H-10), 3.70 (3H, s, keto H-10), 2.86 (1H, dd, J = 17.8, 9.9 Hz, H-5), 2.80 
(1H, m, keto H-5), 2.53 (1H, dd, J = 17.8, 3.8 Hz, H-5), and 2.08 (1H, m, keto H-5); δC 
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(100 MHz, CDCl3): 170.4 (C=O), 168.2 (C=O), 152.7 (C-3), 143.0 (C-7), 110.4 (C-8), 
107.9 (C-9), 106.2 (keto),  97.1 (C-4), 72.9 (keto C-3), 68.9 (C-6), 67.7 (keto C-6), 62.9 
(C-2), 51.6 (C-10, keto C-10), 31.9 (C-5), 26.1 (keto C-5); m/z (ESI+) 247 (M + Na)+. 
(Found 247.0575 (M + Na)+. C11H12NaO5 requires 247.0577).
  
 
Methyl 4-hydroxy-6-phenyl-5,6-dihydro-2H-pyran-3-carboxylate (339) 
 
Dihydropyran 264 (0.10 g, 0.42 mmol), L-Selectride® (0.43 mL, 0.43 mmol), THF (11 
mL); purification (hexane – ethyl acetate = 4: 1), percentage yield, 0.074 g, 74 %, light 
yellow oil. υ max/cm-1 (film) 2952 (C-H), 2922 (C-H), 2852 (C-H), 1664 (C=O), 1622 
(C=O), 1445 (C=C), 1269 (C-O), 1209 (C-O), 1066 (C-O), 1027 (C-O), 699 (Ar); δH  (400 
MHz, CDCl3): δ 11.29 (OH, s), 7.43‒7.29 (5H, m, H-7), 4.70 (1H, m, keto H-6), 4.67 
(1H, dd, J = 10.48, 3.71 Hz, H-6), 4.59 (1H, m, keto H-3), 4.55-4.36 (2H, m, keto H-2), 
4.44 (1H, d, J = 14.0, H-2ax), 4.39 (1H, d, J = 14.0 Hz, H-2eq), 3.81 (3H, s, H-8), 3.80 
(3H, s, keto H-8), 3.02-2.68 (2H, m, keto H-5) and 2.67-2.49 (2H, m, H-5); δC (100 MHz, 
CDCl3): 170.4 (C=O), 168.7 (C=O), 167.8 (keto), 140.7 (C-3), 139.8 (keto), 128.9 (keto 
Ar), 128.6 (keto Ar), 128.2 (Ar), 128.0 (Ar), 125.8 (Ar), 125.5 (keto Ar), 97.1 (Ar), 80.3 
(keto), 75.5 (C-6), 68.2 (keto C-6), 63.4 (C-2), 57.2 (keto C-2), 52.3 (keto C-8), 51.4 (C-
8), 49.4 (keto), 48.6 (keto), and 35.7 (C-5); m/z (ESI+) 257 (M + Na)+. (Found 257.0782 
(M + Na)+. C13H14NaO4 requires 257.0784).
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(E)-Methyl 4-hydroxy-6-styryl-5,6-dihydro-2H-pyran-3-carboxylate (340) 
 
Dihydropyran 269 (0.10 g, 0.38 mmol), L-Selectride® (0.17 mL, 0.17 mmol), THF (5 
mL); purification (hexane – ethyl acetate = 4: 1), percentage yield 0.051 g, 51 %, light 
yellow oil. υ max/cm-1 (film) 2953 (C-H), 2839 (C-H), 1665 (C=O), 1626 (C=O), 1441 
(C=C), 1263 (C-O), 1211 (C-O), 1059 (C-O), 965 (Ar), 795 (Ar), 746 (C=C), 692 (C=C); 
δH  (400 MHz, CDCl3): δ 11.78 (OH, s), 7.41‒7.23 (5H, m, H-9), 6.65 (1H, d, J = 16.0 
Hz, H-8), 6.58 (1H, m, keto H-8), 6.23 (1H, dd, J = 16.0, 6.0 Hz, H-7), 6.19 (1H, m, keto 
H-7), 4.48 (1H, d, J = 13.9, H-2ax), 4.47 (1H, m, keto H-2ax), 4.32 (1H, d, J = 13.9 Hz, 
H-2eq), 4.28 (1H, m, H-6), 4.26 (1H, m, keto H-2eq), 3.79 (3H, s, keto H-10), 3.77 (3H, 
s, H-10), 2.84 (1H, m, keto H-5), 2.67 (1H, m, keto H-5) and 2.69‒2.38 (2H, m, H-5); δC 
(100 MHz, CDCl3): 170.5 (C=O), 168.5 (C=O), 136.4 (C-3), 136.0 (Ar), 132.3 (keto C-
8), 131.8 (C-8), 128.8 (keto Ar), 128.7 (Ar), 128.4 (keto) 128.1 (C-7), 128.1 (Ar), 127.3 
(keto C-7), 126.8 (keto Ar), 126.7 (Ar), 97.2 (C-4), 78.8 (keto), 74.0 (C-6), 68.0 (keto), 
62.9 (C-2), 52.4 (keto), 51.6 (C-10), 47.7 (keto) and 34.3 (C-5); m/z (ESI+) 283 (M + Na)+. 
(Found 283.0934 (M + Na)+. C15H16NaO4 requires 283.0941).
  
 
 
Methyl 4-hydroxy-6-(((triisopropylsilyl)oxy)methyl)-5,6-dihydro-2H-pyran-3-
carboxylate (341) 
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Dihydropyran 265 (0.09 g, 0.27 mmol), L-Selectride® (0.30 mL, 0.30 mmol), THF (8 
mL); purification (hexane – ethyl acetate = 4: 1), percentage yielded 0.062 g, 65 %, light 
yellow oil. υ max/cm-1 (film) 2924 (C-H), 2865 (C-H), 1774 (C=O), 1729 (C=O), 1709 
(C=O), 1148 (C-O), 1057 (C-O), 881 (C=C); δH  (400 MHz, CDCl3): δ 11.78 (OH, s), 
4.69‒4.66 (2H, m, keto H-2), 4.43 (1H, d, J = 13.9, H-2ax), 4.22 (1H, d, J = 13.9 Hz, H-
2eq), 3.93 (1H, m, keto H-6), 3.88 (1H, m, H-6), 3.83-3.79 (2H, m, H-7), 3.76 (3H, s, keto 
H-8), 3.75 (3H, s, H-8), 3.62‒3.59 (2H, m, keto H-7), 2.82 (1H, m, keto H-5), 2.61‒2.28 
(2H, m, H-5), 2.31 (1H, m, keto H-5) and 1.06-1.05 ( 21H, m, OTIPS); δC (100 MHz, 
CDCl3): 170.4 (C=O), 169.2 (C=O), 97.1 (C-4), 79.1 (keto C-6), 74.4 (C-6), 66.0 (C-7), 
63.1 (C-2), 52.2 (C-8), 51.3 (keto), 44.1 (keto), 31.1 (C-5), 17.9 (OTIPS) and 11.8 
(OTIPS); m/z (ESI+) 367 (M + Na)+. (Found 367.1905 (M + Na)+. C17H32NaO5Si requires 
367.1911).  
 
Methyl 4-hydroxy-6-propyl-5,6-dihydro-2H-pyran-3-carboxylate (342) 
    
Dihydropyran 263 (0.10 g, 0.50 mmol), L-Selectride® (0.50 mL, 0.50 mmol), THF (13 
mL); purification (hexane – ethyl acetate = 4: 1), percentage yielded 0.089 g, 89 %, light 
yellow oil. υ max/cm-1 (film) 2957 (C-H), 2871 (C-H), 1666 (C=O), 1441 (C=C), 1213 
(C-O), 1074 (C-O), 807 (C=C); δH  (400 MHz, C6D6): δ 12.09 (OH, s), 4.50 (1H, d, J = 
13.7, H-2ax), 4.40 (1H, m, keto H-2ax), 4.11 (1H, d, J = 13.7 Hz, H-2eq), 4.05 (1H, m, 
keto H-2eq), 3.22 (3H, s, H-10), 3.21 (3H, s, keto H-10), 3.20 (1H, m, H-6), 3.05 (1H, m, 
keto H-6), 2.12 (2H, m, keto H-5), 2.08 (1H, m, H-5), 1.94 (1H, m, H-5), 1.47‒0.96 (4H, 
m, H-7, H-8) and 0.79 (3H, t, J = 7.2 Hz, H-9); δC (100 MHz, C6D6): 170.5 (C=O), 169.7 
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(C=O), 97.3 (C-4), 73.2, 70.0 (keto C-2), 62.9 (C-2), 54.0 (keto C-6), 52.0 (keto C-10), 
50.5 (C-6, C-10), 37.7, 34.5 (C-5), 18.3 (C-7,C-8) and 13.9 (C-9); m/z (ESI+) 223 (M + 
Na)+. (Found 223.0938 (M + Na)+. C10H16NaO4 requires 223.0941).
  
 
General procedure for the acylation of 3, 6-disubstituted-
tetrahydropyran-4-ones. Formation of enol acetates. 
The THP mixture (0.03 mmol), acetic anhydride (0.10 mL, 0.10 mmol) and DMAP (2 
mol%) were stirred in pyridine (0.47 mL) at 40 °C for 40 minutes. The mixture was cooled 
to room temperature and concentrated in vacuo. Then partitioned between Et2O (30.0 mL) 
and H2O (10.0 mL). The organic layer was washed with H2O (10.0 mL) and brine (10.0 
mL), then dried over MgSO4 and concentrated in vacuo. Flash column chromatography 
(hexane – ethyl acetate =  4:1) gave the product. 
 
Methyl 4-acetoxy-6-(furan-2-yl)-5,6-dihydro-2H-pyran-3-carboxylate (316) 
 
Tetrahydropyran 338 (0.04 g, 0.19 mmol), acetic anhydride (0.60 mL, 0.60 mmol), 
DMAP (2 mol%), pyridine (3.00 mL); purification (hexane – ethyl acetate = 4: 1), 
percentage yield 0.031 g, 71 % colorless oil. υ max/cm-1 (film) 2953 (C-H), 2847 (C-H), 
1760 (C=O), 1723 (C=O), 1671 (C=C), 1365 (CH3), 1253 (C-O), 1173 (C-O), 1132 (C-
O), 1059 (C-O), 743 (C=C); δH  (400 MHz, CDCl3): δ 7.41 (1H, s, H-7), 6.41 (1H, m, H-
8), 6.35 (1H, m, H-9), 4.80 (1H, dd, J = 9.0, 4.1 Hz, H-6), 4.51‒4.48 (2H, m, H-2ax, H-
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2eq), 3.72 (3H, s, H-11) 2.89 (1H, m, H-5), 2.55 (1H, m, Hz, H-5) and 2.52 (3H, s, H-
10); δC (100 MHz, CDCl3): 168.4 (C=O), 163.1 (C=O), 153.3 (C-3), 152.2 (C-12), 143.0 
(C-7), 116.5 (C-4), 110.4 (C-8), 108.3 (C-9), 68.7 (C-6), 64.0 (C-2), 51.8 (C-11), 32.4 
(C-5) and 21.0 (C-10); m/z (ESI+) 289 (M + Na)+. (Found 289.0692 (M + Na)+. 
C13H14NaO6 requires 289.0683).
  
 
(E)-Methyl 4-acetoxy-6-styryl-5,6-dihydro-2H-pyran-3-carboxylate (320) 
 
Tetrahydropyran 340 (0.015 g, 0.05 mmol), acetic anhydride (0.19 mL, 0.19 mmol), 
DMAP (2 mol%), pyridine (0.94 mL); purification (hexane – ethyl acetate = 4: 1), 
percentage yielded 0.01 g, 56 % light yellow oil. υ max/cm-1 (film) 2951 (C-H), 2844 (C-
H), 1761 (C=O), 1723 (C=O), 1248 (C-O), 1172 (C-O), 1142 (C-O), 1051 (C-O), 748 
(Ar), 693 (Ar); δH  (400 MHz, CDCl3): δ 7.40‒7.23 (5H, m, H-9), 6.68 (1H, d, J = 16.0 
Hz, H-8), 6.23 (1H, dd, J = 16.0, 6.1 4.1 Hz, H-7), 4.63 (1H, d, J = 15.0 Hz, H-2ax), 4.43 
(1H, d, J = 15.0 Hz, H-2eq), 4.33 (1H, m, H-6), 3.72 (3H, s, H-11), 2.52 (1H, m, H-5), 
2.37 (1H, m, H-5) and 2.24 (3H, s, H-10); δC (100 MHz, CDCl3): 168.4 (C=O), 163.3 
(C=O), 153.8 (C-3), 136.3 (Ar), 132.1 (C-7), 128.7 (Ar), 128.1 (Ar), 127.6 (C-8), 126.7 
(Ar), 116.5 (C-4), 73.9 (C-6), 64.3 (C-2), 51.8 (C-11), 34.9 (C-5) and 21.0 (C-10); m/z 
(ESI+) 325 (M + Na)+. (Found 325.1053 (M + Na)+. C17H18NaO5 requires 325.1046).
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Methyl 4-acetoxy-6-phenyl-5,6-dihydro-2H-pyran-3-carboxylate (317) 
 
Tetrahydropyran 339 (0.07 g, 0.31 mmol), acetic anhydride (1.04 mL, 1.04 mmol), 
DMAP (2 mol%, pyridine (5.00 mL); purification (hexane – ethyl acetate = 4: 1), 
percentage yielded 0.059 g, 68 % solid white. υ max/cm-1 (film)  2949 (C-H), 2842 (C-
H), 1765 (C=O), 1718 (C=O), 1664 (Ar), 1166 (C-O), 1131 (C-O), 1060 (C-O), 743 (Ar), 
700 (Ar); δH  (400 MHz, CDCl3): δ 7.38‒7.28 (5H, m, H-7), 6.69 (1H, d, J = 16.0 Hz, H-
2ax), 4.67 (1H, m, H-6), 4.49 (1H, d, J = 16.0, 4.0 Hz, H-2eq), 3.74 (3H, s, H-8), 2.63 
(1H, m, H-5), 2.47 (1H, m, H-5) and 2.24 (3H, s, H-9); δC (100 MHz, CDCl3): 168.4 
(C=O), 163.3 (C=O), 154.1 (C-3), 140.1 (Ar), 128.7 (Ar), 128.2 (Ar), 125.9 (Ar), 116.5 
(C-4), 75.5 (C-6), 64.9 (C-2), 51.7 (C-8), 36.5 (C-5) and 21.0 (C-9); m/z (ESI+) 299 (M + 
Na)+. (Found 299.0894 (M + Na)+. C15H16NaO5 requires 299.0890).
  
 
Methyl 4-acetoxy-6-(((triisopropylsilyl)oxy)methyl)-5,6-dihydro-2H-pyran-3-
carboxylate (319) 
 
Method acylation of THP, THP 341 (0.04 g, 0.11 mmol), acetic anhydride (0.38 mL, 0.38 
mmol), DMAP (2 mol%), pyridine (0.63 mL); purification (hexane – ethyl acetate = 4: 
1), isolated yielded 0.029 g, 65 % light yellow oil. υ max/cm-1 (film)  2924 (C-H), 2865 
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(C-H), 1774 (C=O), 1729 (C=O), 1148 (C-O), 1057 (C-O); δH  (400 MHz, C6D6): 4.70 
(1H, dd, J = 15.5, 2.0 Hz, H-2ax), 4.33 (1H, dd, J = 15.5, 3.4 Hz, H-2eq), 3.82 (1H, dd, J 
= 10.0, 5.0 Hz, H-7), 3.70 (1H, dd, J = 10.0, 5.0 Hz, H-7), 3.65 (1H, m, H-6), 3.30 (3H, 
s, H-8), 2.59 (1H, m, H-5), 2.27 (1H, m, H-5), 2.02 (3H, s, H-9) and 1.18-1.17 (21H, m, 
OTIPS); δC (100 MHz, C6D6): 167.7 (C=O), 163.0 (C=O), 154.9 (C-3), 116.7 (C-4), 74.7 
(C-6), 66.1 (C-7), 64.8 (C-2), 50.8 (C-8), 32.0 (C-5), 20.6 (C-9), 18.1 (OTIPS) and 12.2 
(OTIPS); m/z (ESI+) 409 (M + Na)+. (Found 409.2022 (M + Na)+. C19H34NaO6Si requires 
409.2017).  
 
Methyl 4-acetoxy-6-propyl-5,6-dihydro-2H-pyran-3-carboxylate (318) 
 
Tetrahydropyran 342 (0.09 g, 0.45 mmol), acetic anhydride (1.49 mL, 1.49 mmol), 
DMAP (2 mol%), pyridine (1.41 mL); purification (hexane – ethyl acetate = 4: 1), isolated 
yielded 0.056 g, 51 % light yellow oil. υ max/cm-1 (film) 2957 (C-H), 2872 (C-H), 1768 
(C=O), 1726 (C=O), 1250 (C-O), 1212 (C-O), 1177 (C-O); δH  (400 MHz, CDCl3): 4.53 
(1H, dd, J = 15.0 Hz, H-2ax), 4.31 (1H, dd, J = 15.0 Hz, H-2eq), 3.70 (3H, s, H-11), 3.60 
(1H, m, H-6), 2.30‒2.14 (2H, m, H-5), 2.23 (3H, s, H-10) 1.64‒1.50 (5H, m, H-7, H-8) 
and 0.93 (3H, t, J = 7.2 Hz, H-9); δC (100 MHz, CDCl3): 168.4 (C=O), 163.5 (C=O), 
154.7 (C-3), 116.3 (C-4), 73.5 (C-6), 64.6 (C-2), 51.7 (C-11), 37.4 (C-7), 35.0 (C-5), 21.0 
(C-10), 18.5 (C-8) and 14.1 (C-9); m/z (ESI+) 265 (M + Na)+. (Found 265.1052 (M + 
Na)+. C12H18NaO5 requires 265.1046).
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General procedure for L-Selectride reduction of dihydropyrans with 
electrophile quench:  
A 1.0 M solution of L-Selectride® in THF (0.04 mL, 0.04 mmol) was added to a stirred 
solution of DHP (0.04 mmol) in THF (1.00 mL) at ‒78 °C. The mixture was stirred for 1 
hour at ‒78 °C, then the electrophile (0.40 mmol) was added. Then, the reaction mixture 
was stirred at room temperature until completion, followed with mixture were diluted 
with Et2O (10.0 mL) and quench with sat. aq. NHCl4 (10.0 mL). The aqueous layer was 
washed with Et2O (10.0 mL) and the combined organic extracts were washed with brine 
(20.0 mL), dried over MgSO4 and concentrated in vacuo. Purification by flash column 
chromatography (hexane – ethyl acetate with 4 : 1) to afforded the product. 
 
(3S*,6S*)-Methyl 6-(furan-2-yl)-3-methyl-4-oxotetrahydro-2H-pyran-3-
carboxylate (325) 
 
Dihydropyran 259 (0.10 g, 0.45 mmol), L-Selectride® (0.45 mL, 0.45 mmol), MeI (0.56 
mL, 9.00 mmol), THF (11 mL); purification (hexane – ethyl acetate = 4: 1), percentage 
yield 0.062 g, 57 % light yellow oil. Diastereomers (1: 0.3). υ max/cm-1 (film) 2957 (C-
H), 2872 (C-H), 1768 (C=O), 1726 (C=O), 1249 (C-O), 1212 (C-O), 1175 (C-O), 1148 
(C-O), 1055 (C-O), 797 (C=C), 771 (C=C); δH  (400 MHz, CDCl3): δ 7.42 (1H, m, H-7), 
6.39‒6.31 (2H, m, H-8, H-9), 5.19 (1H, dd, J = 6.3, 5.0 Hz, H-6), 4.17 (1H, dd, J = 12.0, 
2.8 Hz, H-6 minor), 4.63 (1H, d, J = 11.6 Hz, H-2ax minor), 4.28 (1H, d, J = 12.0 Hz, H-
2ax), 3.78 (3H, s, H-10), 3.53 (1H, d, J = 12.0 Hz, H-2eq), 3.48 (1H, d, J = 11.6 Hz, H-
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2eq minor), 3.21 (1H, dd, J = 14.4, 12.0 Hz, H-5 minor), 3.03 (1H, dd, J = 15.0, 6.3 Hz, 
H-5), 2.91 (1H, dd, J = 15.0, 5.0 Hz, H-5), 2.72 (1H, dd, J = 14.4, 2.8 Hz, H-5 minor), 
1.32 (3H, s, H-11) and 1.26 (3H, s, H-11 minor); δC (100 MHz, CDCl3): 203.4 (C=O), 
171.4 (C=O), 151.4 (C-12), 143.3 (C-9), 110.3 (C-7), 109.9 (C-8), 74.5 (C-6 minor), 73.9 
(C-2 minor), 71.7 (C-6), 70.6 (C-2), 58.3 (C-3), 52.8 (C-10), 44.2 (C-5 minor), 41.9 (C-
5), 16.9 (C-11) and 15.4 (C-11 minor); m/z (ESI+) 261 (M + Na)+. (Found 261.0743 (M 
+ Na)+. C12H14NaO5 requires 261.0733). 
 
(3S*,6S*)-Methyl 3-methyl-4-oxo-6-phenyltetrahydro-2H-pyran-3-carboxylate 
(321) 
(prepared by James Burroughs) 
 
Dihydropyran  264 (0.10 g, 0.43 mmol), L-Selectride® (0.43 mL, 0.43 mmol), MeI (0.53 
mL, 8.62 mmol), THF (11.00 mL); purification (hexane – ethyl acetate = 4: 1), isolated 
yielded 0.063 g (59 %) light yellow oil. υ max/cm-1 (film) 3032 (Ar), 2953 (C-H), 2877 
(C-H), 1736 (C=O), 1710 (C=O), 1268 (C-O), 1233 (C-O), 1095 (C-O), 1075 (C-O), 699 
(Ar), 762 (Ar); δH  (400 MHz, CDCl3): δ 7.41‒7.31 (5H, m, H-9), 4.89 (1H, dd, J = 9.5, 
4.1 Hz, H-6), 4.29 (1H, d, J = 11.7 Hz, H-2ax), 3.94 (1H, d, J = 11.7 Hz, H-2eq), 3.79 
(3H, s, H-8), 2.86 (1H, dd, J = 15.2, 9.5 Hz,  H-5ax), 2.75 (1H, dd, J = 15.2, 4.1 Hz,  H-
5eq) and 1.54 (3H, s, H-9); δC (100 MHz, CDCl3): 204.9 (C=O), 171.3 (C=O), 139.8 (Ar), 
128.8 (Ar), 128.4 (Ar), 126.0 (Ar), 79.5 (C-6), 72.5 (C-2), 58.6 (C-3), 52.6 (C-8), 45.1 
(C-5) and 18.6 (C-9); m/z (ESI+) 271 (M + Na)+. (Found 271.0936 (M + Na)+. 
C14H16NaO4 requires 271.0941).
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(3S*,6S*)-Methyl 3-methyl-4-oxo-6-((E)-styryl)tetrahydro-2H-pyran-3-carboxylate 
(324) 
 
Dihydropyran 269 (0.12 g, 0.46 mmol), L-Selectride® (0.47 mL, 0.47 mmol), MeI (0.57 
mL, 9.30 mmol), THF (12.00 mL); purification (hexane – ethyl acetate = 4: 1), percentage 
yield 0.063 g, 53 % light yellow oil. υ max/cm-1 (film) 3026 (Ar), 2952 (C-H), 2875 (C-
H), 1733 (C=O), 1713 (C=O), 1232 (C-O), 1264 (C-O), 1114 (C-O), 1088 (C-O), 967 
(Ar), 748 (Ar), 693 (Ar); δH  (400 MHz, C6D6): δ 7.18‒7.02 (5H, m, H-9), 6.44 (1H, d, J 
= 16.0 Hz, H-8), 5.94 (1H, dd, J = 16.0, 5.3 Hz, H-7), 4.19 (1H, d, J = 11.6 Hz, H-2ax), 
4.06 (1H, ddd, J = 9.0, 5.3, 4.4 Hz, H-6), 3.66 (1H, d, J = 11.6 Hz, H-2eq), 3.36 (3H, s, 
H-10), 2.41 (1H, dd, J = 15.0, 4.4 Hz,  H-5eq), 2.29 (1H, dd, J = 15.0, 9.0 Hz,  H-5ax) 
and 1.31 (3H, s, H-11); δC (100 MHz, C6D6): 203.2 (C=O), 171.9 (C=O), 136.6 (Ar), 
132.2 (C-7), 128.9 (Ar), 128.1 (Ar), 127.9 (Ar), 126.9 (C-8), 77.7 (C-6), 72.1 (C-2), 58.7 
(C-3), 52.0 (C-10), 43.9 (C-5) and 18.1 (C-11); m/z (ESI+) 297 (M + Na)+. (Found 
297.1095 (M + Na)+. C16H18NaO4 requires 297.1097).
  
 
(3S*,6S*)-Methyl 3-methyl-4-oxo-6-(((triisopropylsilyl)oxy)methyl)tetrahydro-2H-
pyran-3-carboxylate (323) 
 
Dihydropyran 265 (0.09 g, 0.28 mmol), L-Selectride® (0.30 mL, 0.30 mmol), MeI (0.34 
mL, 5.60 mmol), THF (8.00 mL); purification (hexane – ethyl acetate = 4: 1), percentage 
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yield 0.057 g, 57 % light yellow oil. υ max/cm-1 (film) 2942 (C-H), 2866 (C-H), 1738 
(C=O), 1715 (C=O), 1105 (C-O); δH  (400 MHz, C6D6): 4.13 (1H, d, J = 11.4 Hz, H-2ax), 
3.73 (1H, d, J = 11.4 Hz, H-2eq), 3.58 (1H, dddd, J = 10.0, 3.5, 3.8, 3.8, Hz H-6), 3.45 
(1H, dd, J = 8.0, 3.8 Hz, H-7), 3.40 (1H, dd, J = 8.0, 3.8 Hz, H-7), 3.36 (3H, s, H-8), 2.59 
(1H, dd, J = 15.1, 10.0 Hz, H-5ax), 2.25 (1H, dd, J = 15.1, 3.5 Hz, H-5eq), 1.43 (3H, s, 
H-9) and 1.05‒1.04 (21H, m, OTIPS); δC (100 MHz, C6D6): 205.0 (C=O), 171.1 (C=O), 
78.6 (C-6), 73.0 (C-2), 65.9 (C-7), 58.8 (C-3), 51.9 (C-8), 40.2, 18.6 (C-9), 18.1 (OTIPS) 
and 12.2 (OTIPS); m/z (ESI+) 381 (M + Na)+. (Found 381.2065 (M + Na)+. C18H34NaO5Si 
requires 381.2068).  
 
(3S*,6R*)-Methyl 3-methyl-4-oxo-6-propyltetrahydro-2H-pyran-3-carboxylate 
(322) 
 
Dihydropyran 263 (0.10 g, 0.50 mmol), L-Selectride® (0.50 mL, 0.50 mmol), MeI (0.62 
mL, 10.10 mmol), THF (13.00 mL); purification (hexane – ethyl acetate = 4: 1), 
percentage yielded 0.063 g, 58 % colorless oil. υ max/cm-1 (film) 2956 (C-H), 2929 (C-
H), 2872 (C-H), 1738 (C=O), 1714 (C=O), 1263 (C-O), 1100 (C-O); δH  (400 MHz, 
C6D6): δ  4.08 (1H, d, J = 11.5 Hz, H-2ax), 3.62 (1H, d, J = 11.5 Hz, H-2eq), 3.38 (3H, s, 
H-10), 3.24 (1H, m, H-6), 2.12 (1H, dd, J = 15.0, 3.6 Hz,  H-5eq), 1.99 (1H, dd, J = 15.0, 
10.2 Hz,  H-5ax), 1.35 (3H, s, H-11), 1.32‒0.93 (4H, m, H-7, H-8) and 0.74 (3H, t, J = 
7.3 Hz, H-9); δC (100 MHz, C6D6): 204.3 (C=O), 171.9 (C=O), 77.8 (C-6), 72.2 (C-2), 
58.8 (C-3), 51.8 (C-10), 44.2 (C-5), 37.7 (C-8), 18.7 (C-11), 18.5 (C-7) and 14.0 (C-9); 
m/z (ESI+) 237 (M + Na)+. (Found 237.1100 (M + Na)+. C11H18NaO4 requires 237.1097).
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(3S*,6S*)-Methyl 3-allyl-6-(furan-2-yl)-4-oxotetrahydro-2H-pyran-3-carboxylate 
(330) 
 
Dihydropyran 259 (0.10 g, 0.45 mmol), L-Selectride® (0.45 mL, 0.45 mmol), Allyl 
Bromide (0.77 mL, 9.00 mmol), THF (11.00 mL); purification (hexane – ethyl acetate = 
4: 1), percentage yield 0.047 g, 47 % light yellow oil. υ max/cm-1 (film) 2954 (C-H), 1716 
(C=O), 1227 (C-O), 1145 (C-O), 1075 (C-O), 1013 (C-O), 988 (C=C), 745 (C=C); δH  
(400 MHz, CDCl3): δ 7.13 (1H, m, H-7), 6.36‒6.32 (2H, m, H-8, H-9), 5.83 (1H, m, H-
12 minor), 5.77 (1H, m, H-12), 5.13 (1H, m,  H-13), 5.07 (1H, dd, J = 7.6, 6.9 Hz, H-6), 
4.69 (1H, dd, J = 12.0, 2.8 Hz, H-6 minor), 4.62 (1H, d, J = 12.0 Hz, H-2 minor), 4.25 
(1H, d, J = 12.0 Hz, H-2ax), 3.77 (3H, s, H-10), 3.70 (1H, d, J = 12.0 Hz, H-2eq), 3.57 
(1H, d, J = 12.0 Hz, H-2 minor), 3.16 (1H, dd, J = 14.4, 11.6 Hz, H-11 minor), 2.97 (1H, 
dd, J = 15.2, 6.1 Hz, H-11), 2.89 (1H, dd, J = 15.2, 5.6 Hz, H-11), 2.73 (1H, dd, J = 14.4, 
2.8 Hz, H-5 minor), 2.63 (1H, dd, J = 14.0, 6.9 Hz, H-5), 2.48 (1H, dd, J = 14.0, 7.6 Hz, 
H-5) and 2.35 (1H, dd, J = 14.4, 12.0 Hz, H-5 minor); δC (100 MHz, CDCl3): 202.6 
(C=O), 170.3 (C=O), 151.3 (C-14), 143.3 (C-7), 132.1 (C-12), 119.2 (C-13), 110.4 (C-
8), 109.8 (C-9), 73.9 (C-6 minor), 73.2 (C-2 minor), 71.8 (C-6), 68.7 (C-2), 62.1 (C-3), 
52.6 (C-10), 44.8 (C-11 minor), 42.5 (C-11) and 35.4 (C-5); m/z (ESI+) 287 (M + Na)+. 
(Found 287.0886 (M + Na)+. C14H16NaO5 requires 287.0890). 
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(3S*,6S*)-Methyl 3-allyl-4-oxo-6-(((triisopropylsilyl)oxy)methyl)tetrahydro-2H-
pyran-3-carboxylate (328) 
 
Dihydropyran 265 (0.09 g, 0.28 mmol), L-Selectride® (0.30 mL, 0.30 mmol), Allyl 
Bromide (0.48 mL, 5.60 mmol), THF (8.00 mL); purification (hexane – ethyl acetate = 
4: 1), isolated yielded 0.061 g, 57 % light yellow oil. υ max/cm-1 (film) 2943 (C-H), 2866 
(C-H), 1739 (C=O), 1715 (C=O), 1231 (C-O), 1124 (C-O), 1083 (C-O), 881 (C=C), 680 
(C=C); δH  (400 MHz, C6D6): δ 6.05 (1H, dddd, J = 16.8, 9.9, 7.1, 7.0 Hz, H-10), 5.29 
(1H, dd, J = 16.8, 1.8 Hz Hz, H-11trans), 5.14 (1H, dd, J = 9.9, 1.8 Hz, H-11cis), 4.17 
(1H, d, J = 11.6 Hz, H-2ax), 4.14 (1H, d, J = 11.6 Hz, H-2eq), 3.70 (1H, m, H-6), 3.50 
(2H, m, H-7), 3.47 (3H, s, H-8), 2.90 (1H, dd, J = 13.6, 7.0 Hz, H-9), 2.79 (1H, dd, J = 
13.6, 7.1 Hz, H-9), 2.73 (1H, dd, J = 15.0, 8.0 Hz, H-5ax) and 2.33 (1H, dd, J = 15.0, 3.2 
Hz, H-5eq) and 1.16‒1.14 (21H, m, OTIPS); δC (100 MHz, C6D6): 203.6 (C=O), 170.1 
(C=O), 133.2 (C-10), 119.4 (C-11), 78.7 (C-6), 70.3 (C-2), 65.8 (C-7), 62.7 (C-3), 51.8 
(C-8), 41.0 (C-5), 36.0 (C-9), 18.1 (OTIPS) and 12.2 (OTIPS); m/z (ESI+) 407 (M + Na)+. 
(Found 407.2211 (M + Na)+. C20H36NaO5Si requires 407.2224).
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(3S*,6S*)-Methyl 3-allyl-4-oxo-6-((E)-styryl)tetrahydro-2H-pyran-3-carboxylate 
(329) 
 
Dihydropyran 269 (0.10 g, 0.38 mmol), L-Selectride® (0.09 mL, 0.40 mmol), allyl 
Bromide (0.66 mL, 7.74 mmol), THF (10.00 mL); purification (hexane – ethyl acetate = 
4: 1), percentage yielded 0.097 g, 83 % light yellow oil. υ max/cm-1 (film) 2952 (C-H), 
1736 (C=O), 1712 (C=O), 1226 (C-O), 1073 (C-O), 1031 (C-O), 966 (C=C), 748 (C=C); 
δH  (400 MHz, C6D6): δ 7.19‒7.02 (5H, m, H-9), 6.45 (1H, dd, J = 16.0, 1.2 Hz, H-8), 
5.95 (1H, dd, J = 16.0, 5.4 Hz, H-7), 5.88 (1H, dddd, J = 17.1, 10.1, 7.5, 7.0 Hz,  H-12), 
5.05 (1H, dd, J = 17.1, 4.4 Hz, H-13trans), 4.99 (1H, dd, J = 10.1, 4.4 Hz, H-13cis), 
4.16(1H, d, J = 11.8 Hz, H-2ax), 4.03 (1H, dddd, J = 9.0, 5.4, 4.2, 1.2 Hz, H-6), 3.98 (1H, 
d, J = 11.8 Hz, H-2eq), 3.36 (3H, s, H-10), 2.69 (1H, dd, J = 13.8, 7.0 Hz, H-11), 2.52 
(1H, dd, J = 13.8, 7.5 Hz, H-11), 2.41 (1H, dd, J = 14.7, 4.2 Hz, H-5eq) and 2.31 (1H, dd, 
J = 14.7, 9.0 Hz, H-5ax); δC (100 MHz, C6D6): 202.6 (C=O), 170.6 (C=O), 136.6 (C-8), 
133.0 (C-12), 132.1 (Ar), 128.9 (Ar), 126.9 (Ar), 119.4 (C-13), 77.8 (C-6), 69.8 (C-2), 
62.7 (C-3), 51.9 (C-10), 44.8 (C-5), and 35.9 (C-11); m/z (ESI+) 323 (M + Na)+. (Found 
323.1242 (M + Na)+. C16H21NaO4 requires 323.1230).
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(3S*,6S*)-Methyl 3-allyl-4-oxo-6-phenyltetrahydro-2H-pyran-3-carboxylate (326) 
(prepared by James Burroughs) 
 
Dihydropyran 264 (0.10 g, 0.43 mmol), L-Selectride® (0.43 mL, 0.43 mmol), allyl 
Bromide (0.74 mL, 8.62 mmol), THF (11.00 mL); purification (hexane – ethyl acetate = 
4: 1), percentage yielded 0.061 g, 52 % light yellow oil. υ max/cm-1 (film)  2952 (C-H), 
2875 (C-H), 1736 (C=O), 1711 (C=O), 1227 (C-O), 1076 (C-O), 763 (Ar), 699 (C=C); 
δH  (400 MHz, CDCl3): δ 7.42‒7.32 (5H, m, H-7), 5.80 (1H, m, H-10), 5.20 (1H, dd, J = 
17.2, 4.4 Hz, H-11trans), 5.15 (1H, dd, J = 10.1, 4.4 Hz, H-11cis), 4.86 (1H, dd, J = 9.3, 
4.6 Hz, H-6), 4.21 (1H, d, J = 11.8 Hz, H-2ax), 4.12 (1H, d, J = 11.8 Hz, H-2eq), 3.79 
(3H, s, H-8) and 2.82‒2.71 (4H, m, H-5, H-9); δC (100 MHz, CDCl3): 203.8 (C=O), 170.2 
(C=O), 139.9 (C-10), 132.1 (Ar), 128.8 (Ar), 128.4 (Ar), 126.0 (Ar), 119.9 (C-11), 79.6 
(C-6), 70.1 (C-2), 62.5 (C-3), 52.5 (C-8), 46.2 (C-5) and 36.1 (C-9); m/z (ESI+) 297 (M + 
Na)+. (Found 297.1101 (M + Na)+. C16H18NaO4 requires 297.1097).
  
 
 
(3S*,6R*)-Methyl 3-allyl-4-oxo-6-propyltetrahydro-2H-pyran-3-carboxylate (327) 
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Dihydropyran 263 (0.10 g, 0.50 mmol), L-Selectride® (0.50 mL, 0.50 mmol), allyl 
Bromide (0.87 mL, 10.10 mmol), THF (13.00 mL); purification (hexane – ethyl acetate 
= 4: 1), percentage yielded 0.063 g, 52 % light yellow oil. υ max/cm-1 (film) 2958 (C-H), 
2873 (C-H), 1737 (C=O), 1712 (C=O), 1229 (C-O), 1081 (C-O), 922 (C=C); δH  (400 
MHz, CDCl3): δ 5.76 (1H, dddd, J = 17.4, 10.2, 7.3, 7.2 Hz, H-12), 5.18 (1H, dd, J = 
17.4, 1.4 Hz, H-11trans), 5.10 (1H, dd, J = 10.2, 1.4 Hz, H-11cis), 4.05 (1H, d, J = 11.8 
Hz, H-2ax), 4.01 (1H, d, J = 11.8 Hz, H-2eq), 3.74 (3H, s, H-10), 3.74 (1H, m, H-6), 2.69 
( 1H, dd, J = 13.8, 7.3 Hz, H-11a), 2.64 (1H, dd, J = 13.8, 7.2 Hz, H-11b), 2.45 (1H, dd, 
J = 14.8, 3.6 Hz, H-5), 2.36 (1H, J = 14.8, 10.0 Hz, H-5), 1.51‒1.34 (4H, m, H-7, H-8) 
and 0.93 (1H, t, J = 7.0 Hz, H-9); δC (100 MHz, CDCl3): 204.6 (C=O), 170.3 (C=O), 
132.3 (C-12), 119.7 (C-13), 78.1 (C-6), 70.1 (C-2), 62.5 (C-3), 52.4 (C-10), 45.2 (C-5), 
37.7 (C-7), 36.0 (C-11), 18.4 (C-8) and 13.9 (C-9); m/z (ESI+) 263 (M + Na)+. (Found 
263.1264 (M + Na)+. C13H20NaO4 requires 263.1254).
  
 
(3S*,6S*)-Methyl 3-benzyl-4-oxo-6-(((triisopropylsilyl)oxy)methyl)tetrahydro-2H-
pyran-3-carboxylate (333) 
 
Dihydropyran 265 (0.10 g, 0.29 mmol), L-Selectride® (0.29 mL, 0.29 mmol), benzyl 
bromide (0.69 mL, 5.84 mmol), THF (7.30 mL); purification (hexane – ethyl acetate = 4: 
1), percentage yielded 0.078 g, 62 % colorless oil. υ max/cm-1 (film) 2942 (C-H), 2865 
(C-H), 1736 (C=O), 1713 (C=O), 1121 (C-O), 1074 (C-O), 881 (Ar), 682 (Ar); δH  (400 
MHz, C6D6): δ 7.48‒7.02 (5H, m, H-10), 4.15 (1H, d, J = 12.0 Hz, H-2ax), 3.97 (1H, d, 
J = 12.0 Hz, H-2eq), 3.64 (1H, m, H-6), 3.43 (2H, m, H-7), 3.34 (3H, s, H-8), 3.42 (1H, 
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d, J = 13.0 Hz, H-9), 3.27 (1H, d, J = 13.0 Hz, H-9), 2.79 (1H, dd, J = 15.0, 10.6 Hz, H-
5ax), 2.22 (1H, dd, J = 15.0, 3.4 Hz, H-5eq) and 1.08‒1.00 (21H, m, OTIPS); δC (100 
MHz, C6D6): 203.7 (C=O), 169.6 (C=O), 131.2 (Ar), 128.6 (Ar), 128.1 (Ar), 127.9 (Ar), 
79.0 (C-6), 69.2 (C-2), 65.8 (C-3), 64.2 (C-7), 51.7 (C-8), 40.5 (C-5), 36.6 (C-9), 18.1 
(OTIPS) and 12.2 (OTIPS); m/z (ESI+) 457 (M + Na)+. (Found 457.2388 (M + Na)+. 
C24H38NaO5Si requires 457.2381).
  
 
(3S*,6S*)-Methyl 3-benzyl-4-oxo-6-((E)-styryl)tetrahydro-2H-pyran-3-carboxylate 
(334) 
 
Dihydropyran 269 (0.09 g, 0.37 mmol), L-Selectride® (0.37 mL, 0.37 mmol), benzyl 
bromide (0.88 mL, 7.44 mmol), THF (9.00 mL); purification (hexane – ethyl acetate = 4: 
1), percentage yielded 0.066 g, 51 % light yellow oil. υ max/cm-1 (film) 2958 (C-H), 2860 
(C-H), 1734 (C=O), 1712 (C=O), 1209 (C-O), 1070 (C-O), 742 (Ar), 703 (Ar); δH  (400 
MHz, CDCl3): δ 7.42‒7.19 (10H, m, H-9, H-12), 6.67 (1H, dd, J = 16.1, 1.0 Hz, H-8), 
6.26 (1H, dd, J = 16.1, 5.7 Hz, H-7), 4.59 (1H, dddd, J = 8.6, 5.7, 4.5, 1.0 Hz, H-6), 4.11 
(1H, d, J = 12.2 Hz, H-2ax), 4.05 (1H, d, J = 12.2 Hz, H-2eq), 3.73 (3H, s, H-10), 3.34 
(1H, d, J = 13.5 Hz, H-11), 3.20 (1H, d, J = 13.5 Hz, H-11), 2.83 (1H, dd, J = 14.8, 8.6 
Hz, H-5) and 2.73 (1H, dd, J = 14.8, 4.5 Hz, H-5); δC (100 MHz, CDCl3): 204.0 (C=O), 
169.8 (C=O), 136.0 (Ar), 135.1 (Ar), 132.9 (C-8), 130.7 (Ar), 128.8 (Ar), 128.5 (Ar), 
128.4 (Ar), 127.4 (Ar), 127.3 (Ar), 126.8 (C-7), 78.1 (C-6), 68.7 (C-2), 63.8 (C-3), 52.5 
(C-10), 44.6 (C-5), and 36.7 (C-11); m/z (ESI+) 373 (M + Na)+. (Found 373.1401 (M + 
Na)+. C22H22NaO4 requires 373.1410).
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(3S*,6S*)-Methyl 3-benzyl-4-oxo-6-phenyltetrahydro-2H-pyran-3-carboxylate 
(331) 
 
Dihydropyran 264 (0.05 g, 0.21 mmol), L-Selectride® (0.22 mL, 0.22 mmol), benzyl 
bromide (0.51 mL, 4.30 mmol), THF (6.00 mL); purification (hexane – ethyl acetate = 4: 
1), percentage yielded 0.045 g, 65 % light yellow oil. υ max/cm-1 (film) 2948 (C-H), 2920 
(C-H), 1710 (C=O), 1207 (C-O), 1073 (C-O), 767 (Ar), 702 (Ar), 597 (Ar); δH  (400 MHz, 
CDCl3): δ 7.41‒7.24 (10H, m, H-10, H-7), 4.89 (1H, dd, J = 10.0, 3.9 Hz, H-6), 4.13 (1H, 
d, J = 12.4 Hz, H-2ax), 4.10 (1H, d, J = 12.4 Hz, H-2eq), 3.76 (3H, s, H-8), 3.40 (1H, d, 
J = 13.4 Hz, H-9), 3.33 (1H, d, J = 13.4 Hz, H-9), 2.96 (1H, dd, J = 15.1, 10.0 Hz, H-5) 
and 2.78 (1H, dd, J = 15.1, 3.9 Hz, H-5); δC (100 MHz, CDCl3): 203.9 (C=O), 169.7 
(C=O), 140.1 (Ar), 135.0 (Ar), 130.8 (Ar), 128.9 (Ar), 128.6 (Ar), 128.5 (Ar), 127.3 (Ar), 
126.0 (Ar), 80.0 (C-6), 69.1 (C-2), 63.9 (C-3), 52.4 (C-8), 46.0 (C-5) and 37.0 (C-9); m/z 
(ESI+) 347 (M + Na)+. (Found 347.1252 (M + Na)+. C20H20NaO4 requires 347.1254).
  
 
 
(3S*,6R*)-Methyl 3-benzyl-4-oxo-6-propyltetrahydro-2H-pyran-3-carboxylate 
(334) 
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Dihydropyran 263 (0.05 g, 0.25 mmol), L-Selectride® (0.25 mL, 0.25 mmol), benzyl 
bromide (0.59 mL, 5.04 mmol), THF (5.00 mL); purification (hexane – ethyl acetate = 4: 
1), percentage yielded 0.045 g, 62 % light yellow oil. υ max/cm-1 (film) 2956 (C-H), 2932 
(C-H), 2872 (C-H), 1734 (C=O), 1711 (C=O), 1262 (C-O), 1206 (C-O), 1077 (C-O), 1016 
(C-O), 702 (Ar); δH  (400 MHz, CDCl3): δ 7.27‒7.20 (5H, m, H-12), 3.99 (1H, d, J = 12.2 
Hz, H-2ax), 3.94 (1H, d, J = 12.2 Hz, H-2eq), 3.81 (1H, m, H-6), 3.70 (3H, s, H-10), 3.31 
(1H, d, J = 13.4 Hz, H-11), 3.21 (1H, d, J = 13.4 Hz, H-11), 2.56 (1H, dd, J = 15.0, 9.8 
Hz, H-5), 2.48 (1H, dd, J = 15.0, 3.8 Hz, H-5), 1.58‒1.37 (4H, m, H-7, H-8) and 0.95 
(3H, t, J = 7.16 Hz, H-9); δC (100 MHz, CDCl3): 204.7 (C=O), 169.8 (C=O), 135.2 (Ar), 
130.7 (Ar), 128.5 (Ar), 127.7 (Ar), 78.4 (C-6), 69.0 (C-2), 63.9 (C-3), 52.3 (C-10), 44.9 
(C-5), 37.7 (C-7), 36.8 (C-11), 18.3 (C-8) and 14.0 (C-9); m/z (ESI+) 313 (M + Na)+. 
(Found 313.1416 (M + Na)+. C17H22NaO4 requires 313.1410).
  
 
(3S*,6S*)-mMthyl 3-benzyl-6-(furan-2-yl)-4-oxotetrahydro-2H-pyran-3-
carboxylate (335) 
  
Dihydropyran 259 (0.10 g, 0.45 mmol), L-Selectride® (0.45 mL, 0.45 mmol), benzyl 
bromide (1.07 mL, 9.00 mmol), THF (11.00 mL); purification (hexane – ethyl acetate = 
4: 1), percentage yield 0.060 g, 40 % light yellow oil. υ max/cm-1 (film) 2951 (C-H), 2920 
(C-H), 2845 (C-H), 1714 (C=O), 1227 (C-O), 1207 (C-O), 1069 (C-O), 741 (Ar), 701 
(C=C); δH  (400 MHz, CDCl3): δ 7.40 (1H, m, H-7), 7.28‒7.16 (5H, m, H-12), 6.32 (2H, 
m, H-8, H-9), 5.13 (1H, dd, J = 11.8, 5.7 Hz,  H-6), 4.68 (1H, dd, J = 11.8, 2.8 Hz, H-6 
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minor), 4.63 (1H, d, J = 12.0 Hz, H-2ax minor), 4.15 (1H, d, J = 12.0 Hz, H-2ax), 3.71 
(1H, d, J = 12.0 Hz, H-2eq), 3.70 (3H, s, H-10), 3.57 (1H, d, J = 12.0 Hz, H-2eq minor), 
3.31 (1H, d, J = 13.0 Hz, H-11), 3.07 (1H, d, J = 13.0 Hz, H-11), 3.11 (1H, dd, J = 15.0, 
11.8 Hz, H-5), 2.99 (1H, dd, J = 15.0, 5.7 Hz, H-5) and 2.76 (1H, dd, J = 14.4, 2.8 Hz, 
H-5 minor); δC (100 MHz, CDCl3): 202.9 (C=O), 169.4 (C=O), 151.6 (C-13), 143.5 (C-
7), 135.3 (Ar), 130.4 (Ar), 128.7 (Ar), 127.2 (Ar), 110.4 (C-8), 109.7 (C-9), 74.1 (C-6 
minor), 73.0 (C-2 minor), 71.9 (C-6), 68.3 (C-2), 63.6 (C-3), 52.4 (C-10), 44.9 (C-5 
minor), 42.4 (C-5) and 36.6 (C-11); m/z (ESI+) 337 (M + Na)+. (Found 337.1045 (M + 
Na)+. C18H18NaO5 requires 337.1046).
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Abbreviations  
Å  Ångstrom  
a.u.  atomic units  
acac   acetylacetonate  
BHT   butylated hydroxy toluene (2,6-di-t-butyl-4-methylphenol)  
BINOL  1,1'-bi-2-naphthol  
Boc   t-butyloxycarbonyl  
brsm   based on recovered starting material  
Bz   benzoyl  
cdk4   cycline-dependent kinase 4  
CSA   camphorsulfonic acid  
Cy   cyclohexyl  
Cp   cyclopentadienyl  
d   day  
DBU   1,8-diazabicyclo[5.4.0]undec-7-ene  
DCM  dichloromethane  
DDQ  2,3-dichloro-5,6-dicyano-1,4-benzoquinone  
DET   diethyl tartrate  
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DFT   density functional theory  
DHA  docosahexaenoic acid  
DHP dihydropyran 
DIBAL  diisobutylaluminum hydride  
DIPEA  diisopropylethylamine  
DMAP   4-dimethylaminopyridine  
DME  dimethyl ether  
DMF  dimethylformamide  
DMP  Dess-Martin periodinane  
DMSO  dimethysulfoxide  
DNA   deoxyribonucleic acid  
ESI  electrospray ionization  
eV  electronvolt  
FDA  US Food and Drug Administration  
hr   hour  
HG II   Hoveyda-Grubbs 2nd generation catalyst  
HMDS   hexamethyldisilazide  
HMPA   hexamethylphosphoramide  
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HOMO  highest occupied molecular orbital  
HRMS   high resolution mass spectrometry  
Hz   hertz  
Ipc isopinocampheyl  
i-Pr   isopropyl  
IR   infrared spectroscopy  
IUPAC  International Union of Pure and Applied Chemistry  
J   coupling constant (Hz)  
kg  kilogram  
kJ   kilojoule  
LDA  lithium diisopropylamide  
LUMO  lowest unoccupied molecular orbital  
M  molar  
m-CPBA   meta-chloroperoxybenzoic acid  
Mes   mesityl (2,4,6-trimethylphenyl)  
Ms   mesyl (methanesulfonyl)  
MHz   megahertz  
MMFF94   Merck Molecular Force Field '94  
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MOM   methoxymethyl  
MS   mass spectrometry  
NBS  N-bromosuccinimide  
NCI   National Cancer Institute  
nM   nanomolar  
NMO   N-methylmorpholine-N-oxide  
NMR   nuclear magnetic resonance spectroscopy  
NOE   nuclear Overhauser effect  
PCC   pyridinium chlorochromate  
Piv   pivaloyl  
PMB   p-methoxybenzyl  
py   pyridine  
RNA   ribonucleic acid  
RT  room temperature  
TBAF   tetra-n-butylammonium fluoride  
TBDPS   t-butyldiphenylsilyl  
TBHP   t-butylhydroperoxide  
TBS   t-butyldimethylsilyl  
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tBu   tert-butyl  
TES   triethylsilyl  
Tf   Tf triflate  
TFA   trifluoroacetic acid  
THF   tetrahydrofuran  
THP   tetrahydropyran  
TIPS   triisopropylsilyl  
TPS   triphenylsilyl  
TLC   thin layer chromatography  
TMEDA  N,N,N',N'-tetramethylethylenediamine  
TMS   tetramethylsilyl  
Tol   p-tolyl  
TPS  triphenylsilyl  
Ts  tosyl  
TS   transition state  
ν   vibration frequency (cm-1)  
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